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Abstract 
The aim of this PhD was to develop and optimise an analytical method that 
incorporated zeta potential measurements within tunable resistive pulse sensing 
(TRPS) for biosensing. Modern society is dependent upon the accurate and rapid 
quantification of biological analytes within solution (biological or environmental) and 
on materials (clothing, skin, food). If the characterisation of particles within biological 
samples such as blood, plasma and serum is done simply by optical methods such as 
light scattering or microscopy, the various particulates and molecules, many of which 
are similar in size may not be able to be identified. TRPS is a label-free, non-optical 
based technique that can complete size, concentration, and more recently aided by 
the work in this thesis, zeta potential measurements in real time. Zeta potential could 
be a powerful analytical tool, as it is relative to the charge on an analyte and can be 
measured by monitoring the velocities of analytes as they traverse a nanopore in an 
electric field. Monitoring translocation velocities through the pore and thus zeta 
potentials could allow for an extra signal to help characterise analytes. 
Following a literature review in chapter 1 which focuses on the use of nanoparticles 
and their characterisation within bioassays, a general theory chapter (chapter 2) 
covers common theory and experimental setup used throughout the research. Chapter 
3 contains theory specific to zeta potential measurements using TRPS developed with 
an industrial sponsor to which chapter 4 is the application of this theory. It contains 
details on applying the method of inferring zeta potential from particle velocities to 
measure the change in zeta potential of nanoparticles as their surfaces are 
functionalised with DNA of varying packing density, length, structure, and hybridisation 
times to also determine the sensitivity of the method. As described the zeta potential 
is determined via the particle velocities as they traverse a pore that are determined 
from the signal produced using a TRPS measurement, a blockade. The blockade gives 
information on the particle velocities at relative positions within the pore as well as 
information on the size and charge of the particle. 
TRPS is an evolving analytical platform that can differentiate samples of similar and 
the same size by their charge in a range of electrolyte solutions. This is important for 
whole blood and biological samples, for example, as there will always be other 
biomolecules or contaminants present, of  similar size  that may not  be  the target of 
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interest. A large part of this PhD was the incorporation of DNA aptamers onto 
nanoparticles as recognition elements to a specific target. They were of particular 
interest as aptamers are ssDNA (single-stranded DNA) strands of high affinity and 
specificity to a target analyte. Nanoparticles can be functionalised with DNA aptamers 
or proteins as a means to capture a target analyte. TRPS was used to monitor the 
binding of DNA aptamers to their target proteins, aided by zeta potential 
measurements. The results showed that a smaller zeta potential value was observed 
when a target protein was bound to the aptamer-modified particles. 
As well as protein detection and quantification, a new assay using nanoparticles as 
‘tags’ was investigated, chapter 5. TRPS was used to monitor controlled particle 
aggregation in the presence of target bioparticles mimicking a streptavidin-biotin assay 
at first. It was found that when two differently sized particles, one functionalised with 
biotin and the other streptavidin (70 nm and 115 nm at a 10:1 ratio), the particles in 
excess saturated the larger particles resulting in a large change in size and zeta 
potential that could be monitored using the tunable pores. 
This method was then applied to nanoparticles in complex biological media, including 
plasma, serum, and biological buffers used to suspend bacteriophage samples, two 
examples are given in the thesis; the first in chapter 5 and second in chapter 7. In 
chapter 5, as well as sub 150 nm particles, bacteriophages of similar sizes were 
investigated to test the technique to biologically relevant particles. State of the art 
methods of counting bacteriophage via optical techniques have proven difficult, or 
inconsistent. In preliminary work shown in chapter 6, the characterisation of phage 
samples in their respective media is demonstrated. TRPS has overcome some of 
these challenges and preliminary data has been obtained for the size and charge 
characteristics of different phage types including Salmonella phage and coliphage. 
The study has also progressed to the size and concentration analysis of Clostridium 
difficile phage that has gained interest in recent decades due to their uses in 
therapeutics. 
As an alternative to nanoparticle based assays, the pores themselves were modified 
with DNA aptamers, see chapter 6, for direct detection of a target analyte without the 
need for a particle ‘label’. Pore surface modifications have been completed to enable 
pores  to  be  easily  functionalised  with  DNA  and  this  work  has  enabled  current 
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rectification properties of conically shaped pores to be explored. Limits of detection for 
DNA-modified pores were found to be similar to that of a particle-based assay (5 pM 
and 18 pM, respectively) but the particle assays are more versatile and may be used 
in future for multiplexing experiments. 
Finally, in chapter 7, the technique and methodology were able to monitor changes in 
the behaviour of nanoparticles as they were immersed in protein rich solutions, to 
mimic an in vivo environment. Here the protein corona around the nanoparticles was 
investigated as a function of temperature (25oC and 37oC). The kinetics and binding 
mechanism of high and low affinity proteins forming a protein corona could be 
monitored in real time as well as displacement reactions between various proteins, 
showing the advantages of TRPS technology. 
In summary, from working with a commercial partner and collaborating with other 
institutions, we have delivered 4 papers (plus one JoVE paper) including a review of 
applications of TRPS technology and work detailed in this thesis, presented at 14 
conferences and user meetings, and facilitated the development and implementation 
of zeta potential into bioassays. 
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1 Literature Review 
 
1.1 Introduction 
Nano and micron-sized particles in bioassays have seen an increase in use within 
both research and diagnostic laboratories especially in recent years, see figure 1.1. 
 
 
Figure 1.1 - The frequency of papers relating to detection and quantification of proteins, DNA and 
nanoparticles in the last 6+ years. 
 
Nanotechnology in biological and medical applications has allowed for rapid 
advancements in real-time particle analysis1–5. Rapid and effective nanoparticle 
characterisation relative to size, shape, and surface charge, for example, would help 
gain valuable knowledge on a variety of biological processes and biologically relevant 
particles. 
Particle detection and characterisation is important in many applications of science 
and technology and earlier literature describes the use of flow cytometry6–8 and light 
scattering techniques9–11. For example, dynamic light scattering (otherwise known as 
photon correlation spectroscopy) measures the diffusivity of small particles 
undergoing Brownian motion9. More novel approaches to particle detection, 
quantification,  and  characterisation  incorporate  nanotechnology  using  nanopore 
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sensors and resistive pulse sensing (RPS)12–16 that is based on a Coulter counter 
technology, which allows for colloidal characterisation of nanoparticle-based systems. 
The ideal particle/molecule detection and characterisation method should enable 
direct analysis of entities in their natural environment without the need for radio or 
fluorescent labels at high resolution and sensitivity. This can be a challenge in 
bioscience as biological media, blood, and/or protein rich solutions are complex 
matrices for particle analysis and cause hindrances to the majority of techniques 
readily available. Whilst many sensor platforms, and nanoparticles that are used for 
bioassay we will focus on magnetic particles due to the advantages described below. 
1.2 Magnetic Nanoparticles in Bioassays 
A common particle chosen to facilitate sample handling either via purification or 
preconcentration are superparamagnetic particles (SPPs). These have attracted a lot 
of interest in advancing particle-based assays for drug delivery17–20 and biosensing 
applications21–24. SPPs are commonly used as nanomaterials that can be surface- 
modified and are particularly favoured due to the ease of purification for the resulting 
samples. The main advantage of SPPs is the simple and rapid removal of specific 
analytes from complex sample matrices using nothing more than an external magnetic 
field or a hand held magnet22,25–28. This is particularly useful in biological samples such 
as blood, plasma, urine and biological media as these are the more likely of samples 
to contain several particles and molecules amongst a given sample population as well 
as the particles of interest. Modification of nanoparticles with biological molecules and 
organic ligands is becoming more popular using the nanoparticles themselves as a 
‘label’ in particle-based assay systems24,29–33. 
 
Analysing samples without the need for purification or isolation is preferred when 
studying chemically rich environments (enriched waste plants) or protein rich 
environments (the human body) to get an idea of sample behaviour in natural complex 
environments. To account for this, various work has been carried out to analyse 
protein ‘coronas’ that are formed as a result of contact with nanoparticles34–39. The 
particle surface does impact these effects and previous work has been carried out 
using silica and carboxylated nanoparticles34–37,39–43. Understanding the behaviour 
and  characteristics  of  the  nanoparticles  with  and  without  surface  modification is 
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important for particle analysis in monitoring the effects of the target analytes 
themselves as a result. 
 
One set of powerful techniques for the characterisation of SPP-target interaction are 
optomagnetic methods. These are extremely sensitive and quick in characterising and 
detecting biological molecules using a small sample volume incorporating magnetic 
particles. An example of an optomagnetic set up is displayed in figure 1.244. 
 
 
Figure 1.2 - Optomagnetic set up for a nanoparticle-based assay, figure reproduced from Ranzoni et al44. 
A collimated laser is focused at the centre of four magnets, and the light scattered at an approximate 30o 
angle toward the photodetector44. 
 
SPPs emit different light scattering effects based on different surface properties and 
size. Park et al. introduced a rotating external field (Hex) to superparamagnetic beads 
and established that at a constant Hex, the amplitude of light transmittance increased 
when longer superparamagnetic bead chains were present10. The recorded amplitude 
was correlated with analyte concentration, displaying that an increased concentration 
resulted in bead aggregation. Light scattering techniques can characterise particle 
colloids and aggregates45,46. The light scattering intensity of particles can be reduced 
because of intra-aggregate interference and frictional resistance causing aggregates 
to appear a smaller size than they actually are47. 
1.3 Particle Surface Modifications 
Modifying a nanoparticle’s surface can alter its interactions with analytes in solution 
and therefore have inherent effects on particle velocity in an electric field, zeta 
potential  and  surface  charge.  DNA,  RNA,  proteins,  antigens,  and  cells  are  all 
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examples of entities that can be bound onto a particle’s surface48 (see figure 1.3) 
through a variety of methods including streptavidin-biotin interactions and EDC (N-(3- 
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride) crosslinking chemistry49, 
for example. 
 
 
Figure 1.3 – Example surface modifications and optional functionalities that can be adhered to a 
nanoparticle surface for analyte detection and characterisation. 
 
Aggregation assays, measured via light scattering have been detected and thus 
binding capabilities of select targets monitored using magnetic separation techniques. 
This was shown in a one hour DNA affinity magnetic separation producing a product 
of higher purity than from simply using traditional chromatographic procedures50. 
Functionalising SPP surfaces has also led to advancements in DNA sequencing, 
proteins such as streptavidin has allowed for solid phase sequencing of DNA51, 52, for 
example. 
Medical research is currently being carried out with the use of gold nanoparticles and 
quantum dots to specifically detect and target cancer tumours53, and silica 
nanoparticles to allow for drug delivery to cancer cells only54. Nanoparticles are not 
only extremely useful in diagnostics, they are also used in electronic mechanisms, 
packaging and wastewater treatment55, and biosensors. Biosensor technologies have 
advanced in recent decades with the use of nanomaterials to reduce the time and 
resources required between sampling and obtaining a result. Nanoparticle  synthesis 
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has more recently developed so that intentional adaptations can not only be made to 
their size and shape, but also their compositions. 
The immobilisation of nucleic acids (RNA/DNA) onto particle surfaces has an impact 
on the particle’s behaviour in an electrolyte solution, taking into account factors such 
as the electrical double layer surrounding the particle and subsequently these ion- 
based interactions33. Functionalising nucleic acids onto a surface has been a widely 
used technique leading to interesting findings in genomics and biosensing56–58. They 
are becoming extremely useful for investigating fundamental properties of charged 
polymer chains and modelling their behaviour at solid-liquid interfaces59. Relative to 
this, DNA aptamers are becoming particularly useful in monitoring DNA-protein and 
DNA-DNA interactions32,33,60. Aptamers are single-stranded DNA or RNA molecules 
that bind to a target analyte with high affinity and specificity. They are robust structures 
that allow for a specific target (even at low concentration in a complex mixture) to be 
detected, isolated and thus characterised. 
Although a range of polymer coatings can be assembled onto colloidal particles, the 
polymers that form a spherical effect on the particle are of particular interest61–63. 
Spherical brush polyelectrolytes are bound to the particle by one end and the other 
left free standing64, like with conjugated DNA strands. Immobilising oligonucleotides 
onto surfaces is a key design to many technologies within DNA sequencing65,66, DNA- 
protein interactions67,68, biosensing30,32,69 and targeted drug delivery20,70,71. The 
functionalisation of DNA onto nanoparticle surfaces is now a common practice, and 
within the field of biosensors alone the number of strategies for immobilisation, type of 
nanomaterial, and detection platform are varied enough to fill several reviews3,22,72–76. 
As well as DNA, nanoparticles and various other nanomaterials can be modified with 
other biological molecules such as proteins and bacteria, and organic molecules for 
biomedical77–79  and environmental80 applications. 
1.4 Particle Detection and Characterisation Techniques 
 
1.4.1 Optical Techniques 
 
1.4.1.1 Dynamic Light Scattering (DLS) and PALS 
Optical particle analysis can be carried out using the high throughput technique of 
dynamic light scattering, otherwise known as photon correlation spectroscopy9,81–83. 
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Although this technique is high throughput, temperature control is required to maintain 
a consistent particle diffusion rate relative to their size9,82. DLS is limited in comparison 
to some of the other modern analysis tools as multimodal solutions become a 
challenge as larger particles will dominate the signal produced84, leaving some of 
smaller particles completely unnoticed. DLS is an averaging based technique85 and is 
therefore not as efficient, but is capable of measuring a number of particles of any 
shape as long as an appropriate capture probe (antibody or aptamer) is present for 
the particular analyte. 
Dynamic light scattering has been used with gold nanoparticles to detect the influenza 
A virus. The virus was detected via a specific influenza A antibody as a capture probe 
conjugated to gold nanoparticles, followed by DLS85. The DLS monitored and 
measured the aggregation effects of the labelled nanoparticles. The mean (as DLS is 
an averaging based technique) hydrodynamic diameter was relative to the 
concentration of the target virus85 and hence the analyte was quantified successfully 
within the gold nanoparticle assay. 
Phase analysis light scattering (PALS)86 is similar to DLS in respect to them both being 
averaging techniques and will only report values based on the mean of a whole sample 
population. This is of course not as useful in studying complex mixtures with a range 
of particulates that could be present in a single sample. 
1.4.1.2 Flow Cytometry 
Flow cytometry is a laser based technique used in diagnostics and has evolved in 
recent years to feature magnetic immunoassays8,87. In the last decade, micro flow 
cytometry has been employed to analyse fluorescent-labelled cells and investigate 
protein binding properties. Figure 1.4 displays the various steps carried out for the 
detection of virus-bound magnetic particles. (a) shows mixing the biological samples 
with the magnetic particles, (b) illustrates purification of the target viruses through 
washing, (c) is the capture of antibodies onto the magnetic particles conjugated with 
specifically developed antibodies, (d) shows the purification of the developed 
antibodies, (e) is the fluorescent detection of the analyte as the magnetic particles 
pass through the optical detection region (photo multiplier tube), and (f) displays 
magnetic particle sorting with the use of microvalves87. 
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Figure 1.4 - Schematic representation of integrated microfluidic chips and the use of virus-bound 
magnetic particles. (a) biological sample and magnetic beads mixing, (b) purification of virus bound 
magnetic particles via washing steps, (c) capture of custom developed antibodies onto the virus bound 
magnetic particles, (d) purification of magnetic particles bound to custom developed antibodies and 
excess custom developed antibodies, (e) fluorescent detection of the virus analyte as the particles pass 
through a photo multiplier tube, and (f) magnetic particle sorting using microvalves. Figure reproduced 
from Yang et al87. 
 
1.4.1.3 Nanoparticle Tracking Analysis (NTA) 
An emerging optical technique for particle detection is nanoparticle tracking analysis 
(NTA). This technique gathers data from real-time particle-by-particle analysis by 
measuring the particle diffusion coefficients using a finely focused laser beam through 
a prism2. Nanoparticle tracking has been found to be useful for applications such as 
drug delivery and protein aggregate analysis. Fluorescent labelling can be 
incorporated into NTA to allow for complex, impure samples, such as micro and 
nanovesicles to be analysed2. NTA could be used to identify smaller biomolecules as 
it has been found to visualise and analyse particles ranging from 30 nm to 1000 nm88. 
Although small particle analysis can be achieved, the particle concentration that can 
be analysed is limited to 107-109 particles/mL88. 
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1.4.2 Pore-based Technologies 
In nanopore systems, two types of pores can be investigated, synthetic and biological. 
Biological pores are made up of proteins and peptides and have been utilised in 
studying different properties of water89, 90 as well as nanoelectronics, medicine and 
sensing. In biotechnology, the characterisation of DNA and RNA can be accomplished 
via natural pores as well as cell tumour targets activating multimeric pores to kill the 
appropriate cells91. The delivery of therapeutic molecules via a plasma membrane is 
a challenging aspect of biological advancement but can be overcome by biological 
pores both in vivo and in vitro92, 93. These investigations have also been analysed in 
cancer therapies where nanoparticles have been used as vectors. Synthetic pores, 
with a polyurethane membrane are more established in these fields as they are more 
durable and can have higher resolutions to individual proteins and bases94. Biological 
pores however, have been known to have a better controlled geometry and chemical 
structure that can be identified at atomic precision95. 
Tunable pores have recently been incorporated into RPS technologies (TRPS)15 and 
are more widely used than fixed sized pores because having a fixed sized pore allows 
less versatility as the particles being analysed are restricted to being a certain size. 
Tunable pores of varying sizes have been incorporated in scanning ion occlusion 
spectroscopy (SIOS)96 in order to detect and differentiate particles of different sizes. 
Individual particles can be distinguished from a sample containing a mixture of 
nanoparticles using real-time scanning of the pore conductivity. Demonstrations of 
distinguishing individual particles through SIOS was observed through DNA-modified 
particles displaying a longer blockade duration97. A variety of other surface modified 
particles have also been analysed using tunable pores98. The main advantage of using 
a tunable pore is the ability to explore multimodal particle size systems97, 99 over light 
scattering techniques that focus more on colloidal particles. 
1.4.2.1 Resistive Pulse Sensing (RPS) 
Small particle analysis has been recently executed through resistive pulse sensing 
using a pore sensor. Synthetic pores are effective tools in small particle analysis and 
have been incorporated into emerging technologies, such as resistive pulse sensing. 
This is a key area of nanotechnology to be explored that is extremely beneficial for 
diagnostic and biomedical fields. Vogel et al. successfully detected and sized a virion 
70-95 nm in diameter, producing highly reproducible data in agreement with both 
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optical methods and TEM12. Resistive pulse sensing is an effective particle detection 
and characterisation technique that consists of an electric field being applied to a 
sample, and monitoring the transportation of particles through a synthetic or biological 
nanopore. Polyurethane membrane based pores are the more readily established as 
they have increased durability and have a higher resolution to individual proteins and 
bases94. 
When an electrical field is applied, the buffer solution (i.e. phosphate buffered saline, 
PBS) is always conductive and a baseline current is observed. A blockade (pulse) in 
the baseline is observed as a particle passes through the nanopore and therefore 
displaces the buffer solution. The blockade magnitude is relative to particle size and 
can be optimised for size and charge analysis through a series of parameters. These 
include the pore stretch, applied voltage, and external pressures/vacuums that may 
be introduced. The parameters can be altered to aid in monitoring the electrical and 
convective movements of particles through the pore, refining the analytical result 
obtained. The pore stretch can be altered due to the elastomeric membranes within 
the pore and can be used many times and reversibly modified to a range of micro and 
nano-sized geometries. 
Aggregation effects can be monitored using resistive pulse sensing methods by 
monitoring the blockade magnitude. For example, if an aggregate of two particles is 
observed, the blockade magnitude will be double that of an individual particle passing 
through. This observation is accountable for dimers, trimers and other sized particle 
aggregates. The aggregates that form are dependent on the binding sites available on 
the analyte. 
Pressure can also be introduced to the pore and increases the particle rate through 
the pore and is therefore relative to the blockade rate. The background current is also 
dependent on the pore size, the larger the pore size, the higher the background 
current97. The particle size is determined from a current vs time relationship. The pulse 
frequency is equivalent to the bead concentration. 
1.4.2.2 Tunable Resistive Pulse Sensing (TRPS) 
A more recent adaptation of resistive pulse sensing is the incorporation of an 
elastomeric tunable pores to create the renowned technology of tunable resistive pulse 
sensing   (TRPS)15,100,101.   The   elastomeric  membranes  used   to   create  tunable 
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nanopores can be used many times and can be reversibly altered to a range of micro 
and nano-sized geometries. Blockages can occur in the pore and are most commonly 
due to impurities, aggregation, or surface adhesion. These blockages are removed by 
increasing the membrane stretch to allow possible aggregates or larger particles to 
pass through, or by applying pressure to force the oversized particles through15. 
Although there are a few minor difficulties with blockages in the pore at times, resistive 
pulse sensing is a technique with some of the highest resolution recorded in the 
detection of multiple particle sizes in a mixture. This was discussed by Anderson et al. 
comparing the technique to dynamic light scattering and other light scattering based 
techniques84. There is negligible bias towards any sized particles using tunable 
resistive pulse sensing (TRPS), unlike in dynamic light scattering techniques. 
TRPS technology has been utilised to analyse size and charge characteristics of 
micron and nano-sized particles. TRPS is currently the only technique that can 
simultaneously measure size and charge in a single measurement33,102. The Izon 
qNano (Izon Science Ltd) is a portable instrument used to detect, quantify, and 
characterise individual particles via TRPS. The device can efficiently determine 
particle size and concentration from a small sample volume (40 μl) when calibrated 
with a known standard. The technology is label-free with respect to fluorophores 
gaining advantages over immunodiffusion techniques and ELISA particle analysis. 
The qNano completes real-time particle-by-particle size and charge analysis rapidly. 
Another advantage of TRPS via the qNano is background noise is reduced by placing 
a Faraday cage over the upper fluid cell. 
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Figure 1.5 – a) Izon qNano instrument, b) a schematic of sample particles translocating a pore membrane 
as a result of an applied electric field, and c) an example of the blockades produced as TRPS outputs that 
can be used to determine the size, concentration, velocity and charge of a sample. 
 
Size, concentration, velocity, and zeta potential measurements can be completed 
simultaneously using TRPS technology. Charge measurements using zeta potential 
are a vital addition to nanoparticle analysis when investigating analytes of similar, if 
not the same, sizes. These measurements can also be used to monitor DNA 
interactions to a target analyte effectively12,32,103, as DNA binding to an analyte can 
result in conformational or physical property changes of the DNA itself or the target 
analyte. 
1.5 Charge Analysis and Zeta Potential Measurements 
In depth charge analysis of nano and micron-sized particles has become increasingly 
popular over the last decade providing data for a wide variety of applications, including 
nanomedicine and diagnostics. Charged particles have been found to be of great use 
to medical sciences, particularly towards cancer therapeutics104,105. 
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The charge characteristics of a particle set are studied through the use of a measured 
zeta potential and can be obtained from the Izon qNano13,33,102,106. Zeta potential, ζ, is 
defined as the electrostatic potential at the plane of shear between the particle- 
associated and the stationary part of the ionic double layer107. 
The compact layer is also known as the Stern layer, which contains strongly bound 
charged particles to the surface, see figure 1.6. Zeta potential is mathematically 
defined  through  the  Smoluchowski  approach107,108,  𝜁𝜁  = 𝜂𝜂µ  ,  where  η  is  dynamic 
є 
viscosity of the fluid, µ is the electrophoretic mobility and є is the dielectric constant of 
the electrolyte solution. The zeta potential is relative to surface charge of particles in 
suspension. A larger zeta potential value is exhibited from particles with excellent 
electrical stability. 
 
 
Figure 1.6 - Schematic illustrating the electrical double layer surrounding a nanoparticle suspended in an 
electrolyte solution. The zeta potential can be defined as the electrical potential at the slip/shear plane. 
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The first calculations of zeta potential were completed by manually extrapolating plots 
using Ferguson analysis109,110 and applying the data to Henry’s equation111. The vast 
majority of zeta potentials have been calculated using light scattering techniques such 
as dynamic light scattering and electrophoretic light scattering (DLS and ELS, 
respectively)112–116. Pore-based methods, whether it be pyramidal pores117 or conical 
pores13,33,102,118. Calculating the zeta potential from tunable resistive pulse sensing 
allows for the combination of small particle analysis with charge analysis. 
1.6 Current Rectification using Nanopores 
Current rectification properties have been investigated for a variety of pore shapes, 
sizes, and materials. A range of materials have been used to create synthetic including 
graphene119–122, polymers97, and silicon nitride123, but it is glass124–127 and polymer- 
based128–130 pores where more prominent studies have been carried out. The vast 
majority of the studies have been completed using conically shaped pores128–131. 
Current rectification effects are largely influenced by the charges of pore walls and as 
such modifying pore surfaces will have inherent effects on the current rectification 
effects produced. It is important to understand these changes to increase the level of 
certainty that it is the detection of a target analyte being monitored and not that of a 
change to the pore surface by a ligand or DNA capture probe, for example. Polymeric 
conical nanopores are particularly useful for understanding these effects as they have 
been reported as successful ion-current rectifiers132–134 with mechanisms reported for 
quartz materials135 that have been applied to polymeric nanopores at this stage. It has 
previously been difficult to process a mechanism for polymeric conical pores based on 
the level of uncertainty present for the vague data available for the chemistry and 
charge of polymer-based membranes. 
Current rectification studies are being investigated to monitor the effects of ions 
surrounding the pore surface and the effects of particle flux through charged pore 
systems. The molarity of electrolyte being used in each study is an important 
consideration in this research as this will inevitably change the ion concentration and 
thus current rectification effects observed. The effects are pH dependent and 
electrolyte concentration dependent136,137. The current effects are stronger at low 
electrolyte molarities 
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1.7 Challenges: Viruses and Bacteriophage 
Particles of sizes sub 150/100 nm can be a challenge for many nanoparticle 
characterisation techniques, hence why emerging technologies such as pore-based 
technologies are a great benefit to biomedicine and nanotechnology. These analytical 
technologies are allowing for further research to be carried out, specifically 
investigating bacteria, viruses, and bacteriophages. A wider variation of pathogenic 
targets is being established forcing the need for additional technologies to be 
created138–140. 
Viruses are small infectious particles that are considered to be detrimental to living 
organisms through their abilities to cause disease. Viruses and virions (virus particles, 
VPs) have robust structures as the viral nucleic acids are encapsulated in a protein 
shell, known as a capsid. VPs are self-assembled protein structures with a relatively 
identical, if not completely identical, structure to their resident virus141. Bacteriophages 
are made up of proteins encapsulating a genome and are considered viruses that 
infect and thus replicate within a bacterium. There is much interest in analysing and 
characterising viruses and phage samples, but they can be significantly smaller than 
whole bacteria/cells so optical and microscopic analysis has proven difficult. The 
ability to effectively analyse small biologically relevant molecules will allow for valuable 
knowledge that would contribute greatly to vaccine and drug delivery system 
developments. Bacteriophage are of particular interest as they are gaining interest as 
possible alternatives and improvements for antimicrobial treatments142,143. 
Traditional detection methods include transmission electron microscopy (TEM)144,145, 
as well as fluorescent and non-fluorescent protein assays146–148. Analytical tools for 
the detection and characterisation of biomolecules such as viruses are constantly 
being developed and improved. Popular virus detection methods for single viruses are 
electrical measurement methods that use nanowire field transistors149. Microfluidics 
has been used to deliver the virus sample to the nanowire array allowing for selective 
virus sensing, and the electrical measurements giving results relating to the surface 
charge of the analyte and conductance changes149. The more modern approaches to 
virus detection and quantification include flow cytometry, enzyme-linked 
immunosorbent assay (ELISA)150, dynamic light scattering (DLS)9, electrochemical 
methods   (electrophoretic   titration   curves151),   resistive   pulse   sensing (RPS)152 
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including tunable resistive pulse sensing (TRPS)12, and the most commonly carried 
out technique being variants of the polymerase chain reaction (PCR)153,154. Other 
modern nanoparticle detection approaches and characterisation methods include flow 
cytometry155, nanoparticle tracking analysis (NTA)88 and TRPS, however, the 
selectivity and sensitivity levels do vary. Dynamic light scattering, for example, is an 
averaging based technique and isn't as effective as particle-by-particle TRPS analysis. 
A great advantage of TRPS technology is that it is a non-colour based technique that 
doesn't require a fluorophore or enzyme detection molecule. Tunable resistive pulse 
sensing displays the most versatility and can determine charge characteristics of a 
small particle through zeta potential measurements, as well as particle size and 
concentration determination. Although nanoparticle tracking analysis is also showing 
some versatility in its measurements, some parameters (such as particle 
concentration) are limited and some NTA measurements could take up to an hour. 
This is significantly longer than a TRPS measurement on the Izon qNano that can be 
completed in minutes. 
Previously, phage concentrations have been determined using plaque assays, a 
technique widely used to isolate phages156, and reverse transcription PCR157. As per 
section 1.2.2, magnetic particle-based assays functionalised with specific capture 
probes have also been used to detect phage contamination158 through an 
electrochemical detection method using electric chips159. In this example, the capture 
probe bound to the particle is selective of specific phage genes/DNA and an assay 
time as low as 25 minutes could detect DNA-phage binding that was a result of phage 
infection and this study was expanded to multiplex detection158. There are currently 
no techniques that can complete concentration measurements alongside activity 
analysis of phage. Currently, techniques such as flow cytometry, epi-fluorescence, 
electron microscopy, and plaque assays are combined to relay information on a given 
sample116. 
1.8 Conclusions 
Of the particle detection technologies discussed, tunable resistive pulse sensing is the 
most versatile of all techniques as it can distinguish between multimodal particles in a 
complex mixture97,99 and does not incur any bias towards different sized particles. 
Other  techniques  such  as  dynamic  light  scattering  and  various  immunoassay 
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techniques are sufficient for particle characterisation but not always as selective or 
sensitive. Synthetic tunable pores allow for complete control over which particle size 
and shape can pass through as well as producing accurate and reliable data quickly. 
The pores are very stable and cost-effective to analyse a number of particle mixtures 
and samples repeatedly. The pores can be modified using simple cross linking 
chemistries and current rectification properties can thus be exploited. TRPS also 
discards the need for a colorimetric analysis as it does not require fluorophores, 
enzymes, or radioactive labels, lowering the toxicity risk when carrying out the 
analysis. The radio-labelled immunoassays have a particular disadvantage as there is 
the problem with radioactive waste being produced. Resistive pulse sensing is a 
simple and cost effective method to quantify proteins and DNA if the appropriate 
particle surface chemistry is established. 
The main advancements in recent decades have evolved from the extended use of 
magnetic beads and surface modification of nanoparticles. Manipulation of their sizes 
and shape is very practical and has allowed for greater sensitivities and selectivity, in 
comparison to more conventional analytical methods. The advancements that have 
been made over recent years are definitely encouraging and have already had an 
impact on biomedical analysis and nanoparticle bioassays. Development in refining 
particle detection and characterisation methods is however, still needed. Tunable 
resistive pulse sensing can simultaneously complete zeta potential, concentration and 
size measurements of a multimodal sample containing dispersed particles. In the last 
few years, combining magnetic beads with TRPS has become an impressive emerging 
field15,100. This combination allows for effective and more accurate particle 
characterisation in relation to particle size, surface charge, and aggregation properties. 
Modifying a particle’s surface chemistry and functionality in relation to biomolecules 
enables characterisation of both the surface functional groups and charge. Further 
work in this field will broaden the applications for current technologies, such as tunable 
resistive pulse sensing. 
Challenges continue to lie with particles and molecules on the smaller end of the 
nanoscale (sub 100 nm) including viruses, cells, and bacteriophages. There are no 
current technologies that can quantify and monitor the activity of small pathogenic 
targets. TRPS is an advancing biosensing method with the potential to help resolve 
some aspects of these current challenges for biomedical analysis. There is still the 
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need for further progress and optimisation of current particle detection and 
characterisation techniques to develop an elevated analytical platform for the detection 
of the more challenging target analytes. 
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2 Theory 
 
2.1 Introduction 
This section aims to give an insight into the common theory used throughout the thesis. 
It will define the theory of the technique used within all of the subsequent studies 
described (tunable resistive pulse sensing) including a background to conically shaped 
pores, theory of behaviours and transport of particles, biomolecules, and other 
examples, as well as a brief introduction of zeta potential relative to particle surface 
charge. 
2.2 Tunable Resistive Pulse Sensing 
Resistive pulse sensing, RPS, can be used to determine size, concentration and 
charge characteristics of particles in an electrolyte solution1–8. Tunable resisitive pulse 
sensing (TRPS) incorporates a tunable, synthetic pore membrane1 allowing for 
versatility in the particle size ranges that can be analysed and is therefore more 
favourable for determining the sizes of an unknown particle set. These elastomeric 
membranes can be used many times and can be reversibly altered to fit a range of 
nano and micron-sized geometries. TRPS utilises the tunable pore as a biosensor and 
uses the portable Izon qNano instrument to complete rapid, real-time measurements 
and particle-by-particle analysis. The qNano instrument setup is shown in figure 2.1. 
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Figure 2.1 - Image of the TRPS electrochemical cell. a) Lower fluid cell that holds 80 µL electrolyte 
solution, b) Polyurethane nanopore membrane placed on jaws and stretched appropriately for analysis, 
c) Upper fluid cell that holds 40 µL solution, d) Faraday cage placed over the fluid cell to reduce 
background electrical noise. 
 
The instrumentation consists of two electrodes and although the qNano is susceptible 
to background electrical noise, this is reduced by a Faraday cage that is placed over 
the upper fluid cell (figure 2.1d). TRPS can complete particle-by-particle analysis of 
complex mixtures and solutions. The technology enables accurate monitoring of a 
particle’s electrophoretic mobility, as well as particle characteristics such as particle 
size and surface charge2,3,5,9–11. 
The electrolyte buffer solution is placed in an upper and lower fluid cells (40 µl and 80 
µL, respectively, were used for all studies described in this thesis) and when an 
external electric field is applied through the two Ag/AgCl electrodes, a baseline current 
is observed. This current is dependent on the pore size, applied potential and ionic 
strength of the electrolyte12 and is shown through equation 2.1 describing Ohm’s law 
and equation 2.1a12. 
 
𝐼𝐼  = 𝑉𝑉 
𝑅𝑅  
Where 𝑅𝑅  =  4𝐿𝐿𝜌𝜌 
𝜋𝜋𝐷𝐷𝑙𝑙𝐷𝐷𝑆𝑆 
(2.1) 
 
(2.1a) 
a) b) 
c) d) 
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When a particle approaches the pore, there is a significant increase in resistance 
observed and as a particle translocates the pore membrane, it displaces the electrolyte 
solution and creates a blockade (pulse) in the baseline current as shown in figure 2.2. 
The properties of the blockade itself can be used to determine the characteristics of 
the passing particle and are defined in figure 2.2. 
 
 
Figure 2.2 - Baseline current and example blockade event present when an electric field is applied and 
when a particle translocates the nanopore. 
 
The magnitude of the blockade, Δip, is the size (volume) of the analyte, FWHM (full 
width half maximum) is the particle translocation time through the nanopore, and the 
blockade frequency is relative to the particle concentration (particles/mL). The 
blockade magnitude is relative to the electrolyte resistivity, ρ, particle diameter, d, and 
pore diameter, D, as shown in equation 2.28,13. 
𝛥𝛥𝑖𝑖𝑝𝑝  = (4𝜌𝜌𝑑𝑑3)/(𝜋𝜋𝐷𝐷4) (2.2) 
 
The TRPS system has an inherent pressure head of approximately 50 Pa due to the 
40 μL of liquid in the upper fluid cell3. An external pressure difference can also be 
introduced across the pore; applying a positive pressure increases the fluid flow from 
the upper fluid cell to the lower fluid cell and therefore increases the particle rate3. An 
external pressure is applied using the variable pressure module (VPM) as an 
accessory to the qNano, see figure 2.3. 
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Figure 2.3 - An example of the variable pressure module (VPM) accessory seen left in the figure partnered 
with the Izon qNano instrument. 
 
The VPM uses a pressure scale of mm and cm where applying 1 cm of positive 
pressure is equivalent to 100 Pa. Introducing a vacuum, or negative pressure, slows 
the flow of liquid through the pore, therefore slowing the particle speeds and can 
even induce a reversed translocation effect back up through the pore in the opposite 
direction and can also be applied externally using the VPM. If a particle passes 
through the pore in the opposite direction, a reversed blockade would be observed. 
An example of a reversed blockade is shown in figure 2.4. 
 
 
Figure 2.4 - An example of a reversed blockade event caused by a particle translocating the nanopore in 
the opposite direction. 
 
Blockages can occur in the pore and are most commonly due to impurities, 
aggregation, or surface adhesion. These blockages are removed by increasing the 
membrane stretch to allow possible aggregates or larger particles to pass through, or 
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by applying pressure to force the oversized particles through3,14. Although there are a 
few minor difficulties with blockages in the pore at times, resistive pulse sensing is a 
technique with some of the highest resolution recorded in the detection of multiple 
particle sizes in a mixture. This was discussed by Anderson et al., comparing the 
technique to dynamic light scattering and other light scattering based techniques15. 
There is negligible bias towards any sized particles using tunable resistive pulse 
sensing (TRPS), unlike in dynamic light scattering techniques. 
2.2.1 TRPS Setup 
All measurements were conducted using the qNano (Izon Science Ltd, NZ) combining 
tunable nanopores with proprietary data capture and analysis software, Izon Control 
Suite. The lower fluid cell always contained the electrolyte buffer (80 µL). The upper 
fluid cell always contained 40 µL of sample (that was suspended in the electrolyte) 
when a measurement was being completed with an inherent pressure on the system 
(47 Pa). The nanopore is placed laterally onto 4 jaws with the pore ID number facing 
up (as described in chapter 2, section 1) and is situated between the upper and lower 
fluid cells. Prior to TRPS analysis, most samples were vortexed and sonicated. During 
each sample run, the system was washed by placing electrolyte buffer (40 µL) into the 
upper fluid cell several times with various pressures applied to ensure there were no 
residual particles remaining and therefore no cross contamination between samples. 
A detailed description of such a tunable resistive pulse sensing device can be found 
in Willmott et al.16  and Vogel et al2. 
2.2.2 Calibration Method for Zeta Potential Measurements 
The nanopore chosen for each study is dependent on the size of the sample particles 
being analysed as well as the size of the calibration particles; the most appropriate 
pore to use will be of a size range that can measure both the calibration and sample 
particles. The different size ranges for each nanopore size provided by Izon Science 
Ltd (NZ) are detailed in table 2.1. 
62  
Nanopore Analysis Size Range (nm) 
NP80 40-255 
NP100 50-330 
NP150 70-420 
NP200 85-500 
NP250 110-630 
NP300 150-900 
NP400 185-1100 
NP600 270-1570 
NP800 385-2050 
NP1000 490-2900 
NP2000 935-5700 
NP4000 1990-11300 
Table 2.1 – Description of analysis size ranges of each nanopore ID supplied by Izon Science Ltd. 
 
The calibration particles are measured at 3 applied voltages that are dependent on the 
applied stretch and consequent baseline current observed. Each sample 
measurement should be performed using a baseline current of 100+ nA, to allow us to 
compare data sets across several runs and pores. To account for variation in the pore 
size from the manufacturing process, the stretch and voltage were adjusted to achieve 
a similar baseline current for each experiment. As well as matching the baseline 
current each sample blockade signal was greater than 0.05 nA, compared to a 
background noise of circa 10 pA. Finally, when performing an experiment a calibration 
was performed on particles of known size and zeta potential. For the purpose of 
measuring and comparing zeta potential, it was imperative that the stretch of the 
nanopore and the applied potential were not changed during a sample or calibration 
measurement of a particular dataset. The sample measurements were all completed 
at the highest or second highest voltage that the calibration measurements were 
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𝑆𝑆  
carried out at. Calibration measurements were completed on each new day analysis 
was completed and when a new nanopore was introduced. 
An external applied pressure can be used with the calibration and sample 
measurements to allow for more dilute/less concentrated samples or samples 
containing a complex mixture of particles (with a potentially wide range of zeta 
potential values, including negative, neutral, and positively charged particles). A 
minimum of two applied pressures are applied at the highest voltage at which the 
calibration particles were measured. 
2.3 Theory of Transport 
The theory of transport of particles through a nanopore depends on a number of 
factors, including external influences, such as an electric field and pressure, nanopore 
geometry, and particle behaviour in an electrolyte solution3. Particle flux is determined 
from Nernst-Planck theory that defines electrophoretic forces, electroosmotic flow, and 
pressure driven flow as contributions towards particle flux, J17. J is also relative to the 
particle concentration, Cs, as well as the velocity of the translocating particle, 𝜈𝜈𝑃𝑃, 
resulting in equation 2.313. 
𝐽𝐽 = 𝐶𝐶𝑠𝑠×𝜈𝜈𝑃𝑃 (2.3) 
 
The magnitude of other forces present, such as electrophoresis and electroosmosis 
means any diffusion contributions can be ignored at this point13. 𝜈𝜈𝑃𝑃 is defined in 
equation 2.43,5. 
 
𝜈𝜈   = 𝑄𝑄 𝜀𝜀𝜁𝜁𝑝𝑝𝑎𝑎𝑟𝑟𝑡𝑡𝑖𝑖𝑐𝑐𝑙𝑙𝑒𝑒 𝜀𝜀𝜁𝜁𝑝𝑝𝑜𝑜𝑟𝑟𝑒𝑒 + 𝐸𝐸 − 𝐸𝐸   𝑃𝑃 𝐷𝐷𝑆𝑆  2 𝜂𝜂 𝜂𝜂 
𝜋𝜋(  2 )  
Where; 𝑄𝑄  =     3𝜋𝜋𝐷𝐷3∆𝑃𝑃 (2.4a) 128𝜂𝜂( 𝐿𝐿 ) 
𝐷𝐷𝐿𝐿−𝐷𝐷𝑆𝑆  
ε is the medium permittivity and η kinematic viscosity, ΔP is the pressure across the 
pore, ζpore and ζparticle are the zeta potentials of the channel pore and particle 
respectively, E is the applied electric field, L is the pore length, and DS and DL are the 
diameters of the entry (small) and exit (large) openings of the pore respectively. 
Combining equations 2.1 and 2.2, where O is the cross-sectional area of the pore, and 
Qp is the pressure driven flow as defined in equation 2.4a17, leads to equation 2.5. 
(2.4) 
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𝐽𝐽 (𝜁𝜁𝑝𝑝𝑎𝑎𝑟𝑟𝑡𝑡𝑖𝑖𝑐𝑐𝑙𝑙𝑒𝑒−𝜁𝜁𝑝𝑝𝑜𝑜𝑟𝑟𝑒𝑒) 𝑄𝑄𝑝𝑝 = 𝜀𝜀 𝐸𝐸 + (2.5) 
𝐶𝐶𝑠𝑠 𝜂𝜂 𝑂𝑂  
When there is no pressure applied across the system, electrophoresis dominates over 
electroosmosis16. Particle mobility in electrophoretic transport only, μ, is defined by 
equation 2.616. 
 
𝜇𝜇 =  𝑞𝑞𝐷𝐷 𝑘𝑘𝐵𝐵𝑇𝑇 (2.6) 
 
The particle velocity is a total of the following velocities; fluidic, 𝜈𝜈𝐹𝐹 , electrophoretic, 𝜈𝜈𝐸𝐸𝑃𝑃, 
and electroosmotic, 𝜈𝜈𝐸𝐸𝑂𝑂 , as well as diffusion, D, shown in equation 2.713. The effect of 
each force on a particle is shown in figure 2.5. 
 
𝜈𝜈𝑃𝑃  = 𝜈𝜈𝐹𝐹  + 𝜈𝜈𝐸𝐸𝑃𝑃  + 𝜈𝜈𝐸𝐸𝑂𝑂  + 𝐷𝐷 (2.7) 
 
 
 
Figure 2.5 - Representation of the three forces acting on a particle as it translocates the nanopore that 
result in total particle velocity. 
 
Figure 2.5 shows the effect each force has on a particle as it translocates the pore 
membrane. Fluidic and electrophoretic forces have a more dominant effect on the 
particle velocity than the electroosmotic forces in a conical pore system, with 
electrophoresis being the most dominant factor16. 
2.3.1 Electroosmosis 
A counter-charge present in an electrolyte solution compensates a particle’s surface 
charge and an ion flow occurs as a result of an applied potential or electric field. The 
ion  flow  will  also  be  influenced  by  the  net  charge  of  the  pore  membrane. 
Electroosmotic velocity (vEO) 
Fluidic/convective velocity (vF) 
Electrophoretic velocity (vEP) 
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Electroosmotic velocity, 𝜈𝜈𝐸𝐸𝑂𝑂 , is defined in equation 2.818 and electroosmotic flux, 𝐽𝐽𝐸𝐸𝑂𝑂 , 
is defined in equation 2.918, where 𝜀𝜀𝜀𝜀0  is the molar permittivity of solution. 
 
𝜈𝜈𝐸𝐸𝑂𝑂  𝜀𝜀𝜀𝜀0𝐸𝐸𝜁𝜁𝑝𝑝𝑎𝑎𝑟𝑟𝑡𝑡𝑖𝑖𝑐𝑐𝑙𝑙𝑒𝑒 = 𝜂𝜂  (2.8) 
 
𝐽𝐽𝐸𝐸𝑂𝑂   =  𝜈𝜈𝐸𝐸𝑂𝑂 𝑂𝑂 (2.9) 
 
2.3.2 Electrophoretic Mobility 
The electrophoretic mobility of a particle is the movement of a particle through solution 
with the influence of an applied electric field. The movement of a charged particle 
through solution can be hindered by a dragging effect caused by the interference of 
counterions in solution that are moving in the opposite direction to the charged particle 
itself causing a resistance to the particle’s movement (see figure 2.5 for an example 
of counterions in solution surrounding a particle). This reduces the speed of the 
particles in electrolyte solution and results in electrophoretic retardation. 
Electrophoretic retardation can be observed when a small particle incorporates a thick 
double layer that results in a large influence on the movement of the small particle18. 
A thin double layer surrounding a large particle will have a lesser effect on the mobility 
of the particle itself18. 
The Helmholtz-Smoluchowski equation (equation 2.1013,19) defines electrophoretic 
mobility, UEP, when taking electrophoretic retardation into account. 
 
 
 
2.4 Particle Stability 
𝑈𝑈𝐸𝐸𝑃𝑃  𝜀𝜀𝜀𝜀0𝜁𝜁𝑝𝑝𝑎𝑎𝑟𝑟𝑡𝑡𝑖𝑖𝑐𝑐𝑙𝑙𝑒𝑒 = 𝜂𝜂 (2.10) 
A particle’s stability is a key factor to its mobility through a pore and is affected by 
particle size and surface properties. Derjagun, Landau, Verwey and Overbeek 
introduced DLVO theory describing the interactions that cause coagulation in a colloid 
system. If there is a potential energy barrier larger than the average kinetic energy of 
the particles, the system is considered stable20. When colliding particles have sufficient 
energy to overcome this barrier, the system becomes less stable and aggregation can 
occur. The rate of coagulation is slowed by a “stability ratio”, denoted VT, the total 
energy of particles interacting and is the sum of VA and VR. VA is the sum of the Van 
der Waals attractive forces, and VR  is the sum of the electrostatic repulsive forces  of 
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the double layer20. From this information, it can be expected that smaller particles 
undergo flocculation more rapidly than larger particles and are therefore less stable in 
solution. 
Both steric and electrostatic repulsion affect colloidal stability. The electrostatic forces 
acting on each particle are determined from the charge distribution of the particle. The 
more even the charge distribution in the electrical double layer, the stronger the 
electrostatic forces. Steric repulsive forces however, arise from any polymers that 
adsorb onto the particle surfaces. The larger the polymer, the more steric hindrance 
there is that prevent Van der Waals forces causing coagulation. 
The zeta potential describes the stability of a colloidal system as it is related to those 
particular repulsive forces, VR, depicted in equation 2.1120, in the double layer. ε is the 
medium permittivity, a is the particle radius, ζ is zeta potential, κ is the Debye length, 
and h is the particle separation. 
𝑉𝑉𝑅𝑅    = 2𝜋𝜋𝜀𝜀𝑎𝑎𝜁𝜁2 ln(1 + 𝑒𝑒−𝜅𝜅ℎ) (2.11) 
 
2.5 Zeta Potential 
For charge stabilised particles, a typical measurement used to represent the surface 
charge, and infer stability, is zeta potential. The zeta potential represents the value of 
the electrostatic potential at the plane of shear of a colloidal system (figure 2.6) and 
typically for nanoparticle systems, zeta potential values of ±30 mV are representative 
of stabilised particles21,22. A smaller zeta potential value is observed when the particles 
in suspension are less stable and flocculating more rapidly. Therefore, a larger zeta 
potential value indicates excellent electrical stability in an electrolyte solution. 
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Figure 2.6 - A schematic definition of zeta potential and the electrical double layer surrounding a particle 
in an electrolyte solution including the effect of high (red) and low (green) ionic strengths. The electrical 
potential at the slip/shear plane defines the zeta potential. 
 
Figure 2.6 shows the effect of ionic strength on zeta potential, a high ionic strength 
results in an increased concentration of counterions that compresses the diffuse 
double layer thus increasing the electrokinetic/electrical potential gradient as a 
function of distance from the particle’s surface, reducing the zeta potential (red curve, 
figure 2.6). A low ionic strength however, will decrease the counterion concentration 
that allows for the diffuse double layer to become extended and thus decreasing the 
electrokinetic/electrical potential gradient as a function of distance from the particle’s 
surface, resulting in a larger zeta potential and Is indicated by the green curve in figure 
2.6. 
The Smoluchowski approach defining zeta potential is displayed in equation 2.1223; 
 
𝜁𝜁𝑝𝑝𝑎𝑎𝑟𝑟𝑡𝑡𝑖𝑖𝑐𝑐𝑙𝑙𝑒𝑒 = 𝜂𝜂µ є (2.12) 
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The Smoluchowski approach supports that a particle’s zeta potential can be 
determined from a particle’s velocity taking into account convective and electroosmotic 
forces, as well as the electrophoretic mobility of the particle. In TRPS, the translocation 
speeds of particles in solution can infer their electrophoretic mobilities through the pore 
due to the attraction to the oppositely charged electrode in the TRPS system. 
Zeta potential measurements can be extracted from the electrophoretic information in 
a given sample. Translocation mobility, µtr, is defined in equation 2.1324. 
 
𝜇𝜇𝑡𝑡𝑟𝑟 = 𝛿𝛿𝛿𝜈𝜈 𝜕𝜕𝐸𝐸𝛿 (2.13) 
 
Where 𝜈𝜈𝛿  = 𝑙𝑙𝑠𝑠  
𝑡𝑡𝑡𝑡𝑟𝑟 and 𝐸𝐸𝛿 = 𝑉𝑉  , representing the average velocity and average electric field 𝑙𝑙𝑒𝑒 
applied. ls and le are the length of the sensing zone and the length the applied voltage 
drops24, ttr is the translocation duration and V is the applied voltage. ls=le in most cases 
as the voltage drops over the sensing zone. 
Following Smoluchowkski’s approximation, translocation mobility can be defined as 
follows; 
 
𝜇𝜇𝑡𝑡𝑟𝑟 = 𝜀𝜀𝜀𝜀0𝜁𝜁 𝜂𝜂 (2.14) 
 
A combination of equation 2.1424, the average translocation velocity, the applied 
voltage, and zeta potential results in equation 2.1524. 
 
𝜈𝜈𝛿  = 𝑙𝑙 ( 1 ), 𝜇𝜇 
 
𝛿𝛿(  1 ) = 𝑙𝑙2      𝑡𝑡𝑡𝑡𝑟𝑟   , 𝑡𝑡 = 𝜂𝜂𝑙𝑙  (2.15) 
𝑡𝑡𝑡𝑡𝑟𝑟 𝑡𝑡𝑟𝑟 𝛿𝛿𝑉𝑉 𝑡𝑡𝑟𝑟  (𝑉𝑉+𝐵𝐵)𝜁𝜁𝜀𝜀𝜀𝜀0  
And therefore zeta potential can be determined by combining equations 2.12-2.15; 
 
𝜁𝜁  = 𝜂𝜂𝑙𝑙 2 𝛿𝛿(  1 ) 𝑡𝑡𝑡𝑡𝑟𝑟 𝛿𝛿(  1 ) = 𝐴𝐴   𝑡𝑡𝑡𝑡𝑟𝑟   (2.16) 𝜀𝜀𝜀𝜀0 𝛿𝛿𝑉𝑉 𝛿𝛿𝑉𝑉  
Where B is an integration constant that is the voltage offset (although is generally an 
𝛿𝛿(  1 ) 
unknown parameter that can vary between experiments.   𝑡𝑡𝑡𝑡𝑟𝑟     can be easily measured 
𝛿𝛿𝑉𝑉 
as the applied voltage and translocation duration are known, 𝜂𝜂𝑙𝑙 
𝜀𝜀𝜀𝜀0 however, includes 
parameters that are more difficult to calculate exactly. From equation 2.1624, the 
following equation can be extracted; 
2 
2 
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𝐴𝐴 = 𝜂𝜂𝑙𝑙 𝜀𝜀𝜀𝜀0 2.17) 
 
From equation 2.1724, A can be calculated from the calibration experiments run with 
particles of a known zeta potential. The zeta potential of a sample set can then be 
calculated exactly using equation 2.16 as the applied voltage and translocation 
duration can be obtained from the TRPS output. 
2.6 Effect of Surface Modifications on Surface Charge 
Polyelectrolyte brushes, such as DNA have been previously studied as surface 
modifications and it has been found that if the outer region of the brushes is open to 
any extent, the electroosmotic flow may have an influence and change the measured 
charge of the brush (the zeta potential may appear lower)25. Spherical brush 
polyelectrolytes include DNA strands that are bound to the particle surface by one end, 
leaving the other free standing into solution26. It has been found that increasing the 
ionic strength causes the brushes to collapse due to electrostatic attractions26. If a 
thinner, denser layer is surrounding the particle, the hydrodynamic resistance of the 
brush coated particle is reduced26. 
 
When using nanomaterials in bioassays, the material must remain suspended in the 
solution for it to capture the analyte. A particle’s surface chemistry design is important 
to avoid sedimentation of irreversible aggregation; there are two mechanisms 
available to prevent this. First is the use of steric stabilisation by placing a neutral 
polymer onto the particle surface, and the second depends upon charge stabilisation 
whereby the repulsive coulombic forces overcome the attractive Van der Waals forces, 
as described previously18,27. 
 
When a polyelectrolyte, such as DNA, is immobilised onto the surface of the 
nanomaterials the DNA can take on two roles. The first is the more natural of the two 
as a capture probe, designed to hybridise to target DNA. The second is a passive role 
where the inherent charge on the phosphate back bone can act as a stabiliser by 
creating a high charge density on the particle surfaces, helping suspend them in 
solution28 
2 
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2.7 Ionic Effects of Conical Pores 
The surface charge of the pore walls is important as it can affect the translocation 
events of nanomaterials as they traverse small pores and thus the pore material/pore 
coating material can be of interest. Such effects could manifest themselves as 
changes in ionic current, and become current rectifiers. Conical pores will typically 
exhibit this effect to a larger extent based on the pore opening diameter being 
equivalent to the electrical double layer thickness29,30 and when the pore walls are 
negative in charge. 
Conventionally, the preferential direction of the flow of cations, for a negatively 
charged pore, is observed to be from the small pore opening to the larger pore opening 
in a conical pore setup30. When the pore walls are negative in charge a smaller ionic 
current is observed at positive potentials and a larger current is observed at negative 
potentials and is due to mainly cations being able to enter a pore, whereas anions are 
often rejected31. Opposite effects are seen when the pore walls are positively and 
indicated that current rectification effects originate from electrostatic interactions 
between ions traversing the pore and the pore walls30. 
The current flow through a conical pore has two contributing factors; the 
electroosmotic flow across the pore surface and migration of ions through the centre. 
For a negatively charged pore and a positive potential, the small pore opening will 
have the highest concentration of cations and thus anions are more likely to be 
rejected, the cations are thus transferring from a region of high cation concentration to 
a region of lower cation concentration and will give smaller current values. When a 
negative potential is applied to the pore, the cations will transfer from a low 
concentration region to a higher concentrated region resulting in a higher 
concentration of ions in the transition region causing a larger (more negative) ion 
current30,32. 
The effects of ionic strength and pH on current rectification are particularly important 
as these have direct implications on the cation/anion concentration throughout the 
pore and the pore wall surface charge, respectively. As you increase the ionic strength 
of the electrolyte, you increase the concentration of cations at the pore opening and 
throughout the pore system and thus a more prominent ion transfer process, albeit at 
positive or negative potentials30. The lower the ion concentration amongst the pore, 
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the smaller the recorded ionic currents, an increased number of ions would result in a 
more ohmic current-voltage response33. 
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3 Zeta Potential Measurements via Tunable 
Resistive Pulse Sensing 
3.1 Introduction 
This chapter will provide the theory for the calculation of zeta potential using tunable 
resistive pulse sensing (TRPS). Zeta potential is a measure of surface charge and can 
give information on the charge effects of a sample in solution. This theory was 
developed in collaboration with Dr Robert Vogel (Izon Science Ltd) and was derived 
using a large series of example experiments and respective data analysis tools. The 
experiments were conducted by myself to help in the development of the method and 
applying it to real samples and assays. 
3.2 Aims and Objectives 
The aim of this chapter is to describe the current theory used to determine zeta 
potential that can be verified using tunable resistive pulse sensing technology. The 
electrokinetic and convective velocity effects are used to calculate zeta potential as a 
function of applied voltage and pressure. 
3.3 Theory 
Zeta potential measurements can be completed using tunable resistive pulse sensing 
technology and provides information on the charge of a sample. The zeta potential 
represents the value of the electrostatic potential as the plane of shear of a colloidal 
system (see chapter 2). The method for determining zeta potential is similar to that by 
Arjmandi et al.1 who describes a calibration based method using resistive pulse 
sensing to measure particle zeta potentials. We adapt the method by considering the 
effect of pressure on the system as this is important in completing zeta potential 
measurements. 
This method is based on measuring the duration of the translocation of particles 
through a nanopore as a function of applied voltage, V, with particle velocities and the 
electric field being averaged over the entire sensing zone of a regular conical pore, I. 
The electric field, E, can be determined using the calculation of pore resistance, so 
that the electric field is entirely parallel to the z-axis (see equation 3.1) 
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𝐸𝐸  (𝑧𝑧) =  −𝐼𝐼 ∗ 𝑑𝑑𝑅𝑅 (3.1) 𝑧𝑧 0  𝑑𝑑𝑧𝑧  
Where Ez, I0, and R being the electric field component along the pore axis (z), 
electric current, and resistance, respectively2. For a voltage, V0, of 0.5 V, a small 
pore opening diameter of 0.8 µm, a large pore opening diameter of 40 µm, and a 
membrane thickness of 250 µm, the maximum electric field is approximately 105 
V/m. The above pore dimensions are estimates, which are in accordance with SEM 
images of pores with similar dimensions to the ones used for some of our studies 
(the example pore in this case is an NP200) done in conjunction with Dr Robert 
Vogel. The electrophoretic mobility is the derivative of 1/T (with T being the signal 
duration) and voltage, V, multiplied by the square of the sensing zone length, l. l is 
a fitting parameter that is included in a calibration constant, which is calculated 
using a calibration particle with known zeta potential. Convection and 
electroosmosis have been neglected for being much smaller than the 
electrophoretic contribution to particle motion. Finally, Henry’s equation is used to 
relate the particle zeta potentials with the measured electrophoretic mobility of 
single particles3. 
The method in conjunction with TRPS technology follows a related approach and is 
described in Blundell et al.,4 where the effects of electroosmosis and convection 
(through an applied pressure) are considered in addition to electrophoresis when 
determining the zeta potential of single particles. An external applied pressure, 
additional to the inherent pressure on the system, may be required for samples of low 
concentration or those containing particles with a wide range of zeta potentials in order 
to capture the whole spectrum of particle zeta potentials in a potentially complex 
sample. Also, without any net pressure, most neutral particles may not translocate the 
pore and hence may not be measured that may result in a skewed set of final results 
from a given sample population. 
The average velocities and electric fields are recorded at multiple points through the 
sensing zone (as opposed to the entrance, exit, or middle of the sensing zone) as 
shown in figure 3.1b. 
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Figure 3.1 – a) Blockade events produced as particles traverse the pore and the resulting blockade shape 
that depicts Δip and FWHM. b) Examples of blockade reference points within each blockade that indicate  
a particle’s position within the pore at any given time. 1/T1.0 represents the time at which the blockade is 
100% magnitude of dRmax. T0.30 and T0.60 are the times at which the blockade is at 30% and 60% of dRmax, 
and are equivalent to positions I0.30 and I0.60. c) A plot of 1/T (/ms) vs voltage (V) used within the  
calibration method to calculate each particle’s translocation time and thus zeta potential amongst a given 
sample population4. 
 
This method identifies the point of greatest resistance in the signal trace, otherwise 
known as maximum blockade magnitude. For each blockade/pulse recorded, the time 
at which the peak occurs is at 100% magnitude, dRmax, (relative to the baseline 
current), can be defined as T1.0. Figure 3.1b shows an example of 4 sections (out of 
the 14 recorded from T0.05 to T0.90) that represent the blockade magnitudes of 60%, 
50%, 40%, and 30% of dRmax and are relative to T0.60, T0.50, T0.40, and T0.30, 
respectively. These values also indicate various positions of particles within the pore 
at given times. When the proportional blockade magnitude is equal for any given 
particle (small or large), these particles are at equivalent positions within the pore, the 
respective positions are denoted as I0.60, I0.50, I0.40, and I0.30, respectively and are 
shown in figure 3.1b. 
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𝑥𝑥 𝑡𝑡𝑜𝑜𝑡𝑡 
𝑥𝑥 
𝑇𝑇 
𝑥𝑥 
𝑇𝑇 
𝑥𝑥  
𝑣𝑣 
𝑥𝑥 
𝑣𝑣 
𝑥𝑥 
The calibration process and zeta potential calculation can be summarised as follows; 
each pore is calibrated using calibration particles (carboxylated polystyrene particles) 
with a known average zeta potential. Using this calibration standard, the pore is 
calibrated by measuring the linear dependence of 1/Tx vs voltage, V. 1/Tx is averaged 
over at least 100 particles for x= 0.30, 0.35, 0.40, 0.45, 0.50, and 0.60. 1/Tix  is 
proportional to the time averaged total particle velocity, 𝑣𝑣𝑖𝑖 of particle i, with lx being 
the position within the pore reached after  𝑡𝑡  = 𝑇𝑇𝑖𝑖 . 
 
 
𝑖𝑖  𝑙𝑙𝑥𝑥  𝑖𝑖 ∫0   𝑥𝑥 𝑣𝑣𝑖𝑖(𝑡𝑡)𝑑𝑑𝑡𝑡  
𝑣𝑣𝑥𝑥𝑡𝑡𝑜𝑜𝑡𝑡  = 𝑇𝑇𝑖𝑖  = 𝑖𝑖 (3.2) 𝑥𝑥  
  1    = ∑𝑁𝑁 1   𝑇𝑇𝑖𝑖  (3.3) 
𝑇𝑇𝑥𝑥 𝑖𝑖=1  𝑁𝑁  
In the same way, 𝑣𝑣𝑥𝑥𝑡𝑡𝑜𝑜𝑡𝑡  is the average over N calibration particles: 
 
𝑣𝑣𝑥𝑥  𝑡𝑡𝑜𝑜𝑡𝑡 𝑁𝑁 𝑖𝑖=1 𝑖𝑖 𝑥𝑥 𝑡𝑡𝑜𝑜𝑡𝑡 /N (3.4) 
 
For the purpose of simplicity, the total velocity averaged over time and particle velocity, 
𝑣𝑣𝑥𝑥𝑡𝑡𝑜𝑜𝑡𝑡 is set equal to 1/Tx. The total particle velocity is the sum of electrokinetic and 
convective velocities: 
 
𝑣𝑣𝑥𝑥𝑡𝑡𝑜𝑜𝑡𝑡  = 𝑣𝑣𝑥𝑥𝑒𝑒𝑙𝑙  + 𝑣𝑣𝑥𝑥 𝑐𝑐𝑜𝑜𝑛𝑛 (3.5) 
 
Equation 3.4 applies for both single particle velocities and velocities averaged over 
many particles. The electrokinetic (electroosmotic and electrophoretic) velocity,  𝑣𝑣𝑥𝑥 𝑒𝑒𝑙𝑙, 
of the calibration particles is determined from the slope 𝑣𝑣𝑉𝑉  of the linear 1/Tx vs voltage 
curves. 
 
𝑉𝑉 
𝑥𝑥 𝐶𝐶𝑎𝑎𝑙𝑙 =  𝑣𝑣𝑥𝑥𝑒𝑒𝑙𝑙 /𝑉𝑉 (3.6) 
 
The electrokinetic velocity per unit voltage is equivalent to the electrokinetic mobility, 
which is the sum of electroosmotic and electrophoretic mobilities. The convective 
velocity of the calibration particles for each Tx is determined from the y-intercept of the 
linear 1/𝑇𝑇𝑥𝑥(≜ 𝑣𝑣𝑥𝑥 𝑡𝑡𝑜𝑜𝑡𝑡) vs voltage curves. The convective velocity per unit pressure is defined 
as 𝑣𝑣𝑃𝑃  and is calculated as follows; 
= ∑ 
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𝑣𝑣 
𝒙𝒙 𝑪𝑪𝒂𝒂𝒍𝒍 
𝑥𝑥 
𝑥𝑥 
𝑥𝑥  𝑥𝑥  
Sample 
𝑃𝑃 
𝑥𝑥 𝐶𝐶𝑎𝑎𝑙𝑙 =  𝑣𝑣𝑥𝑥𝑐𝑐𝑜𝑜𝑛𝑛 /𝑃𝑃 (3.7) 
 
A further iteration of the above calibration method includes the average convective 
velocity  per unit  pressure  of  the calibration particles, 𝒗𝒗𝑷𝑷 (equation  3.7) being 
calculated by measuring the slope of the linear 1/𝑇𝑇𝑥𝑥 (≜ 𝒗𝒗𝒙𝒙𝒕𝒕𝒐𝒐𝒕𝒕) vs pressure, P, curves. 
In these cases, the calibration particle 1/Tx and thus particle velocity values are 
measured at a minimum of two externally applied pressures. This method is applied 
to at least the highest voltage used in each study. 
 
From  this  the  electrokinetic  particle  velocities  of  sample,  (𝑣𝑣𝑖𝑖 )  𝑒𝑒𝑙𝑙 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒 ,  and 
calibration, (𝑣𝑣𝑥𝑥)𝑒𝑒𝑙𝑙 𝐶𝐶𝑎𝑎𝑙𝑙, are related with their zeta potentials, 𝜉𝜉𝑖𝑖 𝑛𝑛𝑒𝑒𝑡𝑡 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒 and 𝜉𝜉𝑛𝑛𝑒𝑒𝑡𝑡 𝐶𝐶𝑎𝑎𝑙𝑙 
(equation 3.8), assuming a linear relationship between velocity (mobility) and zeta 
potential as given in the Smoluchowski approximation5,6. 
 
 
 (𝑣𝑣𝑖𝑖 )𝑒𝑒𝑙𝑙 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒  = (𝑣𝑣𝑥𝑥)𝑒𝑒𝑙𝑙 𝐶𝐶𝑎𝑎𝑙𝑙 𝜉𝜉𝑖𝑖 𝑛𝑛𝑒𝑒𝑡𝑡 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒 𝜉𝜉𝑛𝑛𝑒𝑒𝑡𝑡 𝐶𝐶𝑎𝑎𝑙𝑙  (3.8) 
 
 
 
The net zeta potentials for both sample and calibration particles are the differences 
in the respective particle zeta potentials and the membrane zeta potential, 𝜉𝜉𝑚𝑚 
(equation 3.9). 
 
 
𝜉𝜉𝑝𝑝 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒    =   𝜉𝜉𝑛𝑛𝑒𝑒𝑡𝑡 𝑆𝑆𝑎𝑎𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒 +  𝜉𝜉𝑚𝑚 (3.9) 
 
 
The zeta potential of each sample particle i, ξi , is given by averaging respective 
zeta potential values, calculated at various locations within the pore (equation 3.10), 
with lx  being the position within the pore reached after time, t=Tx. Please note that 
lx  is set to equal 0 right at the narrow pore entrance of the conical pore, where the 
signal magnitude reaches its maximum, as shown in figure 3.2.1b. Zeta potentials 
are evaluated by taking the average at several discrete points, lx. 
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v 
T 
x T 
v , v 
x Cal and v 
∑x ξi ∑x(vi  Sample−vP Cal×𝑃𝑃)/(vVCal×𝑉𝑉) 
ξi =  x Sample = x x x ×ξ + ξ (3.10) Sample Σx Σx net Cal m   i xSample is  the  sum  of  the  time  averaged  electrokinetic  (electroosmotic  and 
electrophoretic) and convection velocity components of sample particulates at 
position lx  within the pore (equation 3.11). 
 i lx  i ∫0  x vi(t)dt  vxSample  = Ti  = i (3.11) x    V x Cal P x Cal , P, and V are electrokinetic velocity per unit voltage, convective velocity 
per unit pressure, applied pressure and voltage for the sample runs respectively. The 
electrokinetic velocity per unit voltage is equivalent to the electrokinetic mobility, which 
is  the  sum  of  electroosmotic  and  electrophoretic  mobility. vV P x Cal are 
calculated by averaging typically over more than 500 calibration particles. ξnet Cal and 
ξm are the zeta potentials of polystyrene standard particles and the membrane 
respectively. The zeta potentials of polystyrene standards and the thermoplastic 
polyurethane membrane can be verified using phase analysis light scattering (PALS) 
and streaming potential techniques, respectively. 
3.4 Summary 
This method describes how zeta potential is calculated using TRPS technology via 
particle electrokinetic and convective velocities as a function of applied voltage and 
pressure. A calibration based method is used here to establish the surface charge of 
the sample particles via their translocation velocities relative to a position in the pore 
at any given time. Calibration particles of known zeta potential are used to achieve the 
difference in particle zeta potential from that of the pore membrane to establish the 
charge effects of the pore walls itself. The determined zeta potential values are a key 
indication of particle surface charge that will be of great use to differentiate samples 
of a similar, if not the same size in a complex sample such as whole blood, 
plasma/serum, or samples in biological media. The theory was developed and tested 
using several rigorous experimental processes and verified using the tunable resistive 
pulse sensing technique. 
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4 Charge Analysis of DNA-Modified 
Nanoparticles 
4.1 Abstract 
Modifying a nanoparticle’s surface and altering their functionality is advantageous for 
protein, DNA, peptide, and small molecule detection, as well as other medical and 
environmental samples. Tunable resistive pulse sensing (TRPS) allows for the 
characterisation of the transport mechanism of both functionalised and unmodified 
nanoparticles as they traverse small pores. RPS systems are already proven to be 
useful in measuring size, concentration and zeta potential of analytes. This chapter 
focuses on utilising TRPS technology to monitor the translocation effects and thus zeta 
potential of nanoparticles with DNA-modified surfaces. Inferring zeta potential from the 
translocation durations of particles is detailed in chapter 2. This method can be applied 
to measure the change in zeta potential upon DNA functionalization of nanoparticles 
and the detection of a range of DNA targets. The parameters investigated as a function 
of zeta potential were as follows; packing density, length, structure, and hybridisation 
time. Each parameter attributed a difference in measured zeta potential for both mean 
values and population distributions as a function of DNA structure and relevant DNA 
binding mechanisms. The signal resolution was encouraging for ssDNA, dsDNA, and 
changes in base length as small as 15 nucleotides. A change in signal was also 
observed for what may appear to be small changes in DNA structure with respect to 
the range of DNA targets studied, including discrimination between partial and fully 
complementary target sequences. The results from the assays studied show great 
potential for the charge method and for application in diagnostic and environmental 
fields. 
4.2 Introduction 
TRPS is a recent adaptation of RPS, a Coulter counter based technology described in 
chapter 1 and 2. Immobilising DNA onto nanoparticle surfaces is important to consider 
when designing nanoparticle-based assays and are becoming increasingly popular, in 
particular for application in DNA-protein interactions1–3 and targeted drug delivery4–6. 
It is now common practice to functionalise nanoparticles with DNA in the biosensing 
field7–9     and   we   are   choosing   to   functionalise   DNA   onto   the   surface   of 
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superparamagnetic particles, allowing for rapid and simple purification steps to enable 
the successful removal of the target analyte. Charge analysis and zeta potential 
measurements can be used to infer the stability of a sample in solution. When DNA is 
immobilised onto the nanoparticle surface, the DNA can take on one of two roles, the 
first being the more natural as the immobilised DNA is treated as a capture probe 
designed to hybridise to target DNA. The second is the more passive role where the 
charge on the DNA due to the phosphate backbone acts as a stabiliser for the particles 
in solution due to the high charge density now on the particle’s surface, thus helping 
suspend them in solution10. 
The charge effects on the particle surface and thus the zeta potential can also differ 
depending on the DNA structure (i.e. single-stranded or double-stranded) based on 
the persistence length of the respective strand. As mentioned previously in chapter 2, 
the persistence length of double-stranded DNA is a 50-fold magnitude higher than that 
of single-stranded DNA, making it far more rigid and less flexible11,12. The mean zeta 
potential does not allow for a true measure of the polyelectrolyte distribution across 
each individual particle to be interpreted so to allow this the spread of a given sample 
population can be used. Investigating the distribution of zeta potential values amongst 
a given sample population means each individual zeta potential value has to be 
measured and a true insight into each sample. Measuring the zeta potential of each 
individual particle is challenging, however other electrophoretic and electrochemical 
techniques have allowed an insight into these measurements10,13 as previously 
discussed in chapter 1. TRPS can monitor particle translocation effects and carry out 
zeta potential measurements utilising its particle-by-particle nature. Particle-by- 
particle analysis allows for every sub population within a sample to be resolved, an 
advantage over ensemble techniques. 
Zeta potential is measured using a similar concept shown by Arjmandi et al. using 
pyramidal shaped pores14. It is a calibration based method that has been discussed in 
chapter 2, the zeta potential is measured based on signal durations of each blockade 
event as a function of applied voltage. The electrophoretic mobility is calculated from 
the particle velocity and applied electric field that can then be used to infer zeta 
potential using the Smoluchowski approach15. The zeta potential is independent of the 
blockade magnitude, making TRPS’ simultaneous size and charge measurements 
possible. 
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The Arjmandi theory14 is adapted applied to a calibration particle standard of known 
zeta potential and then move on to measuring relative changes in zeta potential as a 
function of immobilised DNA. This chapter describes how measured zeta potential is 
correlated to the DNA concentration and thus packing density. The higher the DNA 
concentration immobilised to the nanoparticle surface, the more uniform the zeta 
potential distribution showing uniform polyelectrolyte binding around the surface. The 
method has also been applied to investigating the effects of DNA length and the effect 
of dsDNA. Controlling the packing density on the particle surfaces and the mechanism 
to which the targets bind to the capture probe allows for the sensitivity of the technique 
to be investigated. The sensitivity of the TRPS instrument can allow for target DNA to 
be detected with hybridisation times under 30 minutes. Key to the assay design is the 
DNA length and positioning of the target DNA strand (via complementary sequences) 
to improve and optimise the signal produced. The method is impactful on designing 
nanoparticle based assays and shows the potential in zeta potential measurements 
on biological analytes, showing great advantages in bioassay fields. 
4.3 Aims and Objectives 
The main objective from this work is to determine the sensitivity and selectivity of DNA 
aptamers when functionalised to a nanoparticle’s surface. This is determined from the 
particle translocation velocities that can be translated into zeta potential values, as 
described in chapter 2. Further aims include investigating the effect of a range of DNA- 
modifications on a nanoparticle surface; including the effect of packing density, DNA 
length, DNA structure, and hybridisation time. This is particularly important when 
designing aptamer-based particle assays for future research. 
4.4 Materials and Methods 
 
4.4.1 Chemicals and Reagents 
 
4.4.1.1 Buffers 
The buffer used was PBST, phosphate buffered saline (PBS, 0.01 M phosphate buffer, 
0.0027 M potassium chloride, 0.137 M sodium chloride, pH 7.4) with Tween-20 as a 
surfactant (T, 0.05 (v/v) %) in 200 mL deionised water (18.2 MΩ cm). PBS tablets 
(P4417) and Tween-20 (P1379) were purchased from Sigma Aldrich, UK. 
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4.4.1.2 Particles and Particle Standards 
Streptavidin coated superparamagnetic particles (120 nm, 4352 pmol/mg binding 
capacity, product 03121, as detailed by the supplier) were purchased from Ademtech, 
France. Carboxylated polystyrene particles with a mean nominal diameter of 220 nm 
(CPC200s) were purchased from Bangs Laboratories, US. The specific surface charge 
as determined by the manufacturer was 86 µeq/g and equivalent to a surface charge 
density of 3.2 x 10-19 C/nm2. The CPC200s were measured at a concentration of 1 x 
1010 particles/mL for this study and were used as a particle standard for zeta potential 
measurements. Zeta potentials of CPC200 particles were determined using PALS 
analysis, as detailed in the appendices. 
4.4.1.3 Custom DNA Oligonucleotides 
All oligonucleotides used in this study were purchased as lyophilised powders (100 
pmol/µL) from Sigma Aldrich, UK with customised DNA sequences fit for purpose as 
detailed in table 4.1. Please note the abbreviation [Btn] is relative to a biotin 
modification that was added to the 3’ end of the oligonucleotide, when required. The 
CP abbreviation is to describe the ‘capture probe’, further explained in section 4.5, and 
is the same 25 base DNA sequence used for the varied length study described in 
section 4.5.2. 
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Sequence 
Name 
 
Base Sequence 
Number 
of  
Bases 
VL10mer 5’NNNNNNNNNN[Btn]3’ 10 
VL36mer 
5’TGGGAGTAGGTTGGTGTGGTTGGGGCTCCCCTTTTT[ 
Btn]3’ 
36 
VL50mer 
5’ATACCAGTCTATTCAATTGGGCCCGTCCGTATGGTGG 
GTGTGCTGGCCAG[Btn]3’ 
50 
VL25mer/ 
CP 
5’ATGGTTAAACCTCACTACGCGTGGC[Btn]3’ 25 
cDNA 5’GCCACGCGTAGTGAGGTTTAACCAT3’ 25 
MidT 5’GTAGTGAGGT3’ 10 
EndT 5’GTTTAACCAT3’ 10 
OverT 5’GTGAGGTTTAACCATTTTTTTTTTTTTTTT3’ 30 
Table 4.1 - Summary of DNA oligonucleotides used in this study including details of base sequence and 
base lengths. [Btn] notation indicates a biotin tag attached to the 3’ end of the DNA sequence. The cDNA 
is a complementary DNA strand to VL25mer/CP (capture probe) DNA. cDNA, MidT, EndT, and OverT are 
all examples of target DNA used in this study. 
 
4.4.2 Methods 
 
4.4.2.1 Hybridising DNA to Streptavidin Coated Particles 
120 nm diameter streptavidin coated particles were diluted to a concentration of 1 x 
1010 particles/mL. The diluted particle solutions were then vortexed for 30 s and 
sonicated for 2 mins to ensure monodispersity. 
The biotinylated DNA capture probe was added to the streptavidin coated particles 
(4352 pmol/mg binding capacity as determined by the supplier) at the required 
concentration (concentrations of 10, 20, 30, 47, 95, 140, and 210 nM were investigated 
for CP (capture probe) DNA, and concentrations of 75 and 210 nM were investigated 
for the varied lengths of DNA, VL10, 25 and 50). Once the biotinylated DNA had been 
added, the samples were placed on a rotary wheel at room temperature for 30 minutes. 
Any unbound DNA remaining in solution was then removed via magnetic separation 
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by placing the samples onto a Magrack (GE Healthcare, UK) for 30 minutes. The 
supernatant was then removed and replaced with new PBST buffer. 
4.4.2.2 Addition of Complementary Target DNA 
Target DNA was added in excess (500 nM) to ensure the maximum possible target 
binding was reached. The samples were then placed on a rotary wheel at room 
temperature to investigate the effect of DNA hybridisation time (30 minutes and 16 
hours were investigated for each respective DNA target). It was important to note the 
temperature of the lab 
4.4.2.3 TRPS Setup and Zeta Potential Calibration 
The data capture and analysis software used alongside the qNano instrument (Izon 
Science Ltd, NZ) was Izon Control Suite v.2.2.2.117. Details of the instrument setup 
can be found in chapter 4. The nanopores used for this study were all capable of 
detecting particles in the size range of 85-300 nm (an NP150, as determined by the 
manufacturer, Izon Science Ltd, NZ). This is the most appropriate pore size for these 
experiments based on particles being analysed (120 nm and 220 nm in diameter). The 
calibration method for nanopores used in this study relative to zeta potential 
measurements is detailed fully in chapter 2, section 2.2.2. 
4.5 Results and Discussion 
 
4.5.1 Effects of Packing Density on Zeta Potential 
The zeta potential method was first applied to DNA-modified nanoparticles as a 
function of DNA concentration. ssDNA (25 bases in length, termed capture probe, 
VL25mer/CP) was immobilised onto streptavidin coated particles and the DNA 
concentration ranged from 10-210 nM, whilst the particle concentration remained 
unchanged. The theoretical binding capacity of the streptavidin coated particles (as 
provided by the supplier) was detailed as 188 nM. The highest DNA concentration 
investigated (210 nM) was therefore when the DNA was in excess and therefore 
should result in 100 % coverage of the particles. For comparison, table 4.2 shows the 
mean size and zeta potential values for streptavidin coated particles and figure 4.1 
shows the size (a) and charge (b) distributions of unmodified streptavidin coated 
particles as a base comparison for the samples with DNA functionalisation. 
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Mean Median Mode Minimum Maximum 
Particle Diameter (nm) 
116 ± 1.68 111 ± 1.25 111 94 232 
Zeta Potential (mV) 
-8.94 ± 0.34 -2.88 ± 0.50 -2.37 -25.71 6.09 
Table 4.2 - Particle size (nm) and zeta potential (mV) values for samples where a minimum of 300 
particles were measured and a standard deviation where n=3 independent replicates. 
 
 
a) 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 - a) size and b) zeta potential distributions amongst a given sample population of unmodified 
streptavidin coated particles. A minimum of 300 particles were measured in each sample. 
 
The highest concentration of DNA equated to approximately 12648 pieces of DNA per 
particle (in a sample containing 1 x 1010 particles/mL) and, if each of these strands 
were attached to the surface, would result in approximately 1 DNA strand every 2 nm2 
across the particle surface. Table 4.3 shows the total pieces of DNA per particle for 
each of the DNA concentrations studied. 
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DNA concentration (nM) Number of DNA strands /particle 
10 602 
20 1204 
30 1806 
47 2829 
75 4517 
95 5719 
140 8428 
210 12648 
Table 4.3 - The relative number of DNA strands per particle for each DNA concentration studied, for 
samples containing 1 x 1010 particles/mL. 
 
TRPS can complete simultaneous size and charge measurements, an example of 
which can be seen in figure 4.2. The green and red bars/data points show the 
distributions at the lowest and the middle concentration (10 and 47 nM respectively) 
and the blue bars/data points show the results from the samples with the highest CP 
concentration of 210 nM. The particle-by-particle nature of the technology is depicted 
here as each data point is representative of single particle amongst a sample 
population. 
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Figure 4.2 - Particle size and zeta potential distributions for streptavidin coated particles modified with 
varied concentrations of capture probe DNA. The green bars/diamonds, red bars/squares, and blue 
bars/triangles are representative of particles modified with 10, 47, and 210 nM DNA, respectively. A 
minimum of 570 particles were measured from each sample. Figure reproduced from Blundell et al16. 
 
These data show the advantages of being able to complete rapid size and charge 
measurements simultaneously because although there are no size changes seen 
between the samples (regardless of the CP concentration added), there are changes 
observed for zeta potential between each of the samples. The shift in zeta potential 
values from the base particle (figure 4.1, no hybridised DNA, purple dataset) to those 
hybridised with 10 nM (green dataset) and 210 nM (blue dataset) is shown in figure 
4.3b. The figure shows that even a small amount of DNA as low as 10 nM, equivalent 
to approximately 5% of the particle’s binding capacity, shows a change in zeta 
potential distribution and a change in mean zeta potential of a given sample (see figure 
4.4a), but has no influence on the measured size of the particles (figure 4.3a). 
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Figure 4.3 - Comparison of a) size and b) zeta potential distributions for particles with no hybridised DNA 
(purple bars), 10 nM DNA (green bars), and 210 nM hybridised DNA (blue bars). Each distribution is 
representative of a sample where a minimum of 300 particles were measured. 
 
The mean measured zeta potential values (a) and particle velocities (b) are shown in 
figure 4.4. The particle velocities are determined from the inverse of the translocation 
time it takes for the particle to become 50 % of the way through the pore (1/T0.50), 
which can also be defined as an estimate of the particle speeds (see chapter 3). 
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Figure 4.4 - a) Mean zeta potential (mV) vs capture probe DNA concentration (nM). b) 1/T0.50 (1/particle 
duration through the pore) (/ms) vs capture probe DNA concentration (nM). Figure adapted from Blundell 
et al16. 
 
The results show that an increase in DNA concentration results in a larger measured 
zeta potential and correlate with an increase in DNA concentration resulting in an 
increased particle velocity (figure 4.4b). The larger zeta potential is attributed to the 
negative phosphate backbone of DNA, each phosphate group will contribute to a 
negative point charge, which in turn will increase the charge density close to the 
particle surface. 
Figure 4.5 shows the frequency (as a percentage) of each particle amongst the sample 
population versus the measured zeta potential at each DNA concentration studied. 
When there is a low packing density (and thus a low concentration of DNA immobilised 
to the particle surface), the distribution is relatively narrow with a long skewed tail. 
When more DNA is added to the sample, the distribution appears to widen and is seen 
to have a more symmetrical nature around the mean zeta potential value. The 
histograms again portray the particle-by-particle nature of TRPS, providing a deeper 
insight and a more detailed analysis of the sample. 
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Figure 4.5 - Zeta potential distributions vs frequency as a percentage for samples containing capture 
probe DNA (VL25mer/CP) concentrations of 10, 20, 30, 47, 95, 140, and 210 nM. 
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4.5.2 Effects of DNA Base Length 
The results from section 4.4.1 indicate that a similar relationship should be seen for 
an increase in DNA length as there was for the increase in DNA concentration as more 
bases will mean a longer negative phosphate backbone to affect the particle surface 
charge. The effect of additional charges to the system such as long dsDNA strands 
(4-6 kilo base pairs) hybridised to colloids has previously been investigated by 
Steinbock et al. using microparticles and a microcapillary based Coulter counter 
technology17. TRPS is a sensitive method and to test this, the focus of this study is 
measure changes in zeta potential using much smaller ssDNA strands. The lengths of 
ssDNA chosen were of 10, 25, 36, and 50 base, equivalent to 7.0, 17.5, 25.2, and 35.0 
nm in length respectively if the DNA is fully extended18,19 and two concentrations were 
investigated. 
 
 
Figure 4.6 - a) Mean zeta potential (mV) vs capture probe DNA base length and b) 1/T0.50 (/ms) vs capture 
probe DNA base length where the turquoise bars represent a DNA concentration of 75 nM and the red 
bars represent a DNA concentration of 210 nM. A minimum of 200 particles were measured per sample 
and error bars represent standard deviation where n=2 independent replicates. Figure is adapted from 
Blundell et al16. 
 
The two concentrations studied were 75 and 210 nM, shown by the turquoise and red 
bars, respectively, and both concentrations showed the largest zeta potential value for 
a longer length of DNA (figure 4.6). As expected, a larger zeta potential value was 
observed for the particles hybridised with the longer ssDNA strands that also displayed 
an increase in particle velocity. 
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Figure 4.7 - Overlaid repeat datasets of zeta potential distributions of particles hybridised with a) 75 nM 
and b) 210 nM DNA of varying base lengths. In each sample, a minimum of 200 particles were measured. 
 
At a 75 nM DNA concentration (figure 4.7a), the packing density will be much lower 
and therefore the flexible ssDNA has more space between each strand and can exist 
in what is known as its ‘condensed mushroom’ form20. More space between each 
strand allows for a larger gyration effect20,21 that causes an increase in skewness 
amongst the zeta potential distribution. When the DNA strands are closely packed and 
of a high packing density, the skew is expected to be reduced. Some minor skewness 
may be present in the samples but this may be an inherent property of the streptavidin 
coated particles themselves not having a completely uniform protein coating, data of 
which can be seen in figure 4.7. For each concentration of DNA studied, the width of 
the zeta potential distribution increases as the DNA length is increased. This is due to 
the steric hindrance present with the longer pieces of DNA that may in fact prevent the 
high packing density around the particle’s surface based on their gyration radius that 
can block the binding of the DNA onto the particle surface. From this, it can be said 
that the shorter DNA strands are much more likely to produce a high packing density 
surrounding the particle, and thus these particles will have a more uniform distribution 
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of DNA on their surfaces, resulting in a narrower distribution of zeta potential values. 
The symmetry of the distributions improved when a higher concentration of DNA was 
used and the spreads were seen to be more uniform. This is due to the high packing 
density surrounding the particle for each length of DNA at 210 nM, in comparison to 
the 75 nM DNA samples. The data was reproducible and this is demonstrated from 
overlaid charge distributions for two datasets using 75 and 210 nM DNA. 
4.5.3 Detecting Target DNA Hybridisation 
The technology effectively detected subtle differences in both DNA length and 
concentration, the next investigation entailed detecting a range of target DNA using 
the initial CP DNA and discriminating between ssDNA and dsDNA. The capture probe 
(CP) DNA was the same throughout and was always 25 bases in length. When added 
in excess of the particle binding capacity, any unbound CP DNA was removed before 
any target DNA was added in excess. It is important to note the melting temperatures 
(Tm) of the DNA strands used in this study and to make sure the temperature of the 
lab did not exceed these temperatures whilst these experiments were being 
completed. Table 4.4 shows the melting temperatures of all of the DNA sequences 
used in this study. 
 
Name Base Sequence Melting 
Temperature, Tm 
(oC) 
Capture 
probe (CP) 
5’ATGGTTAAACCTCACTACGCGTGGC[Btn]3’ 
74.7 
cDNA 5’GCCACGCGTAGTGAGGTTTAACCAT3’ 74.7 
MidT 5’GTAGTGAGGT3’ 37.3 
EndT 5’GTTTAACCAT3’ 33.3 
OverT 5’GTGAGGTTTAACCATTTTTTTTTTTTTTTT3’ 67.0 
Table 4.4 - Summary of melting temperatures (Tm) for each of the DNA sequences used in this study. All 
of the DNA hybridisations were completed in PBS (137 mM) at room temperature (≤ 25 oC). 
 
The formation of double stranded DNA can be inferred as it produces a larger zeta 
potential  than  single  stranded  DNA  in  each  target  case,  shown  in  figure  4.8. 
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Hybridising the target DNA with CP functionalised particles for 16 hours (zeta potential 
values represented by the green triangles) showed the largest relative change in zeta 
potential but these differences in zeta could be detected using hybridisation times of 
30 minutes (red squares). 
 
 
 
 
Figure 4.8 - Relative change in zeta potential (mV) from DNA capture probe, CP, at 100 % capacity on the 
particle’s surface to when a variety of DNA targets are hybridised in excess for 30 minutes (red squares) 
and 16 hours (green triangles). Error bars represent standard deviation where n=3 independent replicates 
where a minimum of 400 particles were measured per sample. Figure adapted from Blundell et al16. 
 
The relative changes in zeta potential values can be attributed to the difference in 
persistence length (a 50-fold increase from ssDNA to dsDNA)11,12. The higher the 
persistence length, the larger the hydrodynamic radius of the particle, where two 
competing factors will then affect the surface charge density. One factor is the 
lengthening of the DNA when dsDNA is formed which will result in the phosphate 
groups being more spaced out and further away from the particle surface. Although 
this would result in a smaller charge density, this is countered by the addition of the 
second strand to make it double stranded that doubles the number of negative point 
charges. The more negative point charges, the faster the electrophoretic mobility 
resulting in increased particle velocities and thus larger zeta potential values. 
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Previous TRPS work details the detection of target-probe DNA hybridisation that 
successfully discriminated between ‘probe’ and ‘target-probe’ hybridised particles 
completed by Booth et al.22. However, in these experiments, the example DNA was a 
capture probe consisting of 23 bases with a target strand of 50 bases, extending far 
enough out into solution to be considered as predominantly ssDNA. Our examples 
include a target that does extend out into solution (overhanging target) as well as those 
that don’t and can be considered as predominantly dsDNA. A range of DNA targets 
were investigated that bound to various positions of the capture probe to demonstrate 
the sensitivity and reliability of a TRPS zeta potential measurement. The targets 
studied are defined in table 4.5. 
 
Target Name 
Fully/Partially 
complementary 
Binding Position 
cDNA Fully complementary Binds entirety of CP 
MidT Partially complementary 
Binds to middle 10 bases 
of CP 
EndT Partially complementary 
Binds to end 10 bases of 
CP 
 
OverT 
 
Partially complementary 
Binds to end 15 bases of 
CP and overhangs 15 
bases into solution 
Table 4.5 - Summary of DNA targets investigated in this study, all target DNA was at least partially 
complementary to the 25mer capture probe, CP. 
 
The measured zeta potential values for each target are illustrated in figure 4.8. Any 
target DNA being added to the original capture probe resulted in a larger zeta potential 
value, be it middle binding, end binding, fully complementary, or an overhanging 
target. The relative change in the zeta potential values recorded were all larger when 
the target DNA was hybridised with the particles for an increased hybridisation time of 
16 hours. Figure 4.9 again demonstrates simultaneous size and charge 
measurements that can be completed by TRPS to discriminate between ssDNA 
(capture probe 25mer, orange bars/data points) and dsDNA (capture probe 25mer + 
cDNA target, green bars/data points). The results showed similarities to the effects of 
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DNA concentration, there were no differences observed between the size of the 
particles, but there was a shift in the zeta potential distribution to a larger value when 
dsDNA was present on the particle’s surface. The effect was not as prominent as it 
was for the change in DNA concentration but still showed the detection of subtle 
differences in DNA-nanoparticle system based on DNA structure (ssDNA vs dsDNA). 
 
 
Figure 4.9 - Particle size and zeta potential distributions for streptavidin coated particles modified with 
ssDNA (25mer capture probe) and dsDNA (25mer capture probe + cDNA 25mer). The orange bars/data 
points and green bars/data points are representative of single stranded and double stranded DNA 
samples, respectively. A minimum of 200 particles were measured for each sample. 
 
The overhanging DNA target (OverT) always gave the largest negative zeta potential 
of all of the targets studied and was the largest in length. Although a larger length of 
DNA is expected to give a more negative zeta potential value, you may also encounter 
drag effects when the DNA extends further out into solution that may slow the particles 
down and be interpreted as exhibiting a smaller zeta potential. However, the results 
shown in figure 4.8 indicate that the increase in number of bases (an additional 30 to 
the original capture probe) contributes to the overall increased negative charge density 
surrounding the particle is a more dominant effect than the possible drag effects that 
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may be observed. Another suggestion that may attribute toward this result is the lower 
persistence length of the ssDNA portion extending out into the solution. The lower 
persistence length means a more flexible strand that may in fact coil back and around 
the capture probe, vastly increasing the charge density around the particle surface. 
The coiling effect causing the increase in surface charge density would result in an 
increase in electrophoretic velocity through a ‘hairy layer mechanism’ being created23. 
Seeing as the overhanging DNA will be further from the particle surface, the distance 
between each DNA will increase, spatially allowing for more movement and more 
space to fold, although this effect could also be seen for the partially complementary 
middle binding target (MidT) it will be enhanced for the overhanging target as this 
results in the longest DNA length from the particle’s surface. 
Of great interest is the ability of the measurement to distinguish between the same 
sized target (10 bases) being added but to a different position of the capture probe 
DNA. The end-binding target (EndT) recorded a smaller zeta potential value to the 
middle-binding target (MidT) even though they were both 10 bases in length and both 
forming the same proportion of double stranded DNA. This effect can be attributed 
again to the persistence lengths of single stranded DNA. The MidT binds to the middle 
of the capture probe and thus leaves some ssDNA extending out into solution; this is 
again more flexible than the dsDNA and could fold back on itself to increase the charge 
density around the particle’s surface23, resulting in a larger zeta potential value. When 
the dsDNA is formed at the end of the capture probe sequence (EndT), it is 
hypothesised that the ability for the DNA to fold or coil back to the surface is restricted 
and the oligomer is more rigid across the entire length of the CP DNA, this would in 
effect move the dsDNA charge away from the particle’s surface and lower the surface 
charge density. 
The ability to distinguish between such subtle differences in DNA binding will be of 
great use to the key design of future assays to be analysed on TRPS systems. The 
zeta potential distribution analysis was again useful to analyse the distribution of 
charge across the entire sample population. The charge distribution histograms gather 
insight and give valuable information on each individual particle’s zeta potential. The 
distribution shape changing is an indication of a difference in DNA binding 
mechanisms or the target analyte itself. Histograms from the range of target DNA are 
illustrated in figure 4.10. 
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Figure 4.10 - Zeta potential distributions of i-CP and for each target (ii-Fully complementary target, iii-Mid 
binding target, iv-End binding target, and v-Overhanging partially complementary target) hybridised in 
excess (500 nM) for 16 hours to a particle saturated with CP DNA. Each distribution consists of a sample 
where a minimum of 400 particles were measured. 
 
The various target DNA was then hybridised to a CP DNA hybridised particle with 
different concentrations of CP DNA used on the particle surface, as well as 
investigating hybridisation times. The mean zeta potential values for a low (blue 
diamonds) and high (red squares) CP DNA concentration are illustrated in figure 4.11. 
As well as the binding position of the partially complementary target DNA and the 
effect this has on particle  transport, DNA binding kinetics is also interesting to study, 
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in particular target DNA hybridisation kinetics. There has been various work that has 
shown that the capture of target DNA is influenced by the CP DNA probe density at a 
surface24–27. When the surface is densely packed with single stranded DNA, a dense 
packed polymer brush-like structure is formed. In this case the DNA forms a rigid 
polymer coating that has a measured thickness equivalent to the extended DNA length 
based on its sequence, H28. The electrostatic potential and shear plane position are 
thus determined by the packing density of the DNA, and thus the target DNA 
hybridisation kinetics. Polyelectrolyte layers introduce complications and the 
significance of zeta potential becomes more confounded. For example, when the 
Debye length, κ-1 , is significantly lower than the polyelectrolyte thickness, H, (when κ- 
1/H<<1), the zeta potential may no longer be a direct reflection of the stern potential, 
as the plane of shear will be positioned much further away from the particle’s surface29. 
The interest arises in the fact that when the surface is less densely packed with DNA, 
the plane of shear may in fact enter the DNA layer29 where the original definition of 
zeta potential may be lost. 
 
 
Figure 4.11 - Relative change in zeta potential (mV) from particles functionalised with DNA capture probe, 
CP, to when a variety of targets are hybridised for 30 minutes using CP DNA concentrations of 75 nM 
(blue diamonds) and an excess of 250 nM (red squares). Error bars represent standard deviation where 
n=3 independent replicates where a minimum of 400 particles were measured per sample. 
 
The hybridisation time for target DNA was investigated at both 30 minutes and 16 
hours, to which the samples containing particle surfaces densely packed with CP DNA 
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displayed a widening in zeta potential distribution as the hybridisation time increased. 
This is attributed to the target having more time to reach its desired orientation to 
successfully bind to the capture probe. More time is required for complete 
complementary target binding and when this is available there will be an increased 
proportion of double stranded DNA on the particle’s surface. An increase in the amount 
of dsDNA on the surface will result in a higher surface charge density, resulting in an 
increase in particle velocity and thus a larger zeta potential value recorded. 
When a lower concentration of CP DNA was used with a hybridisation time of just 30 
minutes, the charge distributions were shaped much narrower (figure 4.12a) than the 
target hybridised, for 30 minutes, to a sample with hybridised to a high concentration 
of CP DNA (figure 4.12b). There was also a significant reduction in the tailing effect, 
as illustrated in figure 4.12. 
 
 
Figure 4.12 - Zeta potential distributions for a sample population at a) low CP concentrations (75 nM) and 
a hybridisation time of 30 minutes, b) high CP DNA concentration (250 nM) and a hybridisation time of 30 
minutes, and c) high CP DNA concentration (250 nM) and a hybridisation time of 16 hours for the cDNA 
and OverT respective targets. Figure reproduced from Blundell et al16. Each sample consisted of at least 
400 measured particles. 
 
Previous work by Halperin et al. has shown that a lower CP DNA density results in a 
faster rate of reaction for the target DNA to bind30, explaining the more narrow 
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distribution observed here. When the particle surface is densely populated with the 
capture probe, it is more difficult, and a smaller change is seen in zeta potential for 
low hybridisation reaction times (such as 30 minutes). Therefore, to optimise the 
assay, when using quicker assay times, a lower concentration of CP DNA should be 
used to create a less densely packed surface surrounding the particles. 
The shape of the charge distribution was interesting between samples with a different 
concentration of CP DNA on the surface and for those with varied target DNA 
hybridisation times. The distributions displayed in figure 4.12a appear much more 
Gaussian that that of figures 4.12b and 4.12c based on the increased ease of ability 
to form dsDNA as there is less steric hindrance from other ssDNA that would be 
present on a highly packed surface of ssDNA, therefore the formation of this dsDNA 
is easily detected. The formation kinetics of dsDNA are increased when there the 
target DNA has more space or time to reach the desired orientation for successful 
complementary binding at a faster rate. The larger change in zeta potential seen for 
this sample may also be due to the lower net charge of the particle with less ssDNA 
on the surface (as described in section 4.4.1), in comparison to the particle hybridised 
to a much higher concentration of ssDNA. The target binding still occurs for the capture 
probe samples with a high CP DNA concentration using a hybridisation time of 16 
hours. This example showed the biggest increase in zeta potential values recorded 
based on the increased amount of dsDNA now present on the particle surfaces in 
comparison to the limited amount of dsDNA that can be formed around the particles 
with a lower concentration of ssDNA to start with (its saturation point). 
4.6 Conclusions 
TRPS has demonstrated its ability to successfully detect and characterise both 
unmodified and DNA-modified particles in a real-time measurement simultaneously 
completing size and charge analysis of each sample. The data extracted from particle- 
by-particle analysis allows a new level of detail, using the charge distributions to 
analyse each component of a given sample population. This study has emphasised 
the sensitivity of TRPS technology being able to discriminate between varied DNA 
concentrations on a particle surface, different lengths of ssDNA, and a range of DNA 
targets to the same capture probe. The level of detail obtained from a TRPS 
measurement to discriminate between each DNA target will be of  great use to future 
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nucleotide and colloid research as well as having implications on future aptamer 
assays. Immobilising DNA onto a particle surface alters the particle’s behaviour in an 
electrolyte solution that can be monitored using nanopore systems, the results from 
this study could have implications on future aptamer-based assays for biosensing 
medical applications. Target DNA can be captured in assay times of 30 minutes once 
the capture probe DNA concentration and hybridisation times had been optimised. 
Being able to capture target analytes in such a short incubation time will be incredibly 
useful within diagnostic and medical fields, particularly for point of care assays. 
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5 Characterisation of Modified Nanoparticles, 
Particle Conjugates, and Bacteriophage 
using TRPS 
5.1 Abstract 
Finding a common sensor technology that does not require or rely upon PCR or lateral 
flow for the detection and characterisation of small particles, molecules and analytes 
is challenging. Nanoparticles can be functionalised with a biological component, be it 
DNA or a protein for example, to capture a target analyte and can aid in this challenge. 
The work in this chapter develops two methodologies; The first involved using small 
particle conjugates, the concept was to use a larger particle that gives a large signal 
as a “tag” for a smaller particle/molecule inherently difficult to measure individually. 
Recording the changes in signal upon particle conjugation could overcome current 
challenges. In this concept an assay was developed to confirm the presence of 
proteins on a particle’s surface, and is different from the individual protein detection 
studies carried out prior to this. Here we aim to confirm the presence and then quantify 
their abundance. The detection, quantification and phenotyping of small biological 
particles would be of use to the microvesicle and exosome fields. By measuring the 
relative electrophoretic mobility of individual aptamer-modified nanoparticles, a range 
of protein targets can be selectively detected and quantified on a nanoparticle’s 
surface. 
In the second methodology we look to further optimise the TRPS’ ability to characterise 
small particles directly. We test the system to study the detection of bacteriophages in 
buffer and culture medium. A rapid measurement of phage could be extremely 
beneficial for therapeutic fields, as well as targeted drug delivery systems1,2. 
5.2 Introduction 
There are numerous applications to sub 150 nm particle analysis in fields including 
colloidal science3, nanotoxicology, bionanotechnology, drug delivery4–6. Altering a 
surface or nanoparticle’s surface chemistry, with proteins and/or DNA aptamers for 
example, is proving favourable for monitoring DNA-protein, DNA-DNA or DNA-small 
110  
molecule interactions providing insight into biological activity, as well as providing a 
powerful diagnostic platform4,7–15. DNA aptamers are highly affinitive and specific to a 
target analyte that have been used in several particle-based assays in recent 
years12,16. Functionalised nanoparticles are becoming more popular as analytical tools 
in biosensing technologies due to their versatility and scope for a range of target 
analytes. One emerging technology platform to incorporate such particles is the 
nanopore-based method, resistive pulse sensing, RPS17,18. 
Part of the study is to investigate controlled aggregation of two particles (one 
functionalised with a capture probe and one with a target) and observe a change in 
size and more specifically, charge when the aggregation process takes place. 
Preliminary results of this are detailed in this chapter (section 5.4.2). 
One example, aside from exosomes, where this might be of use is for virus 
applications as therapeutics. We have chosen to use bacteriophage to do this because 
they have shown huge potential in the fight for antimicrobial resistance19,20. They also 
offer an unusual “rod” shape, and are used in a range of media thus making their 
characterisation more challenging. A bacteriophage is a compilation of proteins that 
encapsulate a genome within a bacterium and are known to act like viruses in their 
infection and thus replication properties, and are also known for their antimicrobial 
properties that could be particularly useful in the medical industry. Most bacteriophage 
may need to be suspended in a complex biological medium that they need to be 
purified from for analysis and characterisation. TRPS is a beneficial technique that can 
overcome this difficulty by analysing samples in a range of biological media. TRPS 
has previously been used to complete successful measurements of nanoparticles 
suspended in plasma and serum21, see chapter 7. Monitoring the behaviour of 
nanoparticles in these complex solutions has been widely investigated, in particular 
for study of protein corona formation22–25. TRPS may therefore be deemed suitable to 
analyse bacteriophage in their respective biological environments. Quantifying and 
characterising phage samples in this way will exhibit valuable information surrounding 
their behaviours in solution. Quantifying phages in a sample that infect all hosts can 
be completed using flow cytometry26 and transmission electron microscopy (TEM)27,28 
and phage concentration can be determined using plaque assays29, for example. To 
count the number of phage that infect a specific host, an isolation approach is 
required30 although this may not give a true representation of the proportion of phages 
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present being isolated, as they may infect the host but not the model strain if the 
appropriate phage receptors are not present1. 
5.3 Aims and Objectives 
This chapter presents the use of TRPS to measure protein and DNA-modified 
nanoparticles, aggregation properties of particle conjugates, and a range of 
bacteriophage samples. The experiments detailed in this chapter were conducted to 
determine the versatility of TRPS measurements by analysing a range of samples in 
a variety of solutions/matrices. An aggregation assay was carried out to investigate 
the properties of a dual particle sample that could result in multiple aggregates types, 
each analysed using TRPS technology. 
5.4 Materials and Methods 
 
5.4.1 Chemicals and Reagents 
 
5.4.1.1 Chemicals and Buffers 
Phosphate buffered saline (PBS, 0.01 M phosphate buffer, 0.0027 M potassium 
chloride, 0.137 M sodium chloride, pH 7.4) and 2-(N-Morpholino)ethanesulfonic acid 
hydrate (MES hydrate, 0.10 M, pH 6, ≥99.5 %) were dissolved in deionised water (18 
MΩ cm, TKA, Smart2Pure). PBS tablets (P4417) and MES hydrate (M2933) were 
purchased from Sigma Aldrich, UK. SM buffer (5.8 g NaCl, 2.0 g MgSO4.6H2O, 50 mL 
1 M Tris-Cl (pH 7.5), 5 mL 2 % Gelatin) was made up to 1 L with deionised water and 
autoclaved. 
EDC hydrochloride (N-(3-Dimethylaminopopyl)-N-ethylcarbodiimide hydrochloride, 
E6383) was also purchased from Sigma Aldrich, UK. EZ-LinkTM Pentylamine-biotin (50 
mM, 21345) coupling agent was purchased from Life Technologies, UK. 
5.4.1.2 Particles and Particle Standards 
Streptavidin coated superparamagnetic particles (120 nm, 4352 pmol/mg binding 
capacity, product 03121) and carboxylated superparamagnetic particles (120 nm, 
product 02120) were purchased from Ademtech, France. Carboxylated polystyrene 
particles with mean nominal diameters of 115 nm and 70 nm, CPC100 and CPC70 
respectively, were purchased from Bangs Laboratories, US. CPC100s were used as 
calibration particles for sample zeta potential measurements, the zeta potentials of 
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CPC100s were determined using PALS analysis, a technique described in the 
appendices. 
5.4.1.3 Proteins, Oligonucleotides, and Bacteriophage 
Recombinant  human  vascular  endothelial  cell   growth   factor,   VEGF  
(lyophilised, >95 %, PHC9394) was purchased from Thermo Scientific, UK. The 
custom DNA oligonucleotide, V7t1 biotin31 
(5’TGTGGGGGTGGACGGGCCGGGTAGATTTTT[biotin]3’) was purchased as a 
lyophilised powder (100 pmol/μL) from Sigma Aldrich, UK. The DNA was initially 
suspended in deionised water (18 MΩ cm resistivity, TKA, Smart2Pure) to a 
concentration of 100 μM. Bacteriophage samples were sourced by University of 
Leicester and were suspended in SM and BIH buffers. 
5.4.2 Methods 
 
5.4.2.1 Biotinylation of CPC70 Particles 
Pentylamine biotin (25 mM), CPC70s (1 x 1010 particles/mL), and EDC (1 mg/mL) were 
suspended in MES buffer (0.10 M, pH 6.0) and incubated at room temperature for 2 
hours. The sample was then centrifuged at 13000 rpm for 5 minutes before 
resuspending the new formed pellet in PBS buffer (137 mM, pH 7.4). Prior to TRPS 
analysis, the biotinylated particles were vortexed for 30 seconds and sonicated for 1 
minute. 
5.4.2.2 Conjugation of Small Particles 
Depending on the particle ratio of interest, the required amount of biotinylated CPC70 
particles were added to the required amount of streptavidin coated particles and the 
sample was hybridised on a rotary wheel at room temperature for 10 minutes. The 
biotinylated CPC70s will be further termed as ‘bioCPCs’ and the streptavidin coated 
particles as ‘strept particles’. Table 5.1 describes the volumes and concentration of 
each particle required for the ratios studied. 
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Ratio of 
bioCPC:strept 
particles 
Concentration 
of bioCPC 
particles 
added 
(particles/mL) 
Volume 
of   
bioCPC 
particles 
added 
(μL) 
Concentration 
of strept 
particles 
added 
(particles/mL) 
Volume 
of strept 
particles 
added 
(μL) 
 
Total 
sample 
volume 
(μL) 
1:0 1 x 1010 500 N/A 0 500 
0:1 N/A 0 1.1 x 1010 500 500 
1:1 1 x 1010 250 1.1 x 1010 250 500 
10:1 1 x 1010 250 1.1 x 109 250 500 
Table 5.1 - Required concentration and volume of each particle type involved in the conjugation assay. 
 
5.4.2.3 Protein and DNA Functionalisation of Base Particles 
Streptavidin coated superparamagnetic particles were incubated with the relevant 
biotinylated DNA aptamer via a 30 minute incubation (at room temperature) of 1 x 1010 
particles/mL with the required amount of DNA for 100 % surface coverage on a rotary 
wheel. Carboxylated superparamagnetic particles were functionalised with VEGF 
protein via standard EDC chemistry. VEGF protein (50 nM), Carboxylated particles (1 
x 1010 particles/mL), and EDC (1 mg/mL) were suspended in MES buffer (0.10 M, pH 
6.0) and incubated at room temperature for 2 hours. 
Excess DNA and protein was removed from the solutions via magnetic separation by 
placing the samples on a Magrack for approximately 30 minutes, forming a cluster of 
functionalised particles. The supernatant was then removed and replaced with fresh 
PBS buffer, taking care not to disturb the newly formed particle cluster. Each sample 
was vortexed for 30 seconds and sonicated for at least 1 minute prior to TRPS 
analysis. 
Two assays were investigated in this study; assay 1 involves the aptamer 
functionalised particles with the addition of target protein into the sample solution, 
assay 2 used the protein functionalised particles with the addition of loose DNA 
aptamer  added  to  the  samples.  The  amount  of  protein  and  DNA  added  in the 
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respective assay was equivalent to what would result in 100 % surface coverage of 
the particles. 
5.4.2.4 TRPS Analysis 
All measurements were conducted using the qNano instrument (Izon Science Ltd, NZ) 
combining tunable nanopores (NP100, analysis size range of 40-320 nm as 
determined by the supplier) with proprietary data capture and analysis software, Izon 
Control Suite V3.1.2.53. A detailed method for the TRPS setup can be found in chapter 
2. 
Prior to TRPS analysis, all samples were vortexed for 30 seconds and sonicated for 1 
minute. During each sample run, the system was washed by placing PBS (40 µL) into 
the upper fluid cell several times whilst applying various pressures to ensure there 
were no residual particles remaining and therefore no cross contamination between 
samples. 
5.4.2.5 Zeta Potential Calibration using TRPS 
Based on the size of the sample particles and molecules being analysed and 
calibration CPC100s and CPC200s (115 nm and 200 nm, respectively), the most ideal 
pore to use was an NP100 (optimal size range 40-320 nm). The calibration particles 
are measured at 3 applied voltages that are dependent on the applied stretch and 
consequent baseline current observed. Each applied voltage was run alongside an 
applied pressure (V1P1, V2P1, and V3P1) and the highest voltage of the calibration 
was run at an additional applied pressure also (V1P2), to assess the pressure stability 
of the samples. Each sample measurement was completed at a current of 100 ± 10 
nA in accordance with the calibration runs for a particular NP100 pore. For the purpose 
of zeta potential, it was imperative that the stretch of the nanopore and the applied 
potential were not changed during a sample or calibration measurement of a particular 
dataset. The sample measurements were all completed at the highest or second 
highest voltage that the calibration measurements were carried out at. Calibration 
measurements were completed on each new day analysis was completed and when 
a new nanopore was introduced. 
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5.5  Results and Discussion 
 
5.5.1   Streptavidin-biotin Control Conjugation Assay 
A streptavidin-biotin interaction is known to be of high affinity32 and thus this interaction 
was chosen as a test case for controlled aggregation between two differently sized 
particles. In this case mean nominal diameters, given by the suppliers, were 120 nm 
(streptavidin coated particles) and 70 nm (biotinylated CPC70s). The ratios of each 
particle were closely monitored in attempts to control the number of biotinylated 
particles interacting with each streptavidin coated particle. Three cases were studied: 
a) biotinylated CPC70s in excess (10:1, bioCPC:strept), b) an even ratio of both 
particle types (1:1), and c) streptavidin coated particles only; the results of each ratio 
based on size and zeta potential were investigated. We initially chose to study the 
bioCPCs in excess relative to the strept particles (see figure 5.1c) as this might reflect 
a bioassay more closely, showing much smaller changes in volume that also helps 
study the sensitivity of TRPS technology. 
Figure 5.1 is a schematic for the possible binding effects of the bioCPCs (blue) and 
streptavidin coated particles (red) as a result of incubation with each other at the ratios 
detailed in table 5.1. 
 
Figure 5.1 - Schematics of samples containing streptavidin coated particles (red) and biotinylated 
particles (blue). a) Streptavidin coated particles, b) 1:1 ratio of streptavidin coated and biotinylated 
particles, possibly resulting in larger particle aggregates, and c) 10:1 ratio in favour of the biotinylated 
particles with respect to the streptavidin coated particles that could lead to saturated coverage of the 
streptavidin coated particles. 
 
The size and zeta potential results are summarised in figures 5.2 and 5.3, respectively, 
the streptavidin coated particles recorded a measured zeta potential value of -15 mV, 
which was reduced upon addition of biotinylated CPC70s. The largest effect on zeta 
potential was observed when the biotinylated CPC70s were added in excess, which 
116  
is expected as these samples contained the highest volume of biotinylated particles 
available to shield the negative charge of the streptavidin coated particles. 
 
 
Figure 5.2 - Mean particle diameters measured for varied ratios of biotinylated and streptavidin coated 
particles. Measurements were completed using an NP100 pore and a minimum of 50 particles were 
measured for each sample. 
 
The streptavidin coated particles recorded a mean particle diameter of 118 nm 
amongst a given sample population when measured via TRPS. When equal 
concentrations of each particle type were added, the mean particle diameter increase 
to 307 nm, with a maximum recored particle size of 525 nm, a much larger change in 
size than when the biotinylated CPC70s were added in excess to the streptavidin 
coated particles (a recorded mean particle diameter of 160 nm). Although this change 
was not as large as the 1:1 ratio, there was still a change in the mean particle size by 
42 nm, confirming the presence of the biotinylated CPC70s saturating the surface of 
the streptavidin coated particles. 
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Figure 5.3 - Mean zeta potential values for varied ratios of biotinylated and streptavidin coated particles. 
Measurements were completed using an NP100 pore and a minimum of 50 particles were measured for 
each sample. 
 
When equal concentrations of each particle type were added i.e. 1:1, a reduction in 
zeta potential was again observed due to the gradual shielding of some of the 
negatively charged streptavidin coated particles. The magnitude of change in zeta 
potential was much smaller but this is due to the majority of the streptavidin coated 
particles negative surface charge still being exposed. Figure 5.4 shows a size vs zeta 
potential scatterplot illustrating the effects on size and zeta potential simultaneously 
for each of the particle ratios studied. 
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Figure 5.4 - Zeta potential (mV) vs particle size (nm) plot for each ratio of particles studied. The red 
squares represent streptavidin coated particles only, the blue diamonds and green triangles represent a 
10:1 and 1:1 biotinylated:streptavidin particle ratio, respectively. It should be noted here that each data 
point represents a single particle amongst a given sample population, a minimum of 50 particles were 
measured per sample. 
 
The red outlined squares indicate a sample solely containing streptavidin coated 
particles (strept), these particles recorded a tight size distribution amongst the given 
sample population. When the bioCPCs were added in excess (blue diamonds) the 
mean particle size shifted from 118 nm to circa 150 nm. This size change was typically 
expected when excess bioCPCs were present in the sample as upon aggregation 
there will be a change in electrolyte volume displaced as the aggregated particles pass 
through the pore and thus a different blockade signal observed. Both the strept 
particles and bioCPC particles are spherical in shape so the change in volume 
expected per aggregation of a single bioCPC particle is 22.8 % (table 5.2). Based on 
the surface area of the strept particles, it can be estimated that the surface will become 
saturated when directly aggregated to 6 bioCPC particles, an increase in volume of 
137.1 %, equivalent to a particle diameter change to 153 nm. 
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No. conjugated biotinylated particles to a 
streptavidin coated particle 
Expected percentage increase in 
volume (%) 
1 22.8 
2 45.7 
3 68.5 
4 91.4 
5 114.2 
6 (maximum capacity expected when 
biotinylated particles are in excess) 
137.1 
Table 5.2 - Percentage volume change expected for each aggregated biotinylated CPC70 particle. 
 
Of interest, is the result obtained from the equal ratio of both particles in a sample 
mixture; when the amount of each particle is the same in one sample, the particle size 
range is extended to between 150 and 500 nm. This change may be due to the 
clustering of the streptavidin coated particles around the limited number of biotinylated 
particles in the sample, causing much larger aggregates, described schematically in 
figure 5.1. Out of the ratios studied, the largest change in zeta potential was observed 
when the biotinylated, 70 nm particles were added in excess to saturate the 
streptavidin coated particle surfaces as it allowed for the complete shielding of the 
negative surface charge of the 115 nm particles. Although this ratio (10:1, 
bioCPC:Strept particles) was seen to give the largest change in zeta potential, the 
findings from the 1:1 ratio are still significant because even when the particles are 
seen to cluster and there are less biotinylated particles present, there is still a small 
change in zeta potential observed (circa 2 mV). After investigating the aggregation 
effects induced by a streptavidin-biotin interaction, the assay can be further developed 
to detect and monitor protein-DNA interactions for biologically relevant particles, for 
example. 
5.5.2 Particle ‘tagging’ Experiment via Protein-Aptamer Interactions 
Having shown the aggregation concept could work using the streptavidin and biotin 
interaction, the next stage was to  functionalise small particles with proteins. The first 
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experiment carried out was to test the protein-aptamer interaction for VEGF protein. 
The 120 nm particles in this study were functionalised with the anti-VEGF aptamer, 
V7t1 to 100 % surface coverage (green dataset). Upon addition of excess VEGF target 
protein, a reduction in particle velocity and thus smaller zeta potential (purple dataset), 
was recorded. Figure 5.5 illustrates that change in zeta potential distribution amongst 
given sample population. 
 
 
Figure 5.5 – Zeta potential distribution (mV) of V7t1 aptamer functionalised particles (green dataset) and 
those particles with the addition of soluble VEGF protein (purple dataset). 
 
To confirm the specificity of the V7t1 aptamer, a random aptamer of similar base length 
was also functionalised to a sample of streptavidin coated particles and the VEGF 
target added in excess. Table 5.3 details the particle translocation velocities and zeta 
potentials for particles functionalised both with the random and V7t1 aptamer, both 
particles exhibiting similar translocation and zeta potential properties. Table 5.3, also 
shows the particle velocities of both aptamer functionalised particles when incubated 
with the VEGF protein target. The particles functionalised with the random aptamer 
showed little change in particle velocity when VEGF was added (0.68 /ms), in 
comparison to the V7t1 aptamer functionalised particles that showed a larger change 
in particle velocity when VEGF was added (3.60 /ms). 
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Particle 
Functionalisation 
Average Particle 
Velocity, 1/T0.50 (/ms) 
positioned halfway 
through the pore 
 
Mean Measured Zeta 
Potential (mV) 
Random Aptamer 7.58 ± 0.15 -18.27 ± 0.48 
Random Aptamer + VEGF 6.90 ± 0.23 -17.17 ± 0.61 
V7t1 Aptamer 7.41 ± 0.09 -19.27 ± 0.15 
V7t1 Aptamer +VEGF 3.81 ± 0.39 -13.50 ± 0.64 
Table 5.3 – Particle velocity (/ms) and mean zeta potential (mV) values for particles functionalised with a 
random aptamer, specific V7t1 aptamer and their responses with the addition of VEGF protein. Standard 
deviations were taken of a minimum of 500 particles per sample where n=3. 
 
The velocities can be transferred to zeta potentials and the particles functionalised to 
the non-specific aptamer showed negligible change in the mean zeta potential (1.10 
mV) when VEGF was added, the small change could be attributed to non-specific 
binding to the particle surface. The particles functionalised with the specific V7t1 
aptamer however, showed a smaller mean zeta potential value when the VEGF target 
was added (-13.50 mV, a change of 5.77 mV from the V7t1 aptamer functonalised 
particle). This indicates successful protein binding to the aptamer that creates 
shielding of the negative surface charge exhibited from the DNA aptamers on the 
particle surface. Table 5.4 includes the mean particle diameters of those functionalised 
to the random and VEGF specific aptamers with/without the addition of VEGF protein. 
 
V7t1 
Aptamer 
V7t1 
Aptamer (1) 
V7t1 
Aptamer (2) 
V7t1 Aptamer + 
VEGF 
V7t1 Aptamer + 
VEGF (1) 
163 168 159 190 200 
Random 
Aptamer 
Random 
Aptamer (1) 
Random 
Aptamer (2) 
Random 
Aptamer + 
VEGF 
Random 
Aptamer + 
VEGF (1) 
177 176 179 177 176 
Table 5.4 - Summary of mean particle diameters (nm) for particles functionalised with both the specific 
and non-specific DNA aptamers as well as those samples with the addition of VEGF protein. Each sample 
contained a minimum of 500 particles. 
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The results showed that a mean size change (an increase of approximately 32 nm) 
was only observed for the V7t1 aptamer particles, and not those functionalised with a 
non-specific aptamer. 
Upon addition of the target protein to the VEGF aptamer-modified particles, an 
inherent size change is expected. Although a change in the mean particle diameter is 
evident (see table 5.4), the changes in size amongst the sample population may not 
always be the case, see figure 5.6. 
 
 
Figure 5.6 – Zeta potential (mV) vs particle diameter (nm) for particles functionalised with the specific 
DNA aptamer (green squares) and those upon addition of VEGF protein (purple circles). It should be 
noted that each data point represents a single particle amongst a given sample population and a 
minimum of 250 particles were measured in each sample. 
 
Next the assay was inverted, i.e. the protein placed on the particles surface and DNA/ 
aptamer was present in solution. To investigate this, the 115 nm carboxylated particles 
were functionalised with VEGF protein and loose V7t1 aptamer was then added to the 
samples to monitor successful protein-DNA binding. 
Table 5.5 shows the values recorded for VEGF functionalised onto the 115 nm 
carboxylated particles, the functionalisation was confirmed as successful and was 
shown by a reduction in particle velocity and thus smaller zeta potential value. This is 
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due to the negative carboxyl groups on the particle surface being shielded by the 
positive VEGF protein at pH 7.4 (due to its pI of 8.1). Once the protein was present on 
the particle’s surface, loose DNA aptamer (V7t1) was added to the sample. 
 
Particle 
Functionalisation 
Paricle Velocity halfway 
through the pore (/ms) 
Mean Measured Zeta 
Potential (mV) 
Carboxyl 11.55 ± 0.22 -22.63 ± 0.91 
VEGF 8.78 ± 0.23 -11.87 ± 0.48 
VEGF + V7t1 Aptamer 9.47 ± 0.04 -14.85 ± 0.85 
Table 5.5 - Particle translocation velocity when the particle is positioned 50 % of the way through the 
pore (/ms) and Mean zeta potential (mV) for carboxylated base particle, those functionalised with VEGF 
protein, and VEGF functionalised particles upon addition of loose V7t1 aptamer. Standard deviation was 
taken of a minimum of 500 particles per sample where n=3 independent replicates. 
 
After the aptamer was added to the sample, the mean particle zeta potential became 
more negative that was indicated by the increase in particle velocity. Table 5.6 shows 
a summary of mean zeta potential values from table 5.3 and 5.5 
 
Assay 1 Assay 2 
Streptavidin 
Coated 
Base 
Particle 
(Particle 1) 
Particle 1 
functionalised 
with V7t1 
DNA 
Aptamer 
(Particle 1A) 
 
Particle 
1A + 
VEGF 
Protein 
 
 
Carboxylated 
Base Particle 
(Particle 2) 
Particle 2 
functionalised 
with VEGF 
Protein 
(Particle 2A) 
 
Particle 
2A + V7t1 
DNA 
Aptamer 
-13.48 ± 
0.72 
-19.27 ± 0.15 
-13.5 ± 
0.64 
-22.63 ± 0.91 -11.87 ± 0.48 
-14.85 ± 
0.85 
Table 5.6 - Summary of mean zeta potential values (mV) for both assays investigated in this study. 
Standard deviation was taken of a minimum of 500 particles per sample where n=3 independent 
replicates. 
 
Table 5.6 shows that the addition of loose DNA strands (V7t1 aptamer) to a VEGF- 
modified particle has a smaller effect on the mean measured zeta potential (2.98 mV) 
in comparison to the addition of VEGF protein to the aptamer-modified particle (5.77 
mV). The change in zeta potential was larger when the protein target was added to 
the aptamer functionalised particles rather than the addition of loose DNA aptamer to 
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protein functionalised particles. This may be due to the addition of counterions 
surrounding each particle upon the aptamer binding to the protein on the particle’s 
surface. More counterions may be present to stabilise the single-stranded DNA bound 
to the protein target, which would reduce the particle velocities and thus zeta potential 
values and not give a true representation of the addition of negative DNA strands. 
Another parameter that needs to be investigated as further work is the variation of the 
aptamer and protein surface coverage on the base particle. Varying the packing 
density below 100 % of a particle’s surface may give an indication on the binding 
mechanisms of the protein/DNA target to the relative particle modification. The next 
stage would be to mimic the aggregation assay and use aptamer modified particles to 
bind to protein covered beads. The combination of a change in size and velocity would 
hopefully allow the particles carrying the VEGF protein to be identified, and then the 
magnitude of the size and velocity change could be used to quantify the number of 
proteins on the surface. 
5.5.3 Phage Analysis 
Research of small molecules including biologically relevant particles/molecules has 
become increasingly popular in recent decades, including those in their respective 
mediums. A prime example of this is the analysis of bacteriophages. Bacteriophages 
are viruses that infect bacteria and analysis of such is advantageous in understanding 
microbial systems, figure 5.7 illustrates the shape and structure of bacteriophage 
molecules. 
 
Figure 5.7 - Schematic representation of a bacteriophage molecule, showing its shape and capsid/tail 
components. 
 
The majority of bacteriophages are within the size range of 24 to 200 nm in length 
including a range of phage types. Some of the phages investigated in this study had 
125  
similar structures of icosahedral shaped heads with a subsequent tail. Those studied 
include coliphage which infect E. coli, Salmonella phage, and Clostridium difficile (C. 
difficile) phage. C. difficile phages have gained interest in recent decades for their uses 
in therapeutics based on their highly specific interactions with their biological hosts2. 
In these experiments, a range of bacteriophages were analysed, table 5.7 details the 
size parameters expected of those studied. 
 
Sample 
Name Buffer 
Tail Length, PL 
(nm) 
Capsid Diameter, PC 
(nm) 
Salmonella SM 180 100 
Coliphage SM 100 (15 nm 
diameter) 
70 
CDHM1 BIH 110 (20 nm 
diameter) 
60 
CDHM6 BIH 230 (20 nm 
diameter) 
50 
Table 5.7 - Provided details of bacteriophage samples (based on their type) used in this study including 
capsid diameter, tail length and buffer information. 
 
Each sample was run in its respective buffer, the buffer in which the phage samples 
were prepared, as well as the calibration particles required for the zeta potential 
measurement calibration. The zeta potential was measured for the samples in SM 
buffer, as the molarity and composition of this buffer was similar to that of PBS that 
would allow for the zeta potential to be calculated; BIH buffer however, was not 
compatible so only size and particle velocity data was gathered. 
Figure 5.7 shows the mean (blue) and modal (red) particle diameters for two different 
types of the C.difficile phage (CDHM1 and CDHM6). The modal diameters were more 
similar (142.75 nm and 132 nm for CDHM1 and 6, respectively) than the mean 
diameters (176.75 nm and 151.25 nm for CDHM1 and 6, respectively), suggesting 
there are larger phage molecules or a higher number of aggregates present in the 
CDHM1 sample, more information on the range of measured particle/molecule sizes 
are detailed in table 5.8 and figure 5.8. 
126  
Sample 
Name 
 
Buffer 
Mean 
Measured Size 
(nm) 
Mode Measured 
Size (nm) 
CDHM1 BIH 176.75 ± 3.70 140.75 ± 6.90 
CDHM6 BIH 151.25 ± 4.65 132 ± 3.31 
Table 5.8 - Summary of measured phage sizes for CDHM1 and CDHM6 (mean and mode) amongst a 
sample population. Standard deviation is representative of n=4 independent replicates all containing a 
minimum of 200 measured particles. 
 
 
Figure 5.8 - Mean (blue dataset) and mode (red dataset) particle diameters (nm) for CDHM1 and CDHM6 
phage samples. Error bar are representative of the standard deviation of a minimum of 200 measured 
particles where n=4 independent replicates. 
 
Although both phages were of Clostridium difficile domain, the two different types 
exhibited different properties when analysed using TRPS. The size distributions in 
figure 5.9 show that although the size range of both phage samples were a similar 
spread, there were the presence of larger molecules or possible aggregates in the 
CDHM1 sample (purple dataset). 
127  
 
 
Figure 5.9 - Size distribution of both Clostridium difficile phage samples as a percentage, CDHM1 is 
represented by the purple dataset and CDHM6 is shown by the orange dataset. Each of these samples 
contains a minimum of 200 particles. 
 
Salmonella and coliphage samples were also analysed and compared as both were 
suspended in SM buffer. The mean and modal diameters of the phage, as well as zeta 
potentials were measured by TRPS, results of which are detailed in table 5.9. 
 
Sample 
Name 
 
Buffer 
Mean 
Measured Size 
(nm) 
Mode Measured 
Size (nm) 
Measured Zeta 
Potential (mV) 
Salmonella 
phage 
SM 101.5 ± 0.5 96 ± 4 4.3 
Coliphage SM 88 ± 2.94 87 ± 5.72 8.25 ± 0.85 
Table 5.9 – Summary of size and zeta potential data for salmonella phage samples and coliphage 
samples. Standard deviation is representative of n=3 independent replicates. All samples contained a 
minimum of 200 particles. 
 
Figure 5.10 shows the Salmonella based phage to be 13 nm larger than the coliphage, 
smaller than the expected difference in tail length and capsid diameter (table 5.7). 
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Figure 5.10 - Mean particle diameters (nm) for Salmonella and coliphage samples. Error bars represent 
the standard deviation for samples containing a minimum of 200 particles and where n=3 independent 
replicates. 
 
Size and zeta potential distributions amongst a sample population allows for more 
detailed analysis of a given sample. TRPS analyses particles and molecules 
individually and each blockade event represents a single particle as it traverses the 
pore that are translated into each data point shown in figure 5.11. Both bacteriophage 
studied varied in size and zeta potential distribution shape. The vast majority of entities 
in each sample were encompassed in a similar size range except for some tailing for 
the Salmonella phage indicating the presence of larger particulates or aggregates in 
this sample. 
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Figure 5.11 - Zeta potential (mV) vs particle size (nm) for Salmonella and coliphage samples represented 
by the green triangles and pink squares, respectively. It should be noted that each data point indicates a 
single particle amongst a given sample population. All samples contained a minimum of 250 particles. 
 
One of the advantages of TRPS analysis is the ability to complete simultaneous size, 
concentration, and charge measurements. Techniques that only complete size 
measurements may struggle to differentiate between these two particular phage 
samples based on them both containing phage in an overall similar size range. Figure 
5.11 however, shows the difference in zeta potential distribution shape between the 
samples. The Salmonella sample contained phage with a much narrower zeta 
potential range but the size distribution was wider in shape. This may be attributed to 
this particular bacteriophage having a lower tendency to agglomerate in solution. 
Size and charge properties are important in bacteriophage analysis to gather an 
understanding on their behaviour in their respective environments. Further to this, 
additional information such as pore translocation effects including orientation and 
shape will also impact on their behaviour in solution. TRPS is useful for this 
development as the translocation effects are monitored by the blockade event 
produced as particles traverse the pore. The blockade shape may indicate the 
orientation, direction and transport mechanism of particles as they pass through the 
pore. Figures 5.12a and 5.12b show the peak shape of blockades produced from 
calibration particles (200 nm carboxylated polystyrene) and Salmonella phage, 
respectively. 
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Figure 5.12 - Examples of blockade size and shape with respective enlarged sections for a) carboxylated 
polystyrene calibration particles and b) a Salmonella phage sample. 
 
The calibration particles produce a single, narrow blockade conventional to TRPS 
measurements. The initial drop in current is at the point at which the particle enters 
the pore and the tailing effect back to the baseline current is observed as the particle 
traverses and exits the pore. The blockade produced from a phage sample showed 
different characteristics and resulted in what can be considered a non-conventional 
peak. It should also be noted of the size variation of various particulates present in the 
phage sample (see figure 5.12b), also shown by the green triangles in figure 5.11. 
When the phage enters the pore, the reduction in current is observed as the phage 
displaces the electrolyte; however, this is not a ‘clean’ entry as observed with the 
calibration particles. This blockade shape suggests the phage is translocating the pore 
via a possible ‘tumbling’ mechanism pore, a result of the range of zeta potentials 
amongst the sample, which could be caused from variable head and tail components 
of the phage. Figure 5.11 has shown there are a range of positive, negative and neutral 
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particulates in the phage samples; a positive or neutral particle will traverse the pore 
in the opposite direction and produce a peak opposite to that of the negative calibration 
particle, attributes of which observed in figure 5.12b. The blockade produced by the 
phage can also be interpreted as containing multiple peaks around the pore entry that 
can be interpreted as determining the orientation of the phage as they traverse the 
pore33. As mentioned previously, a phage molecule consists of a capsid head and a 
tail so the difference in charge of both parts could result in the phage traversing the 
pore in a more complicated way than a straight forward spherical particle. Previous 
work has been carried out on gold nanorods that show a similar blockade shape to 
figure 5.12b being exhibited as the rods traverse the pore, the preceding small peak 
before the full blockade event (see enlarged section of figure 5.12b) could be an 
indication of the bacteriophage entering the pore ‘side-on’ and then tumbling to a 
‘head/tail-on’ orientation. 
Further work is required to monitor the behaviour of the phage as they traverse small 
pores to possibly monitor whether the blockade output is influenced by whether the 
phage enters the pore head or tail first. It is apparent that the mode of transport of the 
phage molecules is more complicated than that of a spherical particle (such as the 
calibration particles used in this study). The shape and direction of the blockade 
produced can thus be used to reflect the orientation and direction of the phage 
molecules as they enter and pass through the pore, however further work is required 
to further analyse the transport mechanism of bacteriophages through pores. 
5.6 Conclusions and Further Work 
Tunable resistive pulse sensing (TRPS) has proven useful in detecting particle 
conjugates in complex sample mixtures as well as bacteriophage samples in their 
respective media. The technique can simultaneously complete size and charge 
measurements, allowing for particle agglomeration to be monitored with ease, even to 
the extent of aggregates of 4 times the size of the original particles. Interestingly, when 
one particle is incubated in excess of another, a notable saturation of a particle surface 
is detected by the vast change in zeta potential as the change in particle translocation 
velocity is largely affected by a change in particle surface charge. 
As well as detection and characterisation of particle-particle conjugates via protein- 
protein interactions, the assay has been developed to monitor DNA aptamer-protein 
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interactions within a particle conjugation setting. Preliminary results have found that 
particle velocities as they traverse a pore and thus zeta potential are affected by both 
DNA and protein particle surface modifications. Of interest was the level of sensitivity 
of TRPS that could also monitor the addition of loose protein and DNA to their 
respective target-functionalised particles. The effect was larger for the addition of 
protein to aptamer modified particles and can be attributed to the binding mechanism 
of the protein to the aptamers on the particle surface. This may be different to the 
aptamers binding to proteins already functionalised onto a particle’s surface. Further 
work is required to fully interpret and characterise these differences in binding. A 
further development of this study is to monitor agglomeration effects of both DNA 
aptamer and protein modified nanoparticles in a sample mixture. The aptamer-protein 
based aggregation assay will give valuable insight into the behaviour of biologically 
relevant particles in solution as well as further information on DNA-protein interactions. 
Further work also includes using a ‘scrambled’ anti-VEGF aptamer as well as the 
random aptamer example used in this study to test the protein-aptamer binding. This 
will determine the sequence specificity of the anti-VEGF aptamer. 
Bacteriophage are complex in composition as they are nanoscale entities made up of 
a capsid ‘head’ and subsequent ‘tail’. TRPS is a pore-based technique where the zeta 
potential and translocation events have been monitored by the relative blockade event 
produced as the phage traverse the pore. A ‘double-peak’ is observed as some 
bacteriophage samples translocate the pore and is attributed to a possible tumbling 
effect caused from the oppositely charged head/tail of each phage. Further work is 
required to prove this is the case by looking into controlling the direction the phage 
passing through the pore system. This will enable individual analysis of both the capsid 
heads and subsequent tails of each phage that will allow for more information on 
bacteriophage samples and their behaviour in their respective media. 
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6 Protein Detection using Tunable Pores 
 
6.1 Abstract 
This chapter focuses on developing and comparing a tunable pore platform to detect 
and analyse protein-based assays using resistive pulses and rectification ratios. Both 
methods will be investigated via the quantification of a biomarker, Vascular Endothelial 
Growth Factor (VEGF), a protein of interest in the cancer therapeutics field. The first 
of the two assays incorporates aptamer-modified nanoparticles, measuring their 
translocation speeds through a conical pore. By controlling the aptamer packing 
density on a particle’s surface and measuring each translocation event, a change in 
velocity can be observed for protein concentrations as low as 18 pM, equating to circa 
10 proteins per particle. The second exploits current rectification properties of conical 
pores abolishing the need for particles or other “tagging” elements to the respective 
target. This assay approach encompasses the first reported Layer-by-Layer (LbL) 
assembly of polyelectrolytes directly onto the surface of a polyurethane pore. The 
current rectification ratios confirm the presence of polymers that each produce pH and 
ionic strength dependent currents. A Layer-by-Layer assembly allows for the simple 
immobilisation of DNA aptamers onto the pore surface that demonstrate a specific 
response to the VEGF target. The detection limits for the DNA-modified pore assay 
are 5 pM for VEGF and both this setup and the nanoparticle-assay offer individual 
advantages in their ease in preparation and purpose but differ in their levels of 
sensitivity. Despite the comparable sensitivity, the particle assay offers a larger 
dynamic range. The scope and ease of each assay format allows for a versatile 
technology that can be tailored to suit target analytes. 
6.2 Introduction 
Nanoscale elements within synthetic materials have grown in interest over the last two 
decades1–3 having applications in biosensing4,5, material characterisation6,7, 
quantification of target-ligand interactions8–10, and drug delivery11. Nanoscale 
channels have also been used to mimic biological systems that enables the study of 
ionic transport within confined geometries12–15. Many synthetic nanopores have been 
created in numerous materials including graphene16–19, polymers20, silicon nitride21, 
and glass12,13,22,23. Ion transport and analyte translocation through the channels can 
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be controlled by tuning the applied potential, pore wall charge, pore size, as well as 
the supporting electrolyte concentration and composition. A further degree of 
selectivity can be implemented by modifying the pore walls with selective materials 
and ligands24–26. 
The translocation speed and frequency of materials, such as small molecules, 
proteins, or nanoparticles through pores are also governed by size and charge5,27–30. 
Nanopore sensing systems can be separated into two different categories: Resistive 
Pulse Sensing (RPS) where an analyte translocation event creates a characteristic 
change in resistivity within the pore, and Current Rectification studies that monitor 
current-voltage, I-V, responses dominated by the charges on the pore wall. The flux 
of material through the pore is a function of the small and large pore geometries, Ds 
and Dl, respectively, pore length, L, and analyte charge. RPS has been used to 
measure a range of analytes from single molecules, DNA, proteins and cellular 
vesicles, to cells, bacteria and viruses by controlling the aspect ratio of the pore5,27,30. 
Tunable pores, such as synthetic polyurethane pores, allow for manipulation 
(stretching) in real time to suit a given sample31 and have been incorporated into RPS 
systems for the creation of tunable resistive pulse sensing (TRPS)31,32. The pores are 
conical in shape and in this study, using an NP200, have a typical opening diameter, 
Ds of > 700 nm. The flexibility and versatility of the pores allows for both particle 
translocation effects and current rectification ratios to be monitored, widening the 
scope of the technology. 
6.3 Aims and Objectives 
The main objective from this study was to determine the detection limits for both a 
particle-based assay and current rectification pore-based approach for the same 
target. Both approaches were focused on aptamer-protein interactions and 
sensitivities investigated for each. Experiments were also completed to investigate the 
effects of pore modification with selected polymers and the effect this has on the pore 
as a current rectifier. These current rectification studies will allow for the development 
of label-free assays for analyte detection. 
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6.4 Materials and Methods 
 
6.4.1 Chemicals and Reagents 
 
6.4.1.1 Chemicals, Buffers, and Polymer Coatings 
Poly(ethyleneimine), PEI, low molecular weight (LMW, Mw ~ 2000 g mol-1, 50 % wt., 
408700) and analytical standard high molecular weight (HMW, Mw ~ 750 000 g mol-1, 
50 % wt., P3143); Poly(acrylic acid-co-maleic acid), PAAMA (Mw ~ 3000 g mol-1, 50% 
wt., 416053); Phosphate buffered saline, PBS (0.01 M phosphate buffer, 0.0027 M 
potassium chloride, 0.137 M sodium chloride, pH 7.4), and 2-(N- 
Morpholino)ethanesulfonic acid hydrate, MES hydrate (≥99.5 %, M2933) were 
purchased from Sigma Aldrich, UK. Potassium chloride, KCl (>99 %, P/4240/60) and 
potassium hydroxide, KOH (0.1 M, >85 %, P/5600/60) were purchased from Fisher 
Scientific, UK. Hydrochloric acid, HCl (0.5 M, 37 %) was purchased from VWR, UK. 1- 
ethyl-3-(3-dimethylaminopropyl)carbodiimide, EDC (22980) was purchased from 
Thermo Scientific, UK. HCl and KOH were used to alter the pH of solutions that were 
measured using a Mettler Toledo easy five pH meter with a Mettler Toledo InLab micro 
electrode. 
6.4.1.2 Particles and Nanopores 
Tunable conical polyurethane pores (NP200) were purchased from Izon Science Ltd, 
NZ. Carboxylated polystyrene particles with a mean nominal diameter of 220 nm 
(CPC200) were purchased from Bangs Laboratories, US. Streptavidin coated 
superparamagnetic particles (120 nm, 4352 pmol/mg binding capacity, 03121) were 
purchased from Ademtech, France. All stock particles were vortexed for 30 seconds 
followed by a 2-minute sonication before dilution or further analysis to ensure 
monodispersity. 
6.4.1.3 Proteins, DNA, and Biomarkers 
Fibrinogen from human plasma (≥80 %, F3879), albumin from human serum 
(lyophilised powder, ≥97 %, A9511), γ-globulin from human blood (≥99 %, G4386), 
and bovine serum albumin (BSA, lyophilised powder, ≥96 %, A2153) were purchased 
from Sigma Aldrich, UK. Recombinant human vascular endothelial cell growth factor, 
VEGF (lyophilised, >95 %, PHC9394) was purchased from Thermo Scientific, UK. The 
custom DNA oligonucleotide, V7t1 amine33 
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(5’TGTGGGGGTGGACGGGCCGGGTAGATTTTT, the sequence was synthesised 
with a biotin or amine functional group at the 3’ end) was purchased as a lyophilised 
powder (100 pmol/µL) from Sigma Aldrich, UK. 
All reagents were used without further purification and all solutions were prepared 
using purified water with a resistance of 18 MΩ cm (TKA, Smart2Pure). 
6.4.2 Methods 
 
6.4.2.1 Particle Assay 
Streptavidin coated particles (120 nm diameter) were diluted to a final concentration 
of approximately 5 x 109 particles/mL in PBS. The diluted solutions were then vortexed 
for 30 seconds and sonicated for 2 minutes to ensure they are well dispersed. The 
biotinylated DNA aptamer was added to the streptavidin coated particles (4352 
pmol/mg binding capacity, as determined by the supplier) at 113 and 226 nM for 50 
and 100 % DNA coverage per particle, respectively. The samples were then placed 
on a rotary wheel to incubate at room temperature for 30 minutes. Any unbound DNA 
remaining in solution was then removed via magnetic separation by placing the 
samples onto a Magrack (GE Healthcare, UK) for 30 minutes. The supernatant was 
then removed and replaced with new PBS buffer. The VEGF was added to the 
respective samples at the required concentrations and then placed on a rotary wheel 
at room temperature for 30 minutes before being analysed. 
6.4.2.2 Pore Modification 
The conical polyurethane pores were modified by incubating the pore in the polymer 
(PEI and PAAMA) solutions (5 % wt. in deionised water, 18 MΩ cm) at a stretch of 45 
mm for 2 hours, ensuring the intended pore side was covered with the polymer 
solutions. Once incubated, the pores were rinsed with deionised water. The pores 
were then incubated with the second polymer layer at 45 mm stretch for 2 hours before 
again being rinsed with deionised water. This process was repeated until the required 
number of layers was present. 
To immobilise DNA onto the PAAMA modified pore surface, the aptamer was added 
to solution of 1 mg mL-1 EDC in 100 mM MES buffer (pH 5.9). The final concentration 
of the DNA was 220 nM. The pores were incubated with the DNA/EDC solution for 2 
hours. 
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6.4.2.3 Current-Voltage (I-V) Measurements 
The pores, both modified and unmodified, were mounted laterally between two fluid 
cells (upper and lower, see chapter 2) containing an electrolyte solution. Current- 
Voltage (I-V) curves were recorded using the Izon Control Suite proprietary  software 
v.3.2. The potential was stepped in 100 mV increments from +1.6 to -1.6 V and the 
resulting current measured at each potential. The current rectification properties were 
measured in a range of electrolyte solutions, including KCl solutions ranging from 5 to 
50 mM. When a BSA control was used, 50 nM BSA was incubated with the DNA- 
modified pore for 30 minutes, with the current rectification properties being measured 
in equivalent KCl solutions as with the VEGF samples. 
6.4.2.4 VEGF I-V Assay 
VEGF was suspended in PBS buffer to give the desired final concentration. DNA- 
modified pores were incubated with the VEGF solution where the solution was placed 
solely on the side of the pore with the small pore opening, Ds for 30 minutes. When 
multiple VEGF solutions of varied concentrations were used, the lowest VEGF 
concentrations were measured first, followed by the subsequent higher 
concentrations. The pore was rinsed with water in triplicate and with PBS in triplicate 
after each protein concentration was incubated but prior to the I-V measurements 
using TRPS in the previously mentioned range of electrolyte solutions. A BSA control 
was used at a 50 nM concentration and incubated with the aptamer-modified pore for 
30 minutes prior to I-V measurements (using KCl electrolyte) and was completed 
before adding VEGF to the pore. 
6.4.2.5 TRPS Analysis 
All TRPS measurements were carried out on the qNano instrument (Izon Science Ltd, 
NZ) using an NP200 nanopore (analysis size range of 80-640 nm) alongside Izon 
Control Suite data capture and analysis software v.3.2. A detailed method for the 
TRPS setup can be found in chapter 2. The pore diameters were measured using 
scanning electron microscopy, SEM, and were calculated from the current at a 45 mm 
stretch. Most experiments in this study were run at 45 mm and the applied stretch is 
quantified by the distance between the jaws, also described in chapter 2. 
The velocity of the particles was calculated using the properties of each blockade 
event, or pulse, including the pulse width and duration. Blockade duration events are 
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recorded from the peak (dRmax) of the blockade back to the baseline current; the total 
time this takes gives the blockade duration. A full description of the particle velocity 
calculations can be found in chapter 3 and explains the use of several blockade 
reference points, including T0.50, where 1/T0.50 is used to represent the relative particle 
velocity. 
6.5 Results and Discussion 
 
6.5.1 Particle-Based Assay using Resistive Pulses 
In various resistive pulse sensing strategies, sample handling and assay speed can 
be facilitated using nanomaterials through either; the immobilisation of a target analyte 
onto nanomaterial surfaces to encourage analyte induced aggregation34,35, or 
measuring and monitoring nanoparticle translocation speeds/frequencies upon 
successful binding of a target analyte10,30,36–39, as shown in chapter 5. The charge of 
particles is a major contributing factor to pore translocation speed and frequency, and 
the use of DNA-modified materials/pores is vastly becoming increasingly 
popular10,30,40–42. 
The particle-based assay utilised 120 nm streptavidin coated particles that were 
modified with a biotinylated VEGF aptamer33 at two different percentages of surface 
coverage. The first of the two experiments consisted of the streptavidin binding sites 
being saturated with the VEGF aptamer (termed FC, full coverage, in figures 6.1 and 
6.2); and the second consists of half the binding sites per particle, as per the supplier’s 
specification, being used (50 % aptamer coverage, termed HC, half coverage, in 
figures 6.1 and 6.2). The translocation speeds can also be used to confirm the aptamer 
surface coverage of the streptavidin coated particles, i.e. a particle with a lower 
percentage aptamer coverage will show a slower translocation speed than one with 
100 % aptamer coverage28. Figure 6.1 shows the particle velocities for streptavidin 
coated particles functionalised with 50 % (blue dataset) and 100 % (red dataset) 
aptamer coverage, the trend correlating with data described in chapter 5. The average 
particle velocities are denoted as 1/T0.50 were measured relative to when the particle 
was positioned 50 % of the way through the pore (see chapter 3 for more details). 
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Figure 6.1 - Particle velocity when positioned halfway through the pore (1/T0.50) for particles 
functionalised with VEGF aptamer for half coverage (HC) and full coverage (FC). Error bars represent 
standard deviation when n=3 independent replicates. A minimum of 500 particles were measured per 
sample. 
 
The change in translocation velocity is relative to a blank of an aptamer-modified 
particle that was not incubated with the target protein, results of which are depicted in 
figure 6.2. Previous studies have described how translocation velocity can be 
measured from each blockade event, or pulse, and converted into zeta potentials 
using Henry’s law28. This technique was able to distinguish between various DNA 
coverages and base lengths, as well as a range of DNA structures (i.e. ssDNA/dsDNA) 
on the particle’s surface28, as shown in chapter 5. In this particular study, rather than 
a conversion into zeta potentials, it is the relative changes in translocation velocity 
values that are used to reveal the presence of the DNA and proteins. 
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Figure 6.2 - Relative changes in particle translocation velocity as a function of VEGF concentration (nM}) 
for streptavidin coated particles functionalised with V7t aptamer at 50 % (HC, blue) and 100 % (FC,red) 
surface coverages. Error bars are representative of standard deviation where n=4 independent replicates. 
 
It can be hypothesised that following an aptamer binding to its target, the translocation 
velocities of the particles will change. Figure 6.2 shows the relative changes in 
translocation velocity (from the blank) observed as a function of VEGF concentration, 
with respect to both 50 and 100 % DNA coverages. By tuning the aptamer 
concentration on the particle’s surface, the dynamic range of the assay can be 
extended. 
The aptamer-modified particles with HC plateaued at VEGF concentrations above 2 
nM, which can be attributed to the protein binding capacity being reached and thus the 
maximum change in translocation effects to also be attained. Any additional proteins 
in the sample in this case will not change the numbers on the particle’s surface and 
will therefore not be measured via this technique. The aptamer-modified particles with 
FC exhibited a continuous decrease in particle velocity upon addition of VEGF until 
the protein concentration reached 18 nM, equivalent to circa 1000 proteins per particle. 
For both aptamer coverages, a decrease in translocation velocity was seen as the 
VEGF concentration increased, the addition of VEGF is expected to slow the particle 
translocation velocity as seen in chapter 6. Upon binding to the protein, the aptamer 
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shape is subjected to changing from a ssDNA structure to a folded tertiary structure, 
bringing the DNA closer to the particle surface, which could lead to a higher surface 
charge density on the particle itself. An increased surface charge density would result 
in an increase in particle velocity, however we see an opposite effect; the aptamer 
conformational change to a tertiary structure as it binds the protein target requires an 
increased amount of counter ions to stabilise that tertiary structure, decreasing the 
particle velocity. A decrease in particle velocity may be due to the charge of the protein 
target with a pI of 8.5 that is therefore positively charged at the pH used in this 
experiment (pH 7.4). Other parameters alluding to counter ion condensation include 
the shielding of the polyanionic DNA backbone. Shielding the negative charge on the 
phosphate backbone can evoke an increase in counter ion condensation onto the 
DNA42 and thus resulting in a decrease in particle velocity. Both particle assays (HC 
and FC) see this decrease with respect to their blanks, at a concentration of 18 pM as 
the lower limit of detection. 
Aptamer-modifed nanomaterials have been used in previous works in conjunction with 
the TRPS platform to measure a change in particle translocation frequency as the 
transduction signal10,37. The method presented in this study is more beneficial as it 
capitalises on the ability of TRPS technology to use data from each individual particle 
as they traverse the pore, and doesn’t rely on averaging the data across hundreds of 
particles per minute. The advantages of this include reduced run times a reduction in 
bias for multimodal samples containing different particle concentrations. 
6.5.2 Pore Modifications and Current Rectification Measurements 
An alternative to a particle based assay is to use the change in ionic current through 
the pore, which can be controlled through electrostatic interactions via the pore wall. 
Conical shaped pores show this effect to a greater extent and is typically recorded for 
pore openings where the diameter, Ds, is equal to the electrical double layer 
thickness22,43, although the double layer does not need to fully extend across the pore 
opening22. Larger pores have been seen to exhibit current rectification effects23,44. 
Detailed descriptions of rectification properties of conical pores can be found 
elsewhere43, where the degree of rectification is defined as the ratio of absolute 
currents recorded at a given negative potential and the identical absolute positive 
potential. At lower electrolyte concentrations, conical pores with charged surfaces do 
not exhibit  ohmic behaviour;  the magnitude of  the current  through  the nanopore at 
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negative potentials is greater or smaller than the current at the corresponding positive 
potentials, see figure 6.3. The current ratios can be tuned through variation of the 
electrolyte, pH, ionic strength, and applied voltage. In each case, the current-voltage, 
I-V, curves will record a preferred direction of current flow22,43 as shown in figure 6.3. 
 
 
Figure 6.3 - Schematic of the ion condensation present in the pore system and the respective current- 
voltage response for a positive(PEI) and negative (PAAMA) pore coatings. 
 
Tunable polyurethane pores have a small negative surface charge at pH >528,44. 
Unmodified pores used in this study had a pore diameter, Ds, of approximately 800 nm 
at a stretch of 45 mm, which can be calculated using the measured current in 50 mM 
KCl. The dimensions are likely to be averages as in some instances, the pore opening 
will not be spherical in shape, see figure 6.4. 
 
 
Figure 6.4 - SEM image of the topside of the NP200 pore. 
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Table 6.1 shows the rectification ratios for unmodified pores in 5, 10, 50 mM KCl, and 
PBS (137 mM). For 5 and 50 mM, the current rectification ratios were 1.48 and 1.04 
respectively, illustrating the return of the ohmic response at higher ionic strengths. 
 
Ionic Strength (mM) Rectification Ratio 
5 1.48 
10 1.46 
50 1.04 
PBS (137 mM) 1.09 
Table 6.1 - Rectification ratios for an unmodified pore at each ionic strength studied. 
 
This study focused on seeing if the surface chemistry of the pore could be modified 
simply using a layer-by-layer, LbL, assembly and in this case, PEI and PAAMA 
coatings were investigated. This system is well studied having been previously used 
to modify a range of materials45–50. A LbL assembly was preferred over other 
techniques with polyurethane pores, such as plasma treatment or grafting polymers 
into the matrix via swelling51–53, as it allows for a facile and rapid dip coating strategy. 
A LbL approach also allows for the thickness and porosity of the PEI/PAAMA 
monolayer/bilayer to be controlled in the future as shown by Fu et al46. who used a 
system similar to that by Yang et al48. They both showed the control of the bilayers to 
ensure they do not extend across the pore opening and that the thickness remains 
restricted to a few nanometres, we have adapted this approach to also ensure the PEI 
and PAAMA bilayers did not extend across the pore opening. 
Figure 6.5a illustrates the bilayer construction with alternate PEI and PAAMA layers 
and 6.5b shows the current-voltage curves for unmodified pores, single layer HMW 
PEI modified pores and HMW PEI-PAAMA modified pores, and double alternate layer 
HMW PEI-PAAMA modified pores in 5mM KCl. 
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Figure 6.5 - a) Illustration of the double Layer-by-Layer approach using PEI (blue) and PAAMA (red) 
bilayers. b) Current-Voltage response for each layer as it was coated onto the pore using HMW PEI. The 
black represents the response from an unmodified pore, the filled blue squares and white squares 
represent the 1st and 2nd PEI coatings, respectively. The filled red triangles and white triangles represent 
the 1st and 2nd  PAAMA coatings, respectively. The figures are adapted from Blundell et al54. 
 
Coating the pore surface with HMW PEI resulted in a reduced and enhanced current 
flow through the pore under negative and positive applied potentials, respectively, 
indicating a positive surface charge now on the pore55. The sequential PAAMA coating 
switches the surface charge to negative, resulting in the preferred direction of current 
flow being inverted, also shown in figure 6.5b. All rectification ratios using HMW PEI 
are shown in table 6.2 and were measured at potentials of ±1.6 V. The addition of 
each polymer layer in turn caused a favoured direction of current flow, and can be 
described as an ‘on state’. The magnitude of the rectification ratio is important as it 
can be used to assess the presence and quality of the pore coating. The rectification 
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ratio values were seen to improve as the number of coating layers increased, 
indicating a greater quality of the coating as more layers were present. 
 
 Rectification Ratio (HMW PEI) 
[KCl] (mM) 
Unmodified 
Pore 
PEI Layer 
1 
PAAMA 
Layer 1 
PEI Layer 
2 
PAAMA 
Layer 2 
5 1.38 0.45 2.42 0.37 2.86 
10 1.09 0.67 1.68 0.46 2.44 
50 1.09 0.92 1.10 0.73 2.09 
PBS (137 
mM, pH 
7.4) 
 
1.15 
 
0.81 
 
1.10 
 
0.93 
 
1.29 
 Rectification Ratio (LMW PEI) 
5 1.06 0.87 2.89 0.45 3.07 
10 1.01 0.96 1.21 0.73 1.35 
50 0.98 0.96 1.03 0.95 0.96 
PBS (137 
mM, pH 
7.4) 
 
0.98 
 
1.01 
 
1.00 
 
1.02 
 
0.97 
Table 6.2 - Rectification ratios for unmodified pores and pores modified with each polymer layer using 
HMW PEI (top data) and LMW PEI (bottom data) for each ionic strength studied. 
 
A similar effect was seen for LMW PEI, however the rectification ratios for each 
subsequent PEI and PAAMA layer were smaller than for HMW PEI as shown in figure 
6.6. This is most likely due to the nature of the PEI layer coating the pore surfaces; for 
example, the mechanism for LbL assembly goes through island formation before 
forming a complete layer and it is hypothesised that LMW PEI takes longer to form 
that fully coated surface layer54. Interestingly, even with the two bilayers added onto 
the pore walls, the pore opening remained unobstructed in both PEI cases. 
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Figure 6.6 - A plot describing the current-voltage response for each layer as it was coated onto the pore 
using LMW PEI. The black represents the response from an unmodified pore, the filled blue squares and 
white squares represent the 1st and 2nd PEI coatings, respectively. The filled red triangles and white 
triangles represent the 1st and 2nd PAAMA coatings, respectively. The figures are adapted from Blundell 
et al54. 
 
Figure 6.7 shows the effect of increasing the ionic strength on the current-voltage 
curves, with rectification ratios detailed in table 6.2. Increasing the ionic strength 
caused the rectification ratios for modified pores to tend to 1.0, which indicates a 
reduction in rectification effects. However, it is interesting to note that even at ionic 
strengths surpassing 100 mM KCl and a pore diameter circa 800 nm, some 
rectification is still observed. The current rectification may have been enhanced by the 
nature of the pore modification used here54. 
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Figure 6.7 - Current-voltage responses as a function of electrolyte ionic strength for a) an unmodified 
pore b) a pore modified with a coating of PEI and c) a pore modified with a coating of PAAMA. d) and e) 
show pore to pore reproducibility for both the PEI and PAAMA top coatings, respectively. The blue data 
represents the I-V responses in PBS (137 mM pH 7.4) and the yellow, green and red datasets represent 
the I-V response in 50, 10, and 5 mM KCl, respectively. 
 
The polyurethane pores have a large top surface area, TS, (circa 2.5 mm diameter54). 
During the pore modification LbL process, the top surface is also coated as well as the 
inner pore walls. Modifying both surfaces of the pore has been previously reported as 
151  
having a larger effect on the rectification ratio22. The LbL approach was reproducible 
on multiple pores and showed little hysteresis through multiple cycles and scan 
directions investigated54. It was also important to investigate the longevity of the pore 
coatings and the LbL approach resulted in the coatings being stable over short periods 
of time, even after multiple uses, washes, and being dried and stored overnight (figure 
6.8a/b). Once the coatings had diminished over time (and the rectification effects had 
returned to that of an unmodified pore) the same pore could be recoated and reused 
to show comparable results. 
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Figure 6.8 - Current-voltage responses for the pores coated with PEI/PAAMA bilayer and left for 2 hours 
(green dataset) and 4 days (purple dataset). a) and b) represent the longevity experiment on two different 
pores in 5 mM KCl. b) shows the coating starting to become diminished after 7 days (orange dataset) as 
the I-V response begins to return to that of an unmodified pore (black dataset). Figure is modified from 
that in Blundell et al54. 
 
The polyurethane pores in this study are flexible and altering the pore stretch should 
have inherent effects on the rectification ratio, a smaller stretch produces a higher 
rectification ratio. Figure 6.9 details the current-voltage curves as the stretch is 
decreased from 5 mm to 2 mm. As the pore opening size, Ds, and pore thickness is 
reduced, the observed current at positive potentials decreases. 
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Figure 6.9 - Current-voltage rectification response for a double layer coated pore stretched at 2 (pink 
squares), 3 (white triangles), 4 (white squares) and 5 mm (pink triangles) measured using 5 mM KCl. 
Figure adapted from work by Blundell et al54. 
 
As previously mentioned, changes in pH can also affect the current rectification 
properties of the pores. To test the effect of altering pH, the pore rectification effects 
were investigated at pH 3 and pH 7. Altering the pH will invoke a different charge 
density on the PEI-modified surface, for example a lowered pH of 3 will increase the 
charge density as more amine groups become protonated; which results in an 
increased current flow at positive potentials. Conversely, an increase in pH to a value 
of 7 will reduce the positive charge on the PEI. Changes in the current-voltage curves 
are also observed for the PAAMA-modified surfaces when the electrolyte pH is altered, 
opposite charge density effects to PEI54. At low pH, the charge density across the 
carboxyl groups is reduced and an I-V response similar to that of an unmodified pore 
is observed. A higher pH value of 7, for example will increase the negative charge 
density across the PAAMA surface resulting in a decrease in current flow at positive 
potentials54. 
The current flow through the pore has two contributing factors; the electroosmotic flow 
across the pore surface and migration of ions through the centre. Whilst others have 
shown this to be a small contributing factor to current rectification in smaller pores22, 
and that combined with the effect of the charge on the pore wall and top surface, Ts, 
has   the   largest   contribution   to   the   current   rectification22.  The  observation of 
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rectification behaviour does illustrate that the enriched ion zone at the pore mouth 
used to describe the rectification properties of smaller pores22,40 sufficiently exerts an 
influence across the larger opening, even when the electrical double layer is much 
shorter than the opening, Ds . This effect has also been attributed to biphasic pulse 
behaviour in TRPS44. The reported setup allows for the easy modification of the pore 
wall, and by using different polymers or different thickness it may be possible to further 
tune these larger pores to be ion selective. 
The positioning of the pore coating on the pore was therefore investigated to see 
whether a full pore wall coating (Ts and inner pore walls) is required to cause the 
observed current-voltage responses, or if the PEI/PAAMA bilayer on the top surface 
is sufficient for the response, illustrated in figure 6.10. 
 
 
Figure 6. 10 - Schematic of sole modification of the top surface, Ts of the pore using a double Layer-by- 
Layer assembly of PEI (blue) and PAAMA (red). 
 
 
The current-voltage curves are illustrated in figure 6.11 for each ionic strength studied 
when the PEI/PAAMA bilayer was just added to the topside of the pore via the same 
incubation process. 
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Figure 6.11 - Current-voltage responses for PEI (blue datasets) and PAAMA (red datasets) coated pores 
comparable to an unmodified pore (black datasets) for a) 5 mM KCl, b) 10 mM KCl, c) 50 mM KCl, and d) 
137 mM PBS. 
 
The results showed there was no change in the I-V response upon sole topside 
addition of HMW PEI and PAAMA. The rectification ratios are described in table 6.3 
for each of the electrolytes studied. 
 
 Rectification Ratio 
[KCl] (mM) Unmodified Pore HMW PEI Layer PAAMA Layer 
5 1.64 1.38 1.65 
10 1.12 1.00 1.10 
50 1.05 0.93 1.04 
PBS (pH 7.4) 0.97 0.94 1.09 
Table 6.3 - Table of rectification ratio values for each electrolyte studied for an unmodified pore and a top 
surface-modified pore with PEI and PAAMA. 
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6.5.3 Modifying Pore Walls with ssDNA and Subsequent Protein Detection 
The main motivation for modifying pores with polymers using the LbL approach was 
the ability to introduce functionalities on the pore wall that could be easily coupled with 
biomolecules. Gold-modified pores, for example allow thiol terminated ligands to be 
functionalised to the pore wall or for the use of the carboxyl groups42,56. The ssDNA in 
this study is immobilised onto the pore surfaces via EDC chemistry. Figure 6.12 shows 
the full current-voltage curves for a pore modified with PEI/PAAMA via LbL assembly, 
followed by DNA attachment in 50 mM KCl. A single bilayer of PEI and PAAMA was 
used as it was seen to be a sufficient coating for pore rectification effects to be 
oberserved (verified using I-V curves) and reduced the number of preparation stages. 
As shown in figure 6.12, the DNA-modified pore surface showed smaller rectification 
effects than the PAAMA-modified surfaces. This may be due to the increase in 
counterion condensation that occurs to stabilise the high number of ssDNA strands, 
resulting in inevitable shielding of the high negative charge densities, more ions 
present in the pore could also lead to a higher measured current. 
 
 
Figure 6.12 - Current-voltage response for a DNA-modified pore (orange dataset) in comparison to an 
unmodified (black dataset), PEI-modified (blue dataset), and PAAMA-modified (red dataset) completed in 
50 mM KCl. Figure is adapted from work by Blundell et al54. 
 
Once the DNA had been successfully crosslinked onto the pore surfaces, the pore 
was incubated with the protein target, VEGF and a strong rectification effect was 
observed (figure 6.13 for 50 mM KCl). 
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Figure 6.13 - Current-voltage curve for a DNA-modified pore (orange dataset) and upon the addition of 50 
nM VEGF (purple dataset) measured in 50 mM KCl. 
 
The DNA aptamer-protein interaction caused a decrease in current at positive 
potentials and was specific to VEGF (in the presence of BSA, figure 6.14a-d). The 
rectification properties observed here were similar to those observed for a lysozyme 
system in cylindrically shaped pores56. The reason for such behaviour was attributed 
to the proteins high pI value as well as the protein-DNA binding causing an inverted 
surface charge. The inversion thus resulted in a positive surface charge on one side 
of the pore and overall an asymmetric surface charge resulting in the current 
rectification. Our experiment may produce a similar effect as the introduction of the 
protein on one side of the pore produces a different surface charge density from the 
top to the bottom. Introducing the protein to one side could have resulted in a positively 
charged narrow pore opening (top surface), which would have suggested rectification 
properties to be opposite to what was observed (figures 6.13 and 6.14), i.e. an 
increase in current flow at positive potentials57, and thus was not the case in this study. 
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Figure 6.14 - Current-voltage curves for DNA-modified pores (orange datasets) and those incubated with 
50 nM VEGF protein (purple datasets) against a 50 nM BSA control (green datasets). The runs were 
completed in a) 137 mM PBS, b) 50 mM KCl, c) 10 mM KCl, and d) 5 mM KCl. 
 
The decrease in current at positive potentials, caused by the VEGF binding, is 
hypothesised to be a rectification effect that relies on VEGF’s high pI value (8.2) and 
positive charge. When the protein is bound to the DNA at the pore opening and Ts, the 
cation cloud density is increased at the pore opening. This cation increase is additional 
to the increase in counter ions required to stabilise the aptamer tertiary structure 
formed as it binds to VEGF and these two ionic factors contribute to the decrease in 
conductivity at the pore opening at positive potentials, as described elsewhere22. The 
current-voltage response was also monitored for a DNA-modified pore as a function 
of protein concentration (Figures 6.15 for 50 mM KCl). 
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Figure 6.15 - a) Current-voltage rectification curves with respect to VEGF concentration compared to a 
DNA-modified pore (black dataset) and that modified with a BSA control (red dataset). b) a close up of the 
effect of VEGF concentration on current at positive potentials. Figure reproduced from Blundell et al54. 
 
As the concentration of VEGF increased, the current measured at positive potentials 
decreased until concentrations beyond 5 nM. The rectification ratios for experiments 
in 50 mM are detailed in table 6.4. 
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VEGF Concentration (nM) Rectification Ratio 
5 pM 1.36 
50 pM 1.93 
0.5 nM 3.64 
5 nM 11.60 
50 nM 10.12 
50 nM BSA 1.53 
Table 6.4 - Current rectification ratios for a range of VEGF concentrations, including a BSA control. 
 
6.6 Conclusions and Further Work 
This study has presented a comparison between resistive pulse and current 
rectification aptamer assays using the same technology platform that could each 
detect VEGF to concentrations of 18 pM and 5 pM, respectively. The resistive pulse 
particle assay may offer a format that can be easily prepared and multiplexed by 
pairing each target with a unique particle size or shape. Although this widens the 
dynamic range for analysis, this assay’s sensitivity is limited by the number of proteins 
required on each particle surface to sufficiently alter the surface charge to cause a 
measurable difference in translocation velocity. Further optimisation and assay design 
steps may be required to improve the sensitivity of this technique. This can be 
achieved through specifically designing the particle size and shape to allow for a 
controlled and limited number of aptamers per particle, although this can complicate 
the assay time as the particle flux can be reduced when smaller particles/pores are 
used. The number of aptamers could also be controlled through the use of Janus 
particles to localise the biorecognition sites34. The second assay incorporated a LbL 
polymer assembly onto the polyurethane pore surface allowing for pH and ionic 
strength controlled current flow. The LbL method reported here offers a simple and 
reusable technique in modifying the surface chemistry of the pores. The tunable pores 
used in this study are unique in their abilities and versatility to both assay types 
investigated. 
The LbL pore modification approach is the first reported method that offers pH and 
ionic strength dependent current rectification behaviour on a TRPS system. It is also 
the first reports of the strong rectification on pores of the investigated dimensions, circa 
800 nm. The strength of the rectification properties indicates that the electrical double 
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layer does not need to extend significantly across the pore opening. The pore surfaces 
can be modified easily using the LbL assembly of polymers, such as polyethyleneimine 
(PEI) and polyacrylic acid co-maleic acid (PAAMA). The use of PEI and PAAMA 
allowed for easy modification and reversible changes in pore surface charge, resulting 
in a pH and ionic strength controlled current flow. The LbL assembly is stable for a 
number of days that allows for DNA-modification of the pore wall via standard 
carbodiimide chemistry. However, further work is required to investigate the effects of 
pore modifications on the top surface of the pore and the effects this has on the current 
rectification mechanism, to assess the total electroosmotic flow contribution in these 
systems. Further work is also required using aptamers to other targets, in this example 
an aptamer to BSA would also be useful in the control experiments. 
A potential limitation for future assays lies within complex biological solutions, where 
there is a tendency of proteins to foul the pore wall or particle surfaces58. This limits 
the assay because if non-specific protein fouling occurs to the particle surface or pore 
wall between or throughout experiments, this will impact on the assay’s reproducibility. 
This is because the particle translocation velocity is a contribution of the 
electrophoretic speed of the particle and the electroosmotic contribution of the pore 
wall, which should remain constant throughout experiments to ensure good 
reproducibility. This limitation could be abolished if the particles and/ or pore wall can 
incorporate a non-fouling coating that would prevent the non-specific adsorption of 
proteins that could be investigated as further work. Another potential solution would 
be to modify the pore walls directly to facilitate the detection of a specifically chosen 
analyte. There are other nanopore systems that have used the natural surface 
functionality of the nanomaterial or utilised a gold-modified pore to allow for simple 
attachment of materials56. At present there have been no reported modifications to the 
tunable polyurethane, PU, pores for RPS studies, although there are strategies 
available for the modification of the PU material53,59,60. 
This alternative will reduce the need for external nanomaterial ‘labels’ as the pore can 
be modified to detect a particular analyte itself. 
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7 Behaviour of Nanoparticles in Biological 
Solutions: Study of Protein Corona 
7.1 Abstract 
When introduced to a biological fluid such as blood, nanoparticles interact with the 
variety of biological components, particularly with proteins that result in the formation 
of a ‘protein corona’. The formation of a protein corona can significantly modify the 
behaviour and dynamics of nanoparticles in biological fluids. The use of TRPS 
technology provides a flexible sensing platform allowing for rapid detection and 
characterisation of nanoparticles in a range of environments. This study determines 
interactions between nanoparticles and various components of human blood including 
whole plasma, serum, albumin, immunoglobulin, and fibrinogen through zeta potential 
measurements using TRPS. 
Normal human plasma, serum and physiological concentrations of purified human 
albumin, immunoglobulin, and fibrinogen were studied. The three purified proteins 
have previously been found to be present in all nanoparticle-protein corona studies to 
date and have been validated using TRPS. Preliminary data has shown that 
nanoparticle interactions with human plasma are more prominent than those with 
serum; this has been demonstrated by the changes in zeta potential when 
nanoparticles are immersed in the respective sample. The change in zeta potential 
was monitored as a function of biological constituent, protein concentration, and 
temperature. 
Understanding the impacts on nanoparticle dynamics from each of the ‘protein corona’ 
components studied is important to monitor the nanoparticle-protein binding in 
biological fluids such as human plasma. Here we are making zeta potential 
measurements of the protein corona in solutions that mimic a solution of high ionic 
strength and high protein composition, similar to that of the natural environment. 
Investigating the effect of temperature also allows physiological temperature to be 
taken into account to again mimic the natural environment. Not only can TRPS be 
used to characterise the protein corona in terms of charge, it can also monitor the 
change in ‘hard’ and ‘soft’ corona elements through the introduction of components of 
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higher affinities to the nanoparticle surface (in this case spiking a sample containing 
particles immersed in serum with human plasma. Indication and information about the 
binding kinetics and mechanisms of the protein corona is profoundly useful to 
diagnostic1,2  and drug delivery fields3–5. 
7.2 Introduction 
Analysis of nanoparticles in natural environments is completed less than nanoparticles 
in purified samples with select targets. Purifying samples can sometimes give a 
misrepresentation of how the particles would actually behave in a biologically relevant 
or natural environment. There are several factors that are influential to nanoparticle 
dynamics and behaviour in solution including pH, temperature, and ionic strength. 
When nanoparticles are introduced to biological fluids, an almost immediate response 
is the coverage of the particle surfaces with various proteins and peptides found in 
these solutions. This coverage can otherwise be known as a ‘protein corona’ layer6–8. 
The protein corona composition is the main contributor to changes in the 
nanoparticle’s surface chemistry and thus its behaviour in solution. Changes of this 
magnitude will alter the properties of the particles and have even been reported as 
affecting pathophysiological effects of the particles themselves9. Particles of similar 
compositions but difference surface chemistries will entail different protein corona 
structures6,10  that can be complex and difficult to characterise. 
Previous techniques used to characterise protein corona structures include dynamic 
light scattering11, fluorescence quenching11, differential centrifugal sedimentation12,13, 
mass spectrometry10,14, circular dichroism (CD)11 and electron microscopy11 that have 
also been used to interpret the layer thickness of the corona. The layer thickness and 
density are one of five main components defining a protein corona composition; 
identity and quantity, orientation, conformation, and affinities constitute the other 
four15. As well as studies on the conformation of the protein corona, the affinity is also 
a popular and interesting characteristic, previously measured by size exclusion 
chromatography, surface plasmon resonance and isothermal calorimetry12,13,16. Zeta 
potential, the electrostatic potential at the plane of shear, is one of the more recurrent 
values used to characterise a corona6,8,10,17,18 as an indication of surface charge. 
The structure of a protein corona is detailed and complex and is formed of a series of 
layers that are defined as the ‘hard’ and ‘soft’ corona. The proteins creating the  hard 
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corona layer are those with a higher affinity to the nanoparticle surface than those in 
the soft corona. The soft corona is made up of weaker protein-protein interactions with 
those in the hard corona, whereas the hard corona involves much stronger interactions 
with the nanoparticle surface13,19. Apolipoproteins found in physiological fluids are 
prone to binding to a range of particle surfaces and are present in almost every protein 
corona formation14. 
The initial formation of the corona may not be the structural entirety of the corona itself 
as this is dependent on protein adsorption kinetics and the binding mechanisms that 
will occur in a natural environment. The adsorption, and desorption rate constants of 
the proteins, kon and koff, are key to understanding the binding mechanisms as well as 
the process being naturally time dependent. The adsorption rate is dependent on the 
number of times the protein interacts with the nanoparticle surface alongside the 
probability of successful protein-particle binding20. Desorption of bound proteins will 
depend heavily on the binding strength between the two materials20. If an interaction 
is of low energy and is weak, the koff value will be high and if the interaction is strong 
and of high energy, the koff value will be low. Characterising and validating 
nanoparticle-protein interactions and protein binding from each protein studied will 
develop a much needed further understanding on how nanoparticle exposure to a 
biological matrix can impact on nanomedical fields. 
7.3 Aims and Objectives 
The main aim of this study was the investigation of protein binding kinetics within 
biological solutions and kinetics of formation of a protein corona. Validation of 
nanoparticle-protein interactions in such solutions is important for the future design of 
particle-based assays that can be completed in vivo. 
7.4 Materials and Methods 
 
7.4.1 Chemicals and Reagents 
 
7.4.1.1 Buffers 
Phosphate buffered saline (1 x PBS tablet, 0.01 M phosphate buffer, 0.0027 M 
potassium chloride, 0.137 M sodium chloride, pH 7.4 in 200 mL deionised water (18.2 
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MΩ cm)) was used as the initial electrolyte for analysis. PBS tablets (P4417) were 
purchased from Sigma Aldrich, UK. 
7.4.1.2 Particles and Particle Standards 
Carboxylated polystyrene particles with a nominal diameter of 210 nm, CPC200s, 
were purchased from Bangs Laboratories, US and were used as a calibrant for zeta 
potential analysis, as well as sample particles. The particles were vortexed for 30 
seconds followed by a 2-minute sonication prior to any TRPS analysis or sample 
incubation to ensure monodispersity. 
7.4.1.3 Isolated Proteins and Blood Samples 
The isolated proteins (fibrinogen from human plasma (≥80 %, F3879), albumin from 
human serum (lyophilised powder, ≥97 %, A9511), and γ-globulin from human blood 
(≥99 %, G4386)) were purchased from Sigma Aldrich, UK, without modification of 
purification unless otherwise stated. 
Blood samples were collected and prepared at Peterborough City Hospital Pathology 
Laboratory, UK. Plasma collection was completed using blood from a healthy 
volunteer donor that was collected in citrate medium (Sarstedt, UK) and centrifuged at 
3000 rpm for 8 minutes. Serum was gathered using blood from a healthy volunteer 
donor that was collected into a Sarstedt monovette/collection tube, and was 
centrifuged at 3000 rpm for 6 minutes. The supernatants from each sample were 
transferred into separate sample vials and stored at room temperature prior to use. 
7.4.2 Methods 
 
7.4.2.1 Isolated Protein Studies 
Using PBS as an electrolyte, isolated fibrinogen, γ-globulin, and albumin samples were 
prepared to the following concentrations; 3.2 g/L, 20 g/L, and 43 g/L respectively, as 
to mimic protein concentrations found in human blood. The concentrations of proteins 
were measured from human plasma and serum samples. The samples used in this 
study were analysed by an Instrument Laboratory ACL TOP CTS500 coagulation 
analyser (Werfen, Spain) to obtain the fibrinogen concentration. Albumin and 
immunoglobulin levels were taken from test serum samples that were analysed by a 
Roche Cobas biochemistry analyser (Roche Diagnostics, Switzerland). CPC200s 
were added resulting in a final concentration of 1 x 1010 particles/mL. Each sample 
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was vortexed for 30 s and sonicated for 1 minute before incubation. Samples were 
then incubated at 25oC and 37°C in a mini dry bath (Benchmark Scientific, US) for 10 
minutes prior to TRPS analysis. 
7.4.2.2 Serum and Plasma Studies 
Human plasma and serum were prepared immediately before the experiments to 
minimise ex-vivo artefactual changes. The prepared plasma and serum were 
separately diluted 10-fold with PBS before CPC200s were added to both samples 
resulting in a final particle concentration of 1 x 1010 particles/mL. Samples were 
vortexed for 30 s and sonicated for 1 minute, followed by incubation in a mini dry bath 
(Benchmark Scientific, US) at 25°C and 37°C for 10 minutes before being removed for 
TRPS analysis. It should be noted that it is possible for some proteins in human plasma 
and serum to interact and adsorb onto the pore walls; therefore, a control 
measurement of CPC200s in PBS (of known zeta potential) was completed before 
and after each protein/plasma/serum sample to establish if any changes had occurred 
to the pore itself. 
7.4.2.3 Plasma Spiking Assay 
Human serum was 10x diluted in PBS before CPC200s were added to a final 
concentration of 1 x 1010 particles/mL. Samples were vortexed for 30 s and sonicated 
for 1 minute before being incubated for 10 minutes at 25oC and 37°C in a mini dry bath 
(Benchmark Scientific, US). At 10 minutes, 5% (v/v) human plasma was added to the 
serum samples and the samples were vortexed for 30 s. TRPS measurements were 
completed once the plasma had incubated with the serum sample for 5, 10, 15, 20, 30 
and 60 minutes. 
 
7.4.2.4 TRPS Analysis ad Zeta Potential Calibration 
All TRPS measurements were carried out on the qNano (Izon Science Ltd, NZ) using 
Izon Control Suite data capture and analysis software v.3.1.2.53. The nanopores used 
throughout all experiments were capable of detecting particles in the size range of 
100-300 nm (as stated by the manufacturer, Izon Science Ltd, NZ), denoted as an 
NP200. Full details of TRPS setup and calibration of the nanopores for zeta potential 
measurements using pressure can be found in chapter 2, subsection 2.2.2. 
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7.5  Results and Discussion 
Zeta potential measurements were made using particle velocities as they traversed a 
nanopore membrane. The theory is fully detailed in chapter 3 and can also be found 
elsewhere21,22. In summary, particle translocation effects are measured as a function 
of an applied voltage, where the average particle velocities are taken over the sensing 
zone, in this case a regular conical pore. Figure 7.1 is a summarised representation 
of the components required to complete a zeta potential measurement based on the 
particle electrophoretic mobility through the pore. 
 
 
Figure 7.1 - Example of a TRPS measurement using a conical pore and the signal trace indicating the 
blockade duration times, T with respect to the relevant position within the pore, I. Figure adapted from 
Blundell et al23. 
 
The figure shows the regular conical sensing zone and examples of the blockade 
duration times, T, that are equivalent to the times at which the particle is at a certain 
position within the nanopore, I. For example, T0.4 is the time equivalent to when the 
blockade was at 40 % magnitude and is relative to position I0.4 when the particle is 
60% of the way through the pore; T1.0 is the time equivalent to the blockade being at 
dRmax, at its maximum magnitude, and relative to I1.0 the pore entrance. Each T is 
referred to as a ‘blockade reference point’ and the average particle velocities are 
determined across several of these reference points to reduce any errors in the zeta 
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potential calculation process21. The calibration of the pore membrane has been 
previously described in detail in chapter 2. 
The isolated proteins of choice for this study are human albumin, γ-globulin (4 and 2 % 
relative abundances in both blood plasma and serum, respectively), and fibrinogen 
(0.4 % relative abundance in blood plasma)23. Figure 7.2 demonstrates the zeta 
potential values for each of the isolated proteins incubated with the nanoparticles at 
room temperature (purple bars) and 37oC (orange bars). The green bars indicate a 
control experiment of the nanoparticles in PBS buffer showing that the protein samples 
did not have a direct influence on the zeta potential of the pore itself. These controls 
were important between each protein sample to ensure the zeta potential of the pore 
membrane did not change for each sample as it is a key factor in calculating the 
particle zeta potential, further described in chapter 3. 
 
 
Figure 7.2 - Mean zeta potential (mV) for carboxylated particles in PBS buffer (green bars) and particles 
incubated with fibrinogen, γ-globulin, and albumin for 10 minutes at 25oC (purple bars) and 37oC (orange 
bars) at varied protein concentrations. Error bars represent a standard deviation of n=3 independent 
replicate samples measuring a minimum of 250 particles. 
 
The concentrations of the proteins varied to replicate a natural environment and 
compositions of human blood in the human body. The albumin solution was of a 40 
g/L concentration, the highest of all the isolated proteins studied (fibrinogen and γ- 
globulin were of concentrations of 4 and 20 g/L, respectively), but it should be noted 
that each protein was added to the particles in excess so it is expected that the 
particles will each be saturated by the proteins. Full coverage of the particles by the 
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proteins suggests the proteins will adsorb onto the particle surfaces and a protein 
corona will have formed. This assumption is confirmed by the change in zeta potential 
shown in figure 7.2 as the formation of a protein corona results in a change to the 
particle’s surface chemistry, causing a change in the particle’s velocity and thus zeta 
potential. 
At room temperature, the largest change in zeta potential from nanoparticles in buffer 
was seen for the albumin protein (9.2 mV), with both the fibrinogen and γ-globulin 
showing smaller changes in zeta (3.2 and 3.6 mV, respectively)23. The magnitude of 
change in zeta potential may be due to the isoelectric points of the proteins. Albumin 
has an isoelectric point of 4.7, much lower than fibrinogen (5.8) and γ-globulin (6.6)24. 
Tengvall et al. have found that adsorbed molecules will occupy a larger area of a 
surface when the adsorption pH is further from that of protein itself, due to the 
increased structural instabilities caused by electrostatic repulsions25. The pH of each 
solution (using PBS as an electrolyte) was around 7.4 and it is therefore expected that 
the albumin protein would occupy the largest area of the nanoparticle surface at room 
temperature. 
The albumin protein was of the highest concentration at 40 g/L. To demonstrate that 
the impact on nanoparticle translocation effects was protein dependent and not 
concentration, the nanoparticles were incubated with the 3 isolated proteins of 
constant concentration, 5 g/L at 25oC. The data is summarised in figure 7.3 and shows 
that the largest shift in zeta potential (compared to the particles in PBS buffer control, 
green lines) was still observed for the albumin protein (8.9 mV) followed by γ-globulin 
(4.9 mV) and the smallest change from fibrinogen (4.3 mV)23. This confirms the effects 
on the nanoparticle surface are protein dependent and not concentration dependent 
in this study. 
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Figure 7.3 - Mean zeta potential (mV) of carboxylated particles incubated with 5 g/L of each isolated 
protein studied. Figure adapted from supplementary information from Blundell et al23. Error bars 
represent a standard deviation of n=3 independent replicates measuring a minimum of 200 particles. 
 
The effect of each protein on particle zeta potential was also investigated as a function 
of temperature and it was found that increasing the incubation temperature had a 
significant effect on the protein-nanoparticle interactions. This was shown by the 
significantly larger changes in zeta potential observed for both fibrinogen and γ- 
globulin, particularly γ-globulin (11.3 mV, figure 7.2, from particles in PBS) when the 
incubation temperature was elevated. There was also a larger change in zeta potential 
for albumin, but this wasn’t as significant as it was for the other two proteins. 
A lot more information about the given samples can be extracted due to the particle- 
by-particle nature of TRPS. Each peak observed in the signal trace (figure 7.1) is 
representative of a single particle as it traverses the nanopore showing the analysis of 
every individual particle amongst a sample population. From this, the zeta potential 
distribution can be used to gather additional information about the nanoparticle 
behaviour in the sample solutions. Figure 7.4 is an example of the differences in zeta 
potential distribution between the samples containing each of the isolated proteins. 
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Figure 7.4 - Zeta potential distribution of carboxylated particles incubated with fibrinogen, γ-globulin, and 
albumin (orange, blue, and purple datasets, respectively) at 25oC, filled distributions, and 37oC, outlined 
distributions. 
 
Zeta potential distributions for samples incubated with the particles at room 
temperature (25oC) are shown by the orange (fibrinogen), blue (γ-globulin) and purple 
(albumin) filled datasets and samples incubated with the particles for 10 minutes at 
37oC are shown by the outlined data plots for fibrinogen (orange), γ-globulin (blue) and 
albumin (purple). The shape of the spread of the zeta potential data doesn’t particularly 
change between each of the proteins incubated with the particles at room temperature 
but does widen when the incubation temperature is increased to 37oC. This effect was 
most prominently seen for the fibrinogen data and least so for the albumin sample. 
Between the samples incubated with the particles at 25oC and those incubated at 
37oC, it is γ-globulin that demonstrated the largest change in zeta potential (5.0 mV) 
as a function of temperature The smallest change was demonstrated by the albumin 
protein with a zeta potential difference of 1.3 mV between a lower and higher 
incubation temperature23. From a control sample of particles in buffer, it is the shift in 
the zeta potential spread to smaller zeta potential values when the incubation 
temperature is increased that is significant. The change in zeta potential may be due 
to the protein affinities being influenced by the incubation temperature as previous 
work has found that negative particles have a maximum protein adsorption at 15, 35, 
and 37oC26, explaining why the particles incubated at 37oC showed a larger change 
than those incubated at 25oC. 
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The spread of data concerning particle size and zeta potential is illustrated in figure 
7.5 compared to the particles incubated in PBS buffer (black triangles). Figure 7.5a 
shows the spread of data when the proteins are incubated with the particles at 25oC 
and figure 7.5b shows the data spread when the incubation has occurred at 37oC. 
 
 
 
Figure 7.5 - Zeta potential (mV) vs particle size (nm). The orange, blue and purple data points are zeta 
potential and size distributions for particles incubated for 10 minutes with fibrinogen, γ-globulin, and 
albumin, respectively at a) 25oC and b) 37oC. The black data points represent the carboxylated particles 
in PBS buffer. It should be noted that each data point represents a single particle amongst a given 
sample population where a minimum of 350 particles was measured per sample. Figure adapted from 
Blundell et al23. 
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Of interest, the size distribution of the γ-globulin sample and particularly the fibrinogen 
dataset (blue and orange, respectively) are wider when incubated with particles at 
25oC (182-391 nm for γ-globulin and 183-385 nm for fibrinogen). At 37oC the 
population distributions are narrower and this attributes to the protein binding kinetics 
differing as a function of temperature. As mentioned previously the protein affinities 
can be affected by temperature26, the proteins that have a higher affinity to the 
nanoparticle surface will either form a strengthened, robust hard corona layer or 
induce a slower release or desorption of the proteins from the surface. A robust hard 
corona layer will significantly alter the surface chemistry and thus shielding the original 
negative charge of the particle resulting in a slower velocity through the pore and thus 
a smaller measured zeta potential. A lower incubation temperature may not have 
formed as robust of a hard corona layer and may still have a larger soft corona layer 
surrounding the particle surface based on the findings that maximum protein 
adsorption may not have been reached at 25oC26, which also supports the small 
changes in zeta potential shown in figure 7.2. 
Although there is a lot of interest surrounding isolated protein-nanoparticle 
interactions, the more challenging aspect is when there is a medium containing a 
complex mixture of proteins, such as plasma or serum. Although both similarly 
extracted from whole blood samples, the compositions of both are different. For 
example, the protein composition of serum includes albumin, γ-globulin, and 
apolipoproteins. Plasma however, contains the same proteins as serum but with the 
addition of clotting factors such as fibrinogen (relevant to this particular study). 
Incubating the particles with plasma and serum for 10 minutes will provide valuable 
information on how nanoparticles behave in biological solutions in a complex medium. 
The plasma and serum were both investigated under the same conditions as the 
isolated protein samples, incubated with the nanoparticles for 10 minutes at 25 (blue 
bars) and 37oC (red bars), results summarised in figure 7.6. 
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Figure 7.6 - Mean zeta potential (mV) of particles in PBS buffer (green), particles incubated in plasma and 
serum for 10 minutes at 25oC (blue bars) and 37oC (red bars). Figure adapted from Blundell et al23. Error 
bars represent a standard deviation of n=3 independent replicates. A minimum of 300 particles were 
measured per sample. 
 
There were only very small changes in zeta potential (1.5 and 1.3 mV for plasma and 
serum, respectively) for the samples incubated with the particles at 25oC, as was seen 
for two of the isolated proteins (fibrinogen and γ-globulin) at this incubation 
temperature. However, when incubated with the particles at the higher temperature of 
37oC, only the serum sample showed a significant change in measured zeta potential 
totalling 5.9 mV23. This is interesting as the plasma still only showed a small change 
in mean zeta potential, even once incubated with the particles at an elevated 
temperature (1.9 mV)23. Figure 7.7 shows examples of zeta potential distributions for 
both plasma (red dataset) and serum (blue dataset) incubated with the particles at 
37oC, in comparison to particles suspended in PBS buffer (green dataset). 
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Figure 7.7 - Zeta potential distributions (mV) of particles incubated for 10 minutes at 37oC. The green, red, 
and blue datasets represent the particles incubated with PBS buffer, plasma, and serum, respectively. 
Each sample measured a minimum of 300 particles. 
 
A comparison of the zeta potential distributions for plasma and serum samples 
incubated at the two temperatures is demonstrated in figure 8.8. The effect the 
biological fluids had on the nanoparticles may have been due to their composition. The 
main difference in composition between plasma and serum is the clotting factors 
present in plasma, which will impact on the protein corona structure and therefore the 
protein-nanoparticle interactions15. The difference in protein composition for the 
plasma and serum is what can make protein corona formation challenging in 
physiological conditions as protein-nanoparticle alongside protein-protein interactions 
are occurring simultaneously and sometimes competitively binding to the nanoparticle 
surface15. The competitive binding to the nanoparticle surface is natural between the 
proteins is plasma and serum so the proteins of higher affinity and/or concentration 
will bind to the nanoparticle surface at a faster rate. The protein-protein interactions 
will impact on a protein corona formation as some proteins may have a higher affinity 
to other proteins in the medium over the particle surface. 
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Figure 7.8 - Zeta potential distributions (mV) for particles incubated for 10 minutes with a) plasma and b) 
serum. The filled datasets represent incubations at 25oC and the outlined datasets represent a 37oC 
incubation temperature, a minimum of 300 particles were measured per sample. 
 
Both the plasma (figure 7.8a) and serum (figure 7.8b) showed a change in zeta 
potential distribution shape when the incubation temperature was changed. The 
distributions are much wider when the incubation temperature was lower and much 
narrower on the contrary. The advantages of distribution studies are the subtle 
differences that can be determined outside of the mean values. Although the mean 
zeta potential value for plasma didn’t change much with the incubation temperature, 
the distribution histogram showed significant shape changes. For example, in figure 
8.6, the particles incubated with plasma showed a mean zeta potential value difference 
of a mere 0.4 mV but a change in distribution shape of nearly half the size for 37oC 
(outlined datasets) than for 25oC (filled datasets) as shown in figure 7.8a. 
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Another definition of the distribution shape is median skewness, values that can be 
calculated to indicate the level of skew amongst a given sample population. The 
median skewness values for the plasma and serum experiments are detailed in table 
7.1, where the same effect was seen for both plasma and serum, the higher the 
incubation temperature, the more negative the median skewness value: 
 
 
Biological 
Sample 
 
Incubation 
Temperature (oC) 
 
Incubation Time 
(min) 
Median 
Skewness of 
Sample 
Distribution 
Plasma 25 10 0.111 
Plasma 37 10 -0.065 
Serum 25 10 -0.105 
Serum 37 10 -0.343 
Table 7.1 - Summary of median skewness values for sample population distributions of zeta potential for 
particles in both plasma and serum in PBS at the two investigated incubation temperatures. 
 
It was intriguing to find the impact a small difference in protein composition could have 
on the nanoparticle-protein interactions. To investigate this further, an experiment was 
designed to encourage possible competitive and displacement reactions of proteins 
within the sample. This will interpret the nature of the hard corona and the possible 
definition of proteins having prominent effects as well as the composition and 
formation of the soft corona. This part of the study was relevant to divulge further into 
protein adsorption onto a particle’s surface and in turn, the Vroman effect. The Vroman 
effect is defined as the constant change in protein composition whilst undergoing 
continuous adsorption and desorption at an interface or surface27. The rate constants 
of adsorption, desorption, and dissociation are dependent on the interface itself as well 
as the proteins present in the sample. 
To put this into context, the three isolated proteins studied here (albumin, γ-globulin, 
and fibrinogen) will each adsorb rapidly onto a particle’s surface as they are all of high 
abundance in their respective samples, but it should be known that each protein also 
dissociate from the surface quickly and are generally replaced by apolipoproteins 
almost immediately28. The apolipoproteins have the advantage of a slow dissociation 
constant so will remain on a surface for longer29, even though they are of lower 
abundances and bind to the surface after other proteins in the solution. This leads to 
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the assumption that there are several protein-based competition elements occurring 
when nanoparticles are immersed into biological fluids. Not only is there competition 
for the nanoparticle surface, but also for other proteins in solution that some proteins 
may have a higher affinity for over the nanoparticle surface, which will directly 
influence the protein corona structure and composition. Over time the competitive 
assays occurring within the solution will encourage displacement and exchange 
reactions to the nanoparticle surfaces and the hard/soft coronas. As explained 
previously in the chapter, the hard corona will involve the proteins of higher affinities 
to the particle’s surface and should remain on that surface during and after any 
biophysical occurrences have taken place15. The soft corona, however, involves the 
weaker protein interactions that are expected to dissociate much more rapidly, thus 
encouraging protein exchange much more readily. 
The formation of hard and soft coronas is dependent on the relative concentrations of 
proteins in a given sample, such as plasma and serum, as it is well known that proteins 
of a higher concentration will tend to gain coverage over the nanoparticle surfaces at 
the first instance14 at a faster rate than those of lower concentrations. If the proteins of 
lower concentrations have a higher affinity to the nanoparticle surface, they will 
eventually exchange with the less affinitive proteins that initially occupied the particle 
surfaces. Based on the nature of the study, the process is also surface dependent and 
it should be noted that there have been cases where proteins of the highest 
concentration may also have the highest affinitive properties to a given nanomaterial 
and will therefore adsorb first and have the longest residence time30. 
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Figure 7.9 - a) Mean zeta potential (mV) vs time after plasma introduction to the sample (min). The 
samples were initially incubated with serum for 10 minutes at 37oC and plasma was subsequently added 
and the zeta potential measured at several time intervals. b) A schematic representation of the formation 
kinetics of a hard and soft corona dependent on the plasma/serum proteins present in solution, including 
protein displacement and exchange reactions. b1) particles incubated in serum, followed by introducing 
plasma to the sample for i) 5 minutes, ii) 10 minutes, iii) 15 minutes, and iv) 20-60 minutes. Figure is 
adapted from Blundell et al23. Error bars represent standard deviation where n=3 independent replicates. 
 
Figure 7.9i shows the corona coverage of the particles when they were immersed in 
serum for 10 minutes and plasma for 5 minutes where the serum proteins from the 
serum (as they have been incubated with the particles for longer) or proteins of higher 
concentration/ affinity have formed the hard corona (pink) and the others have formed 
the soft corona (orange). After the plasma has been introduced for 5-10 minutes (7.9ii) 
the proteins present in the plasma, but not the serum (purple), become part of the soft 
corona layer. The introduction of additional proteins will shield the particle’s original 
surface charge and thus result in a smaller zeta potential. After 15 minutes of the 
plasma being present (7.9iii), some of the plasma proteins (purple) may have had an 
eventual higher affinity to the nanoparticle surface causing the original serum protein 
hard corona (pink) to be displaced and exchanged into the soft corona layer13,19. The 
different proteins that have formed the new hard corona layer will have a different 
effect on the nanoparticle itself, which may be responsible for a reduction in the particle 
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velocities and thus zeta potential value. After 20 minutes and tailing off to 60 minutes 
(7.9iv), the zeta potential value started to become larger again suggesting there is less 
of a protein corona surrounding the particle surface. The low density of proteins now 
surrounding the particle may be due to the depletion of the soft corona that only 
incorporates weak protein-protein interactions. The most weakly bound proteins may 
dissipate into solution over time31 and may have been the proteins that were displaced 
from the original hard corona after being reversibly bound to the particle surface. As 
the proteins dissociate away from the nanoparticles, there is less hindrance on the 
particle’s transport and thus a larger zeta potential value is expected to be reported. 
These results are of interest as it shows how the behaviour of nanoparticles can 
change dependent on whether they come into contact with isolated or a complex 
mixture of proteins. 
7.6 Conclusions and Further Work 
This study has investigated the effects the main constituents of a protein corona have 
on a carboxyl nanoparticle surface. The effects on the nanoparticle behaviour varied 
dependent on the medium and complexity of the protein solution, whether the particles 
were immersed with isolated proteins diluted with PBS or in whole plasma/serum 
samples with a range of proteins. This is important for future bioassays regarding the 
protein corona as although the isolated proteins studied each affected the nanoparticle 
surface, particle transport needs to be investigated for samples containing composite 
protein mixtures that may replicate the composition in whole blood, in the human body. 
Formation of the protein corona has been found to be protein dependent at 25oC as 
well as temperature dependent with an increased incubation temperature encouraging 
protein binding to the particle surface. Each isolated protein (albumin, γ-globulin, and 
fibrinogen) and the serum sample showed a large change in zeta potential when 
incubated with the nanoparticles at 37oC, whereas the plasma sample showed little 
change. The plasma did however, have a substantial effect on the zeta potential of 
particles that had previously been incubated with serum (at 37oC), demonstrating 
some of the protein exchange processes that are completed when competition 
between the protein compositions is introduced. Further work on this aspect would be 
to investigate more isolated proteins from plasma/serum including the apolipoproteins 
and other clotting factors, for example. Investigating these proteins individually as well 
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as in mixtures with each other will allow for further information and characterisation of 
the proteins that are more likely to displace/exchange with others in the protein corona 
formation process. It would also be interesting to analyse mixtures of the 3 most 
common proteins found in the corona (albumin, γ-globulin and fibrinogen) to 
investigate their interactions with each other in a less complex medium. 
TRPS has easily identified the formation of a protein corona on a nanoparticle surface, 
both the formation of stable hard/soft corona layers and monitoring weaker protein- 
protein interaction and dissociation effects involved. The single particle analysis 
approach has been advantageous to this study as the distribution analysis of a number 
of samples has given a more detailed picture on the binding kinetics and affinities of 
the proteins to the nanoparticle surfaces. Being able to monitor protein-nanoparticle 
interactions in complex media and in physiological conditions is of great use to 
therapeutic and diagnostic industries, as well as future bioassay/biosensor research. 
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8 Overall Conclusions and Further Work 
Chapter 3 details a derived method for calculating zeta potential using TRPS analysis 
and has been optimised based on signal interpretation and calculating zeta potential 
relative to particle velocity as they traverse small pores. Measuring Zeta potentials has 
then been investigated with respect to DNA/protein packing density, DNA base length 
and structure, target analyte hybridisation time, influence of protein rich solutions, and 
impact of phage samples. Incorporation of a tunable pore into Coulter counter-based 
systems such as RPS allows for the pore stretch to be altered in real time to suit each 
sample during its analysis for optimised measurements to be carried out easily in real 
time. 
It was seen that small differences in DNA base length, concentration, and structure 
could be discriminated in assay times as short as 30 minutes, see chapter 4. The level 
of sensitivity of the measurements were as low as differentiating between 15 bases in 
length and between two different dsDNA structures that in fact have the same DNA 
density (the mid-binding and end-binding partially complementary targets to the 
capture probe DNA). A method and technology that encompassed this level of 
sensitivity and short assay times is encouraging for medical and diagnostic fields. 
Another challenging aspect for these fields is the quantification and characterisation 
of small particles/molecules and chapter 5 summarises experiments designed to 
overcome these challenges. A controlled aggregation assay was devised and first 
demonstrated using a streptavidin-biotin interaction where 115 nm streptavidin coated 
particles were incubated with an excess of 70 nm biotinylated particles, a change in 
size and zeta potential was seen when the smaller particles saturated the 115 nm 
particle surfaces. The aggregation profile when the particle concentrations were equal 
was of interest as a small change in zeta potential was observed as well as a mean 
particle size increase to around 307 nm. This assay design was then applied to an 
aptamer-protein interaction where VEGF and an anti-VEGF aptamer were detected 
using zeta potential measurements with the relevant particle ‘tag’. The aptamer and 
protein particle modifications detailed in chapter 5 have proven successful for small 
analytes such as VEGF protein and results are encouraging for future bacteriophage 
analysis. The prospect of a small particle ‘tagging’ concept drives toward the possibility 
194  
of detecting and characterising several small molecules/entities that are a challenge 
to detect and characterise individually. 
Applications are focused largely toward biomolecules in their respective media and 
natural environments. TRPS has the versatility to carry out measurements in a range 
of biological solutions. Currently bacteriophage, proteins, DNA, and surface-modified 
nanoparticles have been primarily addressed with avenues leading toward viruses, 
bacteria, and blood particulates, for example. Characterisation of the charge effects of 
bacteriophage and their behaviour in solution is limited so introducing experiments 
controlling the orientation of the bacteriophage will be an asset to these fields. 
Applications within biomedical and diagnostic fields as the developed technique can 
detect, quantify and characterise complex samples in real time without the need for a 
fluorescent label, isolation or purification. The technique can be further applied to 
environmental fields. Chapter 5 shows the size analysis of Salmonella phage, 
coliphage, and Clostridium difficile phage samples in their respective media. The 
analysis was extended to zeta potential measurements for the Salmonella and 
coliphage samples. 
Chapter 6 describes other means of protein detection was to modify the pores 
themselves with a DNA aptamer and use the current rectification effects to detect and 
quantify VEGF, this method was compared with a particle assay using aptamer- 
modified particles and detection limits were both found to be in the picomolar region 
(18 pM and 5 pM for the pore and particle-based assays, respectively). There is a 
large scope for the analysis of rod-shaped particles to gain further information on how 
particles and molecules of this design may behave in solution with respect to the TRPS 
technique, and may provide more information on bacteriophage transport mechanisms 
in solution. The effect of counterions and the electrostatic forces within the nanopores 
is not yet fully understood and future experiments may allow for more information to 
be gathered on this particular subject to help expand the current rectification 
experiments and to continue the work on aptamer/protein modified pores for a label- 
free pore based assay negating the need for particles, possibly into a multiplexing 
context. 
Further work is required to optimise multiplexed and multimodal particle analysis of 
samples containing three, four and beyond different sizes of particle. The multiplexing 
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aspect could also be expanded in versatility into the separation of particles with 
differing charges amongst a complex sample population. This would then lead to the 
thorough analysis of whole blood samples without the need for sample purification or 
sample clean up. The analysis of real blood is a profound experiment for the future of 
this technology in hand held point of care devices, for example. Further development 
of a method for multimodal sample analysis includes using numerous particles, each 
specific to a particular protein in a complex sample mixture. By optimising particle- 
based assays with aptamer capture probes, the dynamic range of analyte detection 
and characterisation will be expanded that could eventually lead to reduced non- 
specific binding effects in complex mixtures. 
Chapter 7 shows examples of particle analysis in complex mixtures as carboxyl 
polystyrene particles were immersed in protein rich solutions, including plasma and 
serum leading to protein ‘corona’ formation around the particles. Size and zeta 
potential measurements were completed as a function of temperature and protein 
composition and it was found that a higher, physiological temperature (37oC) showed 
larger changes in zeta potential from particles in PBS in comparison to incubations 
completed at 25oC. The plasma samples also had larger effects on the particle zeta 
potentials that may have been due to the protein composition of plasma, compared 
with serum, and thus the differences in each respective protein corona formation. Of 
interest to this study were the results seen when particles immersed in serum were 
spiked with plasma and this showed a potential shift in the protein corona structure 
(dependent on higher/lower affinity proteins) and a displacement reaction was seen to 
take place and was indicated by the reduction in zeta potential upon addition of plasma 
to the samples. Further work would include further protein mixtures to be investigated 
to try and characterise fully the protein composition within a corona structure and 
report on which specific proteins have which inherent effects on the particle surfaces. 
Inferring zeta potential from particle translocation velocities via TRPS measurements 
is a now a primarily developed method that has been applied to samples in biological 
media, plasma/serum samples, and protein and DNA modified particles. Tunable 
polymer-based nanopores have been used as a biosensor for a range of target 
analytes throughout this project, not only for particle-based assays, but also for target 
biological analytes through pore modification experiments with limits of detection in 
the picomolar region. The nanopores have been easily modified using a firstly reported 
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Layer-by-Layer assembly and can be functionalised with DNA aptamers to detect 
target analytes using current rectification measurements. 
Aptamer development, the ability to analyse complex biological samples, 
understanding nanoparticle transport through pore systems and nanopore rectification 
properties are all important in biosensing toward the accurate and rapid quantification 
of biological analytes. TRPS technology can detect, quantify and characterise various 
analytes in a range of solutions in real time using pore and particle-based assays. The 
completion of zeta potential measurements from particle velocities in addition to this 
is particularly useful for the advancement of TRPS as a versatile analytical platform. 
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9 Appendix 
A summary of PALS analysis and streaming potential measurements used to 
determine the size and zeta potentials of the particle standards, and the zeta potential 
of the polyurethane tunable pores, respectively. 
9.1 Phase Analysis Light Scattering (PALS) 
Phase analysis light scattering is used to determine size and zeta potential values of 
carboxylated polystyrene nanoparticles that are used as standards for zeta potential 
measuements and charge analysis using tunable resistive pulse sensing (TRPS). 
Zeta potentials of CPC100 and CPC200 particles were measured on a Malvern 
Zetasizer Nano ZS. PALS analysis was completed to determine the average zeta 
potential of carboxylated polystyrene standards dispersed in PBS electrolyte. For 
these studies, the measured mean zeta potential of CPC200s, for example, was -20 
mV. Please note that the PALS analysis for the calibration particles used in the 
following studies was completed by Robert Vogel (Izon Science Ltd, NZ, and 
University of Queensland, Australia). 
9.2 Streaming Potential Measurements 
Streaming potential measurements are carried out to determine the zeta potential of 
the regular conical nanopores used for each of the studies described in chapters 5-8. 
Streaming potential and current measurements of the thermoplastic polyurethane 
(TPU) pore membrane were made using a Surpass instrument (Anton Paar GMBH, 
USA). TPU membranes were cut to form a cylindrical cell with an adjustable gap and 
the streaming potential was measured for a range of applied pressures within a cyclic 
pressure sweep. The zeta potential was evaluated with the Surpass Visiolab software, 
applying the Helmholtz-Smoluchowski equation1. The zeta potentials were recorded 
as -11 mV. 
9.3 References 
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biosensor
Emma L. C. J. Blundell,† Laura J. Mayne,† Emily R. Billinge† and Mark Platt*
The article is written as a guide and tutorial that focuses on the use of Tunable Resistive Pulse Sensing, TRPS,
as a platform for the detection of biological analytes. Within the field of biosensors there is a continuous
emergence of new technologies or adaptations to platforms that push the limits of detection or expand
dynamic ranges. TRPS is both unique and powerful in its ability to detect a wide range of biological
analytes; including metabolites, proteins, cellular vesicles, viruses and whole cells. Each analyte can be
analysed on the same platform without modification by changing the pore size, and is simple enough to
follow to allow users from a range of backgrounds to start developing their own assays. The instrument
can provide information regarding analyte concentration, size, and charge. Here we hope to give an
overview of where this technology is being used and provide some guidance to new users, in the hope it
will inspire and enable future experiments.1. Introduction
In this tutorial review we highlight some of the current research
and advances within the eld of Resistive Pulse Sensing, RPS,
focusing on an emerging variant of RPS using tunable pores,
known as Tunable Resistive Pulse Sensing, TRPS. The review
aims to provide an overview of its use of within the eld of
biosensors and provide hints and tips to encourage new users as
they develop their own TRPS methods.
Modern day resistive pulse sensors trace their origins back to
the Coulter counter, created in the 1940s to count and size
biological cells and microorganisms.1,2 The principle ismma graduated from Lough-
orough University with an
pper second class hons MChem
n Chemistry with Analytical
cience in 2013. She is now
orking on a PhD at Lough-
orough in collaboration with
zon Scientic investigating
esistive pulse sensing for the
etection of viruses. Emma is
lso researching elds based
round nanoparticle surface
odications and zeta potential
nalysis.
ytical Science, Loughborough University,
att@lboro.ac.uk
r.
hemistry 2015remarkably simple; two reservoirs are lled with conductive
solutions, each containing an electrode, which are then sepa-
rated by an aperture “the pore”. The sample is added to one of
the reservoirs and an ionic current is passed between the elec-
trodes and through the pore. If an analyte passes through the
pore it occludes the ionic current causing a transient current
decrease known as a “blockade event”. The magnitude of the
blockade event provides the information needed to determine
the size of the analyte, and the number of blockades per unit
time provides information on the analyte concentration, Fig. 1.
The size of the pore ultimately determines the sensitivity of the
technique and thus the analyte that can be analysed, as a
signicant occlusion event is only observed when the analyte is
comparable in size to the pore.3
In the 1990s the Coulter counter was revived in the form of a
biological nanopore sensor with the use of the a-haemolysinLaura Mayne is a PhD student at
the centre for analytical science
at Loughborough University
working on development of new
sensors for radionuclides and
particle modication as part of
the DISTINCTIVE consortium
with Dr Mark Platt, Dr Steve
Christie and Dr Nick Evans. She
received her MChem in Medic-
inal and Pharmaceutical Chem-
istry from Loughborough
University in 2014.
Anal. Methods, 2015, 7, 7055–7066 | 7055
Fig. 1 (A) Sectional schematic of a pore. The sample is typically placed
into the upper fluid cell. (B) Example of baseline current and “blockade”
events (current dips) that are each caused by an analyte traversing the
pore. Each event is analysed for full width half maximum (FWHM)
duration and Dip. (C) The Izon qNano instrument, showing the fluid
cell, teeth and crucifix plastic membrane with aperture.
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View Article Onlineprotein for the detection of ssDNA.4,5 The diameter of the hae-
molysin-pores is around 1.4 nm at its narrowest point and as the
ssDNA passes through the pore, each of the 4 different bases
produces a unique signal allowing the sequence of the DNA to
be determined.3 With improvements in manufacturing, char-
acterisation and nanofabrication techniques it became possible
to reproducibly produce pores from the microscale down to the
nanoscale in a range of materials. Solid-state nanopores oen
support more chemical versatility than biological equivalents,
with carbon nanotubes,6 PDMS,7 glass,8 silicon,9 poly-
carbonate,10 and graphene11 having been used as substrates.
Some of thesematerials have also been incorporated into uidic
devices.2 Here we don't wish to review the synthetic procedures
for preparing biological and solid state pores and we would
direct the reader to reviews found elsewhere.2–4,9,12Emily-Rose Billinge received her
BSc in Neuroscience with Phar-
macology from the University of
Nottingham, UK in 2012. She is
currently a PhD student in
analytical chemistry with Dr
Mark Platt at Loughborough
University, UK in the Centre for
Analytical Science. Her research
is focussed around the develop-
ment of new biosensors incor-
porating aptamers and nano/
microbeads.
7056 | Anal. Methods, 2015, 7, 7055–7066The ability to tune the pore size to the analyte of interest has
allowed the RPS technique to detect analytes that range from
single molecules, DNA, proteins, cellular vesicles to whole cells
including viruses and bacteria, and again detailed reviews on
the types of analytes and applications can be found else-
where.13,14 One property that all solid state and biological pores
share is the xed nature of the pore size. Once prepared and
assembled the pore size cannot be changed, thus pores which
can be reversibly manipulated in real time offer great advan-
tages in this eld.
An elegant and novel adaptation to RPS incorporates a
tunable elastomeric pore, which allows for further versatility as
the pore can be stretched in real time to suit the sample.15
Tunable pores are fabricated by mechanically puncturing a
thermoplastic polyurethane membrane. The membrane is
mounted onto “teeth” in the instrument and then stretched in a
controlled bi-axial, reversible manner to change the pore
geometry, see Fig. 1.
The technique is currently referred to as Tunable Resistive
Pulse Sensing, TRPS, but has been previously known as Scan-
ning Ion Occlusion Spectroscopy, SIOS,16 and variants such as
size-tunable pore sensors, or tunable elastomeric pore sensors
are found in the literature. We will use the term TRPS in this
review as an umbrella term to cover all of these variants unless a
specic quote from a publication is used. TRPS has been
developed to accurately determine the concentration, size and
surface charge of dispersed inorganic particles and whilst we
concentrate on biological analytes within this review, we direct
the reader to key papers for the characterisation and identi-
cation of inorganic particles.17–20
TRPS is much more versatile than solid state pore equiva-
lents, but there are limitations to how much each pore can be
stretched, thus users typically match a membrane with a pore
size to the sample of interest. The company Izon Science Ltd
supplies tunable pores, TPs, in a range of sizes, each with a
wide optimal size range. This enables the user to match a pore
to a specic sample. The pore used for a TRPS measurementMark Platt graduated with a
degree in Chemistry and
Analytical Chemistry from the
University of Salford in 2001. He
moved into the area of liquid/
liquid electrochemistry with
Prof. R. A. W. Dryfe and
obtained his PhD in 2004 from
the University of Manchester. He
spent time as a postdoc in Penn
State (USA), Cambridge then
Manchester (UK) and nally
Dublin (Ire) before taking up an
academic position at Loughborough University. His research
interests sit at the interface between materials, electrochemistry
and analytical chemistry developing sensors for health and
wellbeing.
This journal is © The Royal Society of Chemistry 2015
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View Article Onlinedetermines the size of the particle it can measure, the smallest
pore currently commercially available is the NP100 that has a
size limitation of 70–200 nm. This lower limit is determined by
the smallest analyte size that can produce detectable block-
ades in relation to the background current noise. As these TPs
are relatively inexpensive (tens of euros per pore) it has
enabled laboratories from different disciplines to develop
methods of analysis using RPS without the usual concerns of
synthesis/breaking or blocking the pores. Passing complex
biological samples through a small aperture oen leads to
blockages, and if the blockage is not removed the pore is
unable to perform any further analysis; this is oen the end of
life for many solid-state pores. Along with its versatility to
change the pore size to match the analyte the tunable pore, TP,
also allows users to pause data capture if a blockage occurs,
stretch and open the pore dislodging the trapped analyte, and
then reduce the pore size back to its original size before
continuing with the experiment. Alternatively the TPs are
robust enough that trapped analytes can also be dislodged by
tapping the instrument or by applying a pressure to the upper
uid cell, P1 > P2 (Fig. 1), effectively forcing the buffer and
blockage through.
Given the appearance of simplicity, reduced cost and
versatility, new users could be understood for thinking that
the data analysis is simple. In fact the translocation of a
particle through the pore is complex and some assumptions
are made to simplify the analysis. Current methodologies of
analysis and interpretation owe their thanks to Willmott,
Vogel, Kozak and Trau who have led the way in modelling and
understanding the TRPS technology.15,20–23 Models and meth-
odologies exist within the literature for studying particle
shape, charge, orientation and direction of transport.17,20,23–25
Each translocation event reveals a large amount of informa-
tion on the analyte, such as its size, zeta potential and shape.
Whilst the data is capable of being extracted to interrogate it
with third party soware, the supplier of the instrument
provides an interface (Izon Control Suite) for new users and
where possible here in the tutorial we try to use the basic
features of the soware available to everyone.
For a new technology to be seen as enabling and to be
adopted by the scientic community several key features are
highly desirable; cost effectiveness, ease of use and accurate,
reproducible data. In reality, detailed and accurate data can
sometimes come with a cost, not always in price, but in effort
required to extract the data. Setting up a TRPS measurement is
simple, but getting reproducible data on consecutive runs
requires the analyst to carry out the measurement carefully,
attentively, and with a detailed level of understanding of the
system. However, time and effort exerted during data collection
is rewarded with the high quality of information. As can be
found in cytometry technologies, particle-by-particle analysis of
the sample leads to a much more accurate and sensitive assay.26
Since the rst bioassay publications using TRPS in 2007 the
number of applications and publications has doubled each
year, herein we provide an introduction on how to set up the
system, troubleshooting ideas and a review of the applications
of the TRPS system.This journal is © The Royal Society of Chemistry 20152. Theory
The instrument most widely associated with TRPS is produced
by the company Izon Science referred to as the qNano or qViro,
and as with standard RPS equipment two uid reservoirs are to
be lled with a conducting electrolyte solution. In this setup the
pore is mounted horizontally and reservoirs oriented above and
below the pore membrane, with the sample typically placed into
the top reservoir, see Fig. 1. The qNano uses an elastic size-
tunable pore which is fabricated in a thermoplastic poly-
urethane membrane. The membranes are penetrated with a
needle to create a single pore which is conically shaped.27 The
size and geometry of the fabricated aperture can be modied by
modifying the puncturing needle thus allowing the detection of
particles ranging from 70 nm to 10 mm over the full range of
manufactured pores.16 The cruciform TP is mounted by eyelets
to teeth on the instrument, above the lower uid cell, the system
can be seen in Fig. 1C. The arms can be altered to increase the
stretch on the pore, where it has been shown that applying a
stretch of 10 mm to the membrane increases the pore opening
by 54%.22.1 Analyte size
The conical pore gives rise to an asymmetric current pulse,
Fig. 1, with resistance highest at the narrowest pore constriction
resulting in a sharp drop in current which tails back toward the
original baseline value as the resistance diminishes toward the
base of the pore.20 For a conical pore, the change in the resis-
tance, DR, across the length of the pore. L, is given by eqn (1),28
DR ¼ r
ðL
0
dz
AðzÞ  R (1)
where r is the resistivity of the electrolyte that is lling the pore,
A(z) is the cross sectional area perpendicular to the pore axis z
and R is the pore resistance. When no blockage is present, R is
given by eqn (2),28
R ¼ 4Lr
pDLDS
(2)
where DL and DS are the largest and small pore diameters. When
a particle traverses through the pore, a blockade event is
observed. This blockade is created by the particle displacing a
volume of electrolyte which in turn increases the resistance in
the circuit, temporarily lowering the current. The blockade
magnitude can then be used to size the particles or analyte as
the magnitude of the increased resistance is directly related to
the size of the analyte. Unlike solid state pores where the size of
the pore is always known, the tunable pore must rst be char-
acterised before users can accurately determine the size of the
analyte using TRPS. This is done using calibration beads of a
known size and narrow size distribution andmust be done prior
to sample analysis and under the same conditions.2.2 Analyte concentration
The frequency of the pulses, J, can be related to the concen-
tration of the analyte, Cs, as well as the velocity of the traversingAnal. Methods, 2015, 7, 7055–7066 | 7057
Analytical Methods Tutorial Review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 2
6/
06
/2
01
7 
09
:4
5:
03
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineparticle, vp. The velocity term is the sum of the uidic, vF,
electrophoretic, vE, and electroosmotic, vO, velocities, i.e. vp¼ vF
+ vE + vO. Here we typically ignore the contribution from diffu-
sion due to the magnitude of other forces and end effects are
not taken into account in the analysis. vp can be written as;
vp ¼ Q
p

DS
2
2 þ 3zparticleh E 
3zpore
h
E (3)
where
Q ¼ 3pDs
3DP
128h

L
DL DS
 (3a)
3 and h are the permittivity of the solution and kinematic
viscosity respectively, DP is the pressure across the pore, zpore
and zparticle are the zeta potential of the channel surface and
particle respectively, and E is the electric eld. The pulse
frequency, J, is then related to both the velocity and the particle
concentration, Cs, via the equation; J ¼ Cs  np. For the TRPS
system it has been demonstrated that the forces of electro-
phoresis, electro-osmosis and pressure are usually
dominant.2,15,22,29Fig. 2 Schematic of the variable pressure set up used with the qNano
pore sensor (a). Pressure in the top fluid cell (b) is precisely controlled
via a flexible tubing connection (c) by varying the height difference
between the water level in a partially submerged buret (d) and the
water level of a large water reservoir (e). The buret was equilibrated
with atmospheric pressure by opening a valve (f). Progression of an
experiment where pressure is varied from positive to negative (g).
Reprinted with permission from Anal. Chem., 2012, 84(7), 3125–3131.
Copyright (2012) American Chemical Society.2.3 Varying the pressure across the pore
The reader will note that the pulse frequency is related to the
pressure difference across the pore. With the Izon system there
is always an inherent pressure head guaranteed within the
setup due to gravity, indicated with P1 and P2 in Fig. 1A. Using
the variable pressure system supplied with the instrument users
can vary the ratio between P1 and P2 across the pore. Willmott
et al., showed that pressure-driven transport can be made
dominant,23 which has advantages for studying zeta potential
values. It also helps data analysis with samples that contain a
low concentration of analyte. Such samples would typically have
a low particle count rate, and thus would result in long run time.
By applying a pressure to the cell, P1 [ P2, analytes can be
driven through the pore more frequently reducing the total run
time. Alternatively if a sample is too concentrated, producing
blockade events that are not clearly resolved from one another,
or the particles are moving at too great a velocity, reducing the
information and signal within the peak width, it is possible to
slow the blockade events by the application of vacuum, P2[
P1. As a guide the particle rate should ideally not exceed 1000
particles per min, with an optimum range between 500–700
particles per min.
Pressure ratios are controlled by the variable pressure
module, VPM. The VPM has a mobile ‘arm’ with a scale of 0–20
cm. The amount of pressure applied is relative to the length of
the arm e.g. if the arm is inserted 5 cm into the system, a
pressure of ‘5 cm’ is applied. For a negative pressure, P2 > P1, the
same arm is pulled out of the instrument to the required length
in cm. Each cm of pressure is equivalent to approximately 1000
Pa.21 The unit of cm will be used for the remainder of the review
when denoting a pressure applied to the TRPS system.7058 | Anal. Methods, 2015, 7, 7055–70662.4 Zeta potential theory
Evident from eqn (3) is the relationship between particle
velocity and its zeta potential. Zeta potential is dened as the
electrostatic potential at the border between the diffuse layer
and compact layer30 (also known as the Stern layer)31 of a
colloidal system. Zeta potential is related to the surface charge
of the particle and is oen used as an indicator of colloidal
stability. It also offers a unique and additional parameter to
identify biological analytes when their sizes are comparable, as
Martin et al., demonstrated by measuring the velocity of several
proteins using a solid state pore system.32,33 The Smoluchowski
approach34 dening zeta potential is displayed in eqn (4), where
z is zeta potential, h is dynamic viscosity of the uid, m is
particle mobility and 3 is the dielectric constant.
z ¼ hm
3
(4)
The Smoluchowski approach supports that a particle's zeta
potential can be determined from its velocity taking into account
convective and electro osmotic forces, as well as the electro-
phoretic mobility of the particle. The electrophoretic mobility is
a measure of the translocation time of the analyte through the
pore under an applied electric eld, the convective forces are
attributed to the ow of the solution through the pore due to
gravity and any applied pressures; whereas the electro osmotic
forces relate to the ow of liquid through the pore which arises
from the charge on the pores surface and the movement of
liquid in the electric eld. In their seminal paper Vogel and
Willmott et al., developed a method of balancing the electro
osmotic and electrophoretic effects by balancing the pressure
across the pore allowing zeta potential values to be extracted
from the resistive pulse, their methodology is shown in Fig. 2.35This journal is © The Royal Society of Chemistry 2015
Table 1 Reference guide to problems and solutions
Problem Solution
Introduced particles but can't see peaks  Check pore classication is appropriate for size of interest
 Reduce stretch (minimum 43 mm)
 Sample may be too concentrated, clean pore and dilute sample 1 : 100; if resulting particle rate
is too slow apply pressure
Frequent blockages  Clean pore thoroughly
 Check for bubbles in both uid cells
 Ensure sample is well dispersed – try vortexing, sonicating or the addition of a surfactant – or all
three!
 Increase pore stretch or change to a larger pore if necessary
 Try additional pressure
Unclean pore  Increase stretch and voltage where possible
 Replace the sample/electrolyte with fresh electrolyte buffer several times
 Apply pressure/vacuum to the pore to dislodge any particles ‘stuck’ in the pore
Rate trace not linear  Add pressure for calibration les
 Check for bubbles
 Sonicate and vortex sample
 Dilute sample to reduce risk of blockages
Bubbles frequent  Possibility of too much surfactant, reduce concentration
 Warm working conditions (>30 C) can result in bubbles due to gradual evaporation of buffer
Current rises rapidly/saturates  Fluid leak, remove uid cell from the TRPS instrument and dry thoroughly
 Decrease applied voltage
Current drops rapidly/Current drops to zero  Pore may be partially blocked, troubleshoot to remove the blockage, increasing the stretch and
applying a pressure/vacuum can aid this process
 Air bubbles in the upper or lower uid cell. Remove the liquid from the appropriate uid cell
and replace ensuring no bubbles are present
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View Article Online2.5 Setting up TRPS
TRPS is a relatively simple set up procedure, and users can nd
the protocol within the user manuals, here we include some
useful points that we have adopted as part of our best practice.
The pore membrane is connected to the system via the four
arms, Fig. 1, and the desired pore stretch can be obtained (>43
mm, 43 being the smallest distance between the teeth applying
no stretch to the membrane), the electrolyte is then placed in
the lower uid cell (75 mL). Care needs to be taken to ensure no
bubbles are introduced into the electrolyte, if bubbles do occur
the electrolyte needs to be replaced. If no bubbles are present,
the upper uid cell can be placed on top and twisted into place.
Once the upper uid cell is connected and before you place
liquid into the upper cell switch on the instrument. The current
should be 0.5 nA and stable. If the current is driing or
unstable, there may be a uid leak in the system and the
instrument needs to be turned off, taken apart, cleaned, and
dried thoroughly. The electrolyte solution can then be placed
into the upper uid cell (40 mL). The Faraday cage is placed over
the uid cell to reduce background noise and the system is
switched on using the computer soware. Upon the application
of a voltage a stable baseline should be observed. Sufficient
voltage needs to be applied to ensure a baseline current > 50 nA.
If the baseline is uctuating rapidly or not settling at a current,This journal is © The Royal Society of Chemistry 2015it is not stable and a number of troubleshootingmethods can be
applied (Table 1).
3. Applications of TRPS
3.1 Cells/bacteria
Optical density, OD, measurements are commonly used in
monitoring bacterial growth due to its ease of implementa-
tion.36 OD measurements allow the bacterial growth to be fol-
lowed in real time,37 however the accuracy of these
measurements can be hindered by low sensitivity.37 OD
measurements use an approximation of the cell number and
cell size by changes in the light scattering from the sample.36
Plate counts and microscopes are employed when an account of
the bacteria present is needed; these are usually time-
consuming and laborious as a stain on the bacteria is usually
needed and requires manual counting.38 Other modern bacte-
rial growth monitoring methods such as ow cytometry26,39 and
microscopy40 are also common in the literature. Allen et al.,
developed a method using TRPS to monitor the growth of two
commonly used bacteria; Gram-positive Bacillus subtilis str.168
(BSU168) and Gram-negative Escherichia coli str. DH5a
(DH5a).36 TRPS was used to monitor the bacterial cell concen-
tration and cell volume, both of which can be analysed simul-
taneously,36 see Fig. 3. The cell volume dynamics and the level ofAnal. Methods, 2015, 7, 7055–7066 | 7059
Fig. 3 BSU168 and DH5a growthmonitoring using plate counting, OD
and TRPS methods. Culture BH BSU168 in MG-High. The OD changes
(red, C), particle counts by TRPS in log base 10 (blue, +), and viable
colony counts by plating method in log base 10 (green, :) were
measured in 45min intervals. The averaged triplicatemeasurements of
concentration were shown, and boxplot of volume (fL) measured by
TRPS was included at the top of each subsection, using at least $500
particles. Springer and Applied Microbiology and Biotechnology, 2013,
98, 855, Monitoring bacterial growth using tunable resistive pulse
sensing with a pore-based technique, Allen. C. S et al., Fig. 2.
©Springer-Verlag Berlin Heidelberg 2013. With kind permission from
Springer Science and Business Media.
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View Article Onlinebacterial cell chain formation can be observed by tracking the
spread of the cell volume histogram. Coefficient of variation,
CV, was used to measure the level of dispersion and precision of
the concentration measured by TRPS where a CV lower than 5%
is considered acceptable; CVs observed for the samples were
lower than 2%.36 The low CV was a good indicator that TRPS is
reliable for measuring the concentration of the bacteria present.
When using TRPS, a measurement can be made within a few
minutes which is in contrast to traditional colony-plating
methods which involve long preparation steps of agar plates,
incubation and counting.36 The concentration measured by
TRPS was different than the concentration measured by OD and
colony plating, which is highlighted in Fig. 3. The difference is
due to TRPS counting all the cells present in the liquid and
cannot differentiate between dead and live cells as colony
plating does; in addition cell counting methods are oen
approximated due to the chosen eld of view.363.2 Viruses
Sub 100 nm sized particles are generally a challenge for many
nanoparticle characterisation techniques. Viruses are infectious
agents made up of nucleic acids and are particularly valuable in
scientic and medical research. The virus' genetic material is
contained within a protein shell (capsid) and this as a whole is7060 | Anal. Methods, 2015, 7, 7055–7066known as a virion or virus particle, VP. Virus like particles, VLPs,
are also available with similar capsid properties to VPs. VLPs are
self-assembled protein structures with similar, and sometimes
identical, structure to their resident virus41 and can be applied
to elds including gene therapy and vaccine development. VLPs
have gained further interest in the development of nano-
materials because of their small size (10–200 nm), construction
exibility and structural uniformity.41
Analytical tools for the detection and characterisation of
viruses and VLPs are constantly being developed and improved.
These included ELISA,42 real-time PCR,43,44 loop-mediated
isothermal amplication (LAMP),43,45 multiplex tools incorpo-
rating bead arrays, and next generation sequencing (NGS).42
One of the main challenges for virus detection comes from the
small sizes of virions and VLPs. Small particle analysis by TRPS
systems has been developed recently by Vogel et al., successfully
detecting and sizing virions 70–95 nm in diameter, producing
highly reproducible data in agreement with both optical
methods and TEM (within 6%).22 Optical methods are common
but are generally averaging techniques46 that don't allow for the
versatility of particle-by-particle analysis available from TRPS.
The ability to detect individual 70 nm particles is an exciting
prospect for nanotechnology and current TRPS developments
are allowing for even smaller particles to be analysed on a
particle-by-particle basis.3.3 Cellular vesicles
Cells release numerous types of membrane particles under
physiological and pathological conditions. Originally thought
to be an artefact of the body, research is now demonstrating
that these microvesicles, MVs, may be part of the cell signalling
process, facilitating cellular messaging and the exchange of
RNAs which may even precede the release of protein inam-
mation markers. MVs have recently seen a surge in interest as
they may act as clinically relevant biomarkers and their prop-
erties such as size, concentration and composition could
provide important physiological information and be of poten-
tial use in early diagnostics.47–50 Although their prevalence or
characteristics may be well tied to a range of disorders, a gold
standard technique for their characterisation has yet to emerge.
MVs range in size from around 20 nm to 1 mm and at current
there is a lack of availability of techniques which can accurately
characterise MVs in terms of their size and concentration51,52
with concentration analyses largely varying from instrument to
instrument due to the working range of the method in question
and differences in the minimum detected size.53
For many years the gold standard of particle characterisation
in terms of size accuracy has been electron microscopy.
However, these methods have severely limited abilities to
quantify their concentration. As the concentration of circulating
MVs has been reported to vary in several different physiological
states such as hypercholesterolaemia,54 atherosclerosis55 and
even exposure to pollutants,56 the lack of accurate concentration
analysis is a signicant limitation, requiring a second method
to attain concentration data.57 Flow cytometry is a high-
throughput method for identifying and quantifying analytesThis journal is © The Royal Society of Chemistry 2015
Fig. 4 Determination of EV quality, composition and size distribution. (A) Transmission electron micrograph of CCRF-derived EVs. (B) Izon
qNano analysis of the size distribution and concentration of extracellular vesicles. Cell-depleted CCRF supernatants, containing EVs, were
analysed using an NP400membrane from Izon Ltd, at a stretch value of 47 mm, 120 nA current, and 10 cm water pressure; at least 500 particles
were detected. (C) Confirmation of EV removal by a known size bead spike. We spiked in the EV-depleted CCRF supernatant with known size
reference beads (SKP400D at 4.5  107 particles per mL concentration) to confirm that the detected absence of positive signals in the EV-free
supernatant was not due to a blockade of the nanopore. Springer and Cellular and Molecular Life Sciences, 2014, 71, 4055, Monitoring bacterial
growth using tunable resistive pulse sensing with a pore-based technique, Allen. C. S et al., Fig. 1. ©Springer Basel 2014. With kind permission
from Springer Science and Business Media.
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View Article Onlinebased upon the scattering of light or the uorescence signal of
the particles. Whilst ow cytometry has previously been used to
quantify MVs, a lack of resolution below 200 nm lends bias to
any size or concentration data as many subtypes of MV are
believed to lie below this threshold.54
The application of TRPS within the eld of MV character-
isation is highly advantageous due to the ability to easily t a
range of pores which can detect particles as small as 70 nm
providing a particle-by-particle analysis to elucidate concen-
tration. By using several pores sequentially it is possible to
analyse a wide range of sizes of MVs and due to particle-by-
particle analysis, generate an accurate size distribution
despite the polydispersity of the sample.53,54,58 Using TRPS
makes it possible to attain accurate size and concentration
data for a wide range of vesicles, and in conjunction with
complimentary techniques a rich level of information can be
obtained. Szabo´ et al., investigated the cell-signalling poten-
tial of MVs and conducted an extensive study using a wide
range of techniques to gain a full picture of the effects of MVs
on the gene expression of recipient cells, see Fig. 4. TRPS was
used to determine the concentration and size distribution of
the MVs using two membranes. It was found that recorded
size distributions by TRPS were comparable to values
obtained by SEM and TEM with the mean diameter lying at
around 350 nm.59
In further support of TRPS as a new tool in MV character-
isation, Connolly et al., measured low-density-lipoprotein (LDL)
cholesterol linked to familial hypercholesterolaemia using
TRPS for the MV size and concentration, ow cytometry to
determine MV origin, and gas chromatography to monitor the
fatty acid composition of the MVs; this multifaceted approach is
likely the best way to gain a full view of the vesicles being
investigated. This study was able to monitor the clinicallyThis journal is © The Royal Society of Chemistry 2015relevant progression of apheresis treatment for hyper-
cholesterolaemia by monitoring MV concentration by TRPS.543.4 Particles based bioassays – DNA extraction/detection
Nanoparticle based bioassays are being increasingly developed
for point-of-care assays.60 The immobilisation of biological
components onto their surfaces allows them to be used as drug
delivery agents, bioimaging substrates or to be incorporated
into a range of sensing technologies. The development of
superparamagnetic beads, SPBs, and magnetophoresis devices
have made it possible to rapidly and efficiently separate cells,
proteins and DNA from complex mixtures, such as, plasma,
urine, and culture media, in a manner that does not require
complicated equipment.61,62 By functionalising the SPBs surface
with DNA they can be used to extract target DNA from solution.
TRPS is particularly well suited to the detection of DNA on the
surface of particles. Although there exists a wealth of available
technologies to sequence and characterise DNA samples with
high accuracy, at current many of these techniques require PCR,
gel electrophoresis and uorescence63–65 which are contributors
to lengthy processing and expense involved in DNA analysis.
Several groups have engaged in work with RPS and TRPS
technology to quantify DNA hybridisation63,66 and to monitor
particle surface modications. The benets of using TRPS
technology over conventional techniques is its ability to
generate a label-free signal, fast run time (in most cases sub 5
minutes). Booth et al., devised amethod which incorporated the
use of an applied vacuum to be able to elucidate zeta potential
of beads under several different conditions.66 By applying a
positive potential bias across the pore, polyanionic DNA lends
negative charge to the beads which in turn increases electro-
phoretic mobility. As a vacuum is applied and is graduallyAnal. Methods, 2015, 7, 7055–7066 | 7061
Fig. 5 Schematic illustration of nanopore-based single-nucleotide
detection using a nAu–DNA probe. The ssDNA sequences on nAu-
100b and nAu-18b probes were designed to be complementary to the
mutant (mut) sequence and single mismatched to the wild-type (wt)
sequence. In the presence of a perfectly matched (PM) target, a well-
defined nanoparticle assembly, termed conjugate grouping, forms.
Each distinct conjugate grouping is picked up as an individual signal
(“Yes” signal) when it translocates the pore of the membrane from the
trans to the cis side. Every successful translocation activity is termed a
blockade event, which is characterized by its blockade magnitude (Di)
and baseline translocation duration (Dt). When a single-mismatched
(SM) target is added, the intermediate duplex structure is energetically
unstable and fails to form an assembly structure. The smaller-sized
nAu–DNA probe does not result in an appreciable dip in baseline
current (ic) and is taken to produce a “No” signal. Reprinted with
permission from ACS Nano, 2012, 6, 8815–8823. Copyright (2012)
American Chemical Society.
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View Article Onlineincreased, the frequency of particles moving through the pore
slows, stops and then eventually reverses as beads are pulled
back up from the underside of the pore. This inection point is
relative to the surface charge of the beads as when negative
charge is increased the amount of vacuum applied must also be
increased to overcome the electrophoretic mobility of each
particle.21,67 Using this variable pressure method it was possible
to measure the increased charge loading resultant from DNA
hybridisation.
An additional method utilising the hybridisation of DNA
concerns the specic creation of aggregates using comple-
mentary sequences to join groups of beads together.60
Agglutination assays are easily adaptable to TRPS, aggregate
size is able to be easily determined by monitoring the increase
in volume as each aggregate passes through the pore68,69 via
alterations to the magnitude of the peak and the frequency of
particles through the pore and has been employed for the7062 | Anal. Methods, 2015, 7, 7055–7066study of Au particle agglutination.70 Previous work employs
uorescence and light scattering that both require an addi-
tional label for analysis,71 whereas in TRPS the aggregate is in
effect the label and there is no need for additional markers; in
this sense it is “label-free”. An additional consideration in the
use of aggregation assays is the ability to bring each of the
components into close proximity, one such way to do this is
the employ SPBs as outlined in a proof-of-concept assay in
which 1 and 3 mm SPBs were coated in avidin and then
incubated in the presence of a range of concentrations of
biotin.69 It was found that the application of a permanent
magnet and rolling of sample vials caused increased aggre-
gation due to the beads being brought into closer proximity to
each other, this action was termed magnet assisted aggrega-
tion (MAS).
A similar technique has been used via TRPS to monitor
single nucleotide polymorphisms (SNPs) using the highly
selective aggregation of AuNPs. This was completed by using
probes with a controlled number per AuNP and with a specic
sequence and length such that aggregation occurs only in the
presence of a complete complement target,63 see Fig. 5. The
use of TRPS was advantageous over the use of a solid state
pore for several reasons worth discussing – rstly, the study of
potentially large aggregates poses the threat of blockage;
however, by being able to stretch the pore in real time it is
possible to temporarily pause recording, open the pore, allow
the blockage to pass, restore the desired stretch and resume
recording. In addition, in this study it was possible to tune the
applied stretch so that single particles are not visible above
the level of baseline noise and only aggregates are visible. In
theory this proof-of-concept method could be utilised to
target any desired SNP by tailoring the capture probes of
choice.3.5 Conrming the DNA is on the particles
Due to the negative sugar–phosphate backbone, functional-
ising DNA onto nanoparticles can alter their behaviour within
TRPS due to a change in their surface charge. As the surface
charge of the bead directly impacts upon the pulse frequency,
eqn (3), and the pulse width, FWHM, it is relatively simple to
conrm the presence of DNA on the beads. To do this user
must rst ensure that the increase in pulse frequency is due to
the presence of the DNA and not caused by a change in
particle concentration. First their concentration is to be
veried using calibration beads with the application of large
pressure i.e. P1[ P2 Fig. 1, typically done using a pressure
greater than 5 cm on the pressure module. This pressure
ensures that the dominant force acting upon the beads is the
uidic component of eqn (3). Once the concentration has
been found, a sample of beads before and aer the modi-
cation of DNA is prepared to the same concentration. Both
samples are then run under no additional pressure (0 cm) at a
range of voltages to produce a plot of pulse frequency vs.
voltage, see Fig. 6. The presence of DNA on the particle is
conrmed when there is a larger change in rate as a function
of voltage.This journal is © The Royal Society of Chemistry 2015
Fig. 6 Example of the relationship between applied voltage and
particle rate, for beads of identical concentrations with andwithout the
DNA on their surface.
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View Article Online3.6 Particle–aptamer–protein studies
Many traditional bead-based protein assays have revolved
around the use of antibodies. Where previously antibodies have
been the capture probe of choice, aptamer technologies are
gaining interest.72–75 Aptamers are conventionally generated
through the process known as SELEX76–79 (systematic evolutionFig. 7 Agglutination assay data collected at a stretch of 45.5mm and pote
Variation in Dip and FWHM for 400 fM AuNi rods (1.23 mm longwith CV 20
an analyte. (B) The same rods as (A) at assay time 10 min. Ni segments ar
BSA analyte is varied. Dashed lines represent a 10 min assay with a non-bi
fM AuNiAu rods (0.82 mm long with CV 14%, Ni content 18% by length) in
20%, Ni content 14% by length) at assay time 10 min. Ni segments are fu
data points at 100 fM indicate the change in FWHM and Dip for the same r
each data point, lines joining data points are drawn to guide the eye. Rep
VCH Verlag GmbH & Co. KGaA, Weinheim.
This journal is © The Royal Society of Chemistry 2015of ligands by exponential enrichment), where strong binding
sequences are evolved/enriched from extensive libraries, or by
CLADE (closed loop aptameric directed evolution) which
produces the aptamers ‘on-chip’.80–82 Due to their comparable
selectivity, stability and cost; over the last two decades, aptam-
ers have started to challenge antibodies in their use on many
technology platforms. As discussed above, the modication of
particle surfaces with aptamers should be a process well suited
to TRPS technologies.
Billinge et al., demonstrated TRPS as a label-free detection
platform for the detection of the thrombin protein using SPBs
coated with thrombin aptamer.83 When the thrombin protein
was introduced to the aptamer-coated beads, a decrease in
pulse frequency was observed. The isoelectric point of thrombin
lies at pH 7.1,84 suggesting that in pH 7.4 PBST buffer, as used in
the study, the overall surface charge of the thrombin molecule
should be largely neutral. The shielding of the negative DNA
aptamer with the protein reduced the electrophoretic mobility
of the bead moving through the pore, reected in a reduced
frequency, J, and increased FWHM.
Alsager et al., developed an assay to 17b-estradiol (E2) using
aptamer-coated carboxyl beads monitored with Dynamic Light
Scattering (DLS) and TRPS to observe changes in zeta potential.
In addition to the changes in electrophoretic mobility observedntial of 0.14 V, where red (i) indicates ip and blue (ii) indicates FWHM. (A)
%, Ni content 15% by length) as assay time is increased in the absence of
e functionalized with avidin and the concentration of the biotinylated-
otinylated target. (C) A biotin–avidin assay at 10 min as in (B), using 500
the side-on configuration. (D) 150 fM AuNi rods (1.1 mm long with CV
nctionalized with PDGF aptamer, and the analyte is PDGF. The circled
ods using a control protein. Error bars show the d25 and d75, values for
rinted with permission from Small, 2012, 8, 2436–2444 ©2012 Wiley-
Anal. Methods, 2015, 7, 7055–7066 | 7063
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View Article Onlineby Billinge et al., a change in the size as the aptamer bound to its
target was also observed. TRPS was able to resolve a 20 nm
increase in the mode diameter of beads once the aptamer had
been bound to the beads, followed by a reduction in size as the
target analyte E2 was introduced.85
Additional aptamer-bead based assays are able to be
designed such that if an analyte contains multiple binding
epitopes, aggregate formation can be monitored. Platt et al.,
used a specic class of nanomaterial termed nanorods to detect
femtomolar levels of homodimeric PDGF-BB by monitoring
specic aggregation of nanorods.86 In the same study the
authors also demonstrated the ability to generate aggregates of
specic orientations and differentiate between these in the
presence of different analytes; see Fig. 7.
TRPS has also been used to obtain kinetic information for
aptamer–target interactions, and recorded results similar to
traditional SPR techniques.83 A recent development of this
TRPS-based assay takes advantage of the excellent size
discrimination inherent in a particle-by-particle system. Bill-
inge and Platt have demonstrated the ability to successfully
analyse the binding of two aptamers to their respective proteins
simultaneously; by using the bead size as a label, two different
populations of beads were selectively coated with aptamer and
incubated with a combination of different protein concentra-
tions.87 These key proof-of-concept works demonstrate the
ability of one label-free approach to measure virtually any
aptamer target by tailoring the aptamer of choice.
4. Conclusions
TRPS is a technology platform that is becoming more widely
accepted amongst analytical laboratories as a common platform
for analysis, one of the reasons being the many variants of
samples and analytes that can be analysed. Current TRPS users
have contributed greatly towards the validation of the technique
for future studies with the technology. In our opinion we are at a
tipping point where the data from TRPS no longer needs to be
veried alongside DLS, TEM or other technologies. We predict
that as this technique continues to develop within the indi-
vidual elds of MV, protein and DNA analysis, TRPS will become
more capable of multiplexing across different ohmic elds, and
it is this exciting possibility that makes TRPS an exciting plat-
form to work with.
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ABSTRACT: Resistive pulse sensors, RPS, are allowing the
transport mechanism of molecules, proteins and even
nanoparticles to be characterized as they traverse pores.
Previous work using RPS has shown that the size,
concentration and zeta potential of the analyte can be
measured. Here we use tunable resistive pulse sensing
(TRPS) which utilizes a tunable pore to monitor the
translocation times of nanoparticles with DNA modified
surfaces. We start by demonstrating that the translocation
times of particles can be used to infer the zeta potential of
known standards and then apply the method to measure the
change in zeta potential of DNA modified particles. By
measuring the translocation times of DNA modified nanoparticles as a function of packing density, length, structure, and
hybridization time, we observe a clear difference in zeta potential using both mean values and population distributions as a
function of the DNA structure. We demonstrate the ability to resolve the signals for ssDNA, dsDNA, small changes in base
length for nucleotides between 15 and 40 bases long, and even the discrimination between partial and fully complementary target
sequences. Such a method has potential and applications in sensors for the monitoring of nanoparticles in both medical and
environmental samples.
1. INTRODUCTION
The immobilization of oligonucleotides onto surfaces is a key
design to many technologies within DNA sequencing,1,2
DNA−protein interactions,3−5 biosensing,6−9 and targeted
drug delivery.10−12 The functionalization of DNA onto
nanoparticle surfaces is now a common practice, and within
the field of biosensors alone the number of strategies for
immobilization, type of nanomaterial, and detection platform
are varied enough to fill several reviews.13−19 One family of
nanomaterials favored with purification strategies is super-
paramagnetic particles, SPPs. These particles allow for the
removal of specific analytes from complex sample matrices
using nothing more complicated than a hand-held mag-
net,14,20−23 and the use of SPPs has become increasingly
common. When they are incorporated into fluidic devices they
can be used to continuously sort cells and DNA from liquids24
and are integrated into a variety of detection platforms.14,24,25
When using nanomaterials in bioassays, the material must
remain suspended in the solution for it to capture the analyte. A
particle’s surface chemistry design is important to avoid
sedimentation of irreversible aggregation; there are two
mechanisms available to prevent this. First is the use of steric
stabilization by placing a neutral polymer onto the particle
surface, and the second depends upon charge stabilization
whereby the repulsive Coulombic forces overcome the
attractive van der Waals forces.26,27
For charge stabilized particles, a typical measurement used to
represent the surface charge, and infer stability, is zeta potential.
The zeta potential represents the value of the electrostatic
potential at the plane of shear and typically for nanoparticle
systems, zeta potential values of ±30 mV are representative of
stabilized particles.28 When a polyelectrolyte, such as DNA, is
immobilized onto the surface of the nanomaterials the DNA
can take on two roles. The first is the more natural of the two as
a capture probe, designed to hybridize to target DNA. The
second is a passive role where the inherent charge on the
phosphate backbone can act as a stabilizer by creating a high
charge density on the particle surfaces, helping suspend them in
solution.29 In doing this it is important to consider the structure
of the DNA immobilized onto a nanomaterial’s surface. Single-
stranded and double-stranded DNA varies in persistence
length, which affects the stability and flexibility of the polymer
when immobilized to a surface. For example, dsDNA has a 50-
fold higher persistence length than ssDNA,30,31 making it a far
more rigid polymer. As well as the persistence length, the
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contour length also varies between ssDNA and dsDNA, and
both these parameters will affect the plane of shear and thus
zeta potential.32
When using nanoparticle systems a mean population zeta
potential will not allow the true measure of the ligand
distribution across all of the particles to be interpreted, and
in a typical reaction the ligand density would follow a Gaussian
distribution.33−35 The spread of the population can have an
effect on the reaction kinetics, stability and sensitivity of
nanoparticle based assays.36−38 To build up a true measure of
the spread of zeta potential values for a given particle
population, the zeta potential of each individual particle has
to be measured, and this aspect is challenging, although
electrophoretic and electrochemical techniques allow insight
into these measurements.29,39 Electrophoresis studies have
demonstrated the ability to separate ssDNA and dsDNA
modified particles, and probe the structure of the ssDNA
surfaces.40−42 Alternative technologies for monitoring particle-
by-particle zeta potentials rely upon particle tracking
technologies that monitor the speed of the particles in an
applied electric field.43
A relatively recent technology to be developed for the
characterization of nanoparticles is based upon tunable resistive
pulse sensing (TRPS).44−51 TRPS is based on polyurethane
elastomeric membranes in which the pore geometry can be
altered in real time. The brief set up and theory for TRPS
technologies is as follows: a stable ionic current is established
by two electrodes, separated by a pore; as particles/analytes
translocate the pore they temporarily occlude ions, leading to a
transient decrease in current known as a “blockade event”,
examples of which can be seen in Figure 1a. In the TRPS
arrangement used here, the pore is mounted laterally so that
particles typically move from the upper fluid cell into the lower
fluid cell, aided by an inherent pressure head due to 40 μL of
liquid in the upper fluid cell of approximately 50 Pa,52 and a
positive or negative bias is applied via an electrode under the
pore. By monitoring changes in blockade width or full width
half-maximum (fwhm), blockade magnitude (Δip) and block-
ade frequency (events/min) it is possible to elucidate the zeta
potential,53,54 size,49 and concentration50 of colloidal dis-
persions in situ.49
The methodology for measuring zeta potential using RPS
technologies has seen an evolution of techniques,44,54,55 and
here we use a similar concept as was published by Arjmandi et
al. using pyramidal pores.56 In brief, a calibration based zeta
potential method is applied, based on the measurement of
signal durations of translocation events as a function of voltage.
The electrophoretic mobility is calculated from the derivative of
medium particle velocity and applied electric field. The zeta
potential of each particle can then be obtained from the
measured electrophoretic mobility using the Smoluchowski
approximation.44,57 The calculated zeta potential only depends
on the measured pulse duration and is independent of the
magnitude of the pulse, meaning that simultaneous size and
charge measurements can easily and reliably be carried out.
TRPS’s particle-by-particle nature means that subpopulations
with different zeta potential are able to be resolved, while
ensemble methods such as phase analysis light scattering or
PALS will only report an average zeta potential.
We adapt and apply the theory by first demonstrating its use
with calibration particles and then move to measure changes in
zeta potential for DNA modified nanoparticles. We go on to
measure the change in zeta potential as a function of DNA
concentration on the particles surface. We observe that the
measured zeta potential is correlated to the concentration of
DNA, and as the technique also provides a particle-by-particle
analysis, the distribution of the zeta potential across the sample
population is also produced. As we increase the concentration
of DNA, a more symmetrical Gaussian distribution of charge is
produced, indicating a more uniform ligand distribution around
the nanoparticles. By measuring the zeta potential and shape of
the distribution, we go on to measure the effects of
oligonucleotide length and apply our method to the detection
of dsDNA. By controlling the packing density of the capture
probe (CP) on the particle surface and the mechanism by
which the CP hybridizes to the target, the sensitivity of the
instrument can allow for the detection of target DNA in assay
times under 30 min. Finally we demonstrate that by designing
the length and position of the complementary section to the
target we can improve the signal and detection.
The method will have an impact on designing particle based
assays and the technology shows potential to study zeta
potentials on biological analytes, with clear applications in fields
of bioassays; as well as the monitoring of nanomaterials in
nanotoxicology and nanomedicine where a clear understanding
of the particle surface charge and size can have an influence on
the efficiency and toxicology of particle based drugs.
2. MATERIALS AND METHODS
2.1. Chemicals and Reagents. The buffer used was phosphate
buffered saline with Tween-20 as a surfactant (1 × PBST (0.01 M
phosphate buffer, 0.0027 M Potassium Chloride, 0.137 M Sodium
Chloride, pH 7.4 with 0.05 (v/v)% Tween-20 in 200 mL deionized
water (18.2 Ω cm))). PBS tablets (P4417) and Tween-20 (P1379)
Figure 1. (a) Blockade events produced as particles traverse the pore
and the resulting blockade shape depicting Δip and fwhm. (b)
Blockade shape is relative to particle translocation and a measurement
is made at 8 blockade reference points representing a particle’s
position in the nanopore at any given time (green spots). T1.0 for
example is the time the blockade is at 100% magnitude, dRmax. T0.30
and T0.60 are the times at which the blockade is 30% (I0.30) and 60%
(I0.60) of dRmax respectively. (c) 1/T vs voltage used within the
calibration method to calculate the particle translocation time and
therefore zeta potential of a given sample.
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were purchased from Sigma-Aldrich, U.K. Streptavidin coated
superparamagnetic particles (120 nm, 4352 pmol/mg binding capacity,
product 03121) were purchased from Ademtech, France.
2.2. Carboxyl Polystyrene Particle Standards. Carboxylated
polystyrene particles with a mean nominal diameter of 220 nm were
purchased from Bangs Laboratories, U.S. and are denoted as CPC200.
The specific surface charge as determined by the manufacturer was 86
μeq/g, equivalent to a surface density of 3.2 × 10−19 C/nm2. The
CPC200s were measured at a concentration of 1 × 1010 particles/mL.
2.3. Custom DNA Oligonucleotides. All the oligonucleotides
used in this study were purchased as lyophilized powders (100 pmol/
μL) from Sigma-Aldrich, U.K. with customized DNA sequences fit for
purpose detailed below, please note the abbreviation [Btn] is relative
to a biotin modification; 5′NNNNNNNNNN[Btn]3′ (VL10, 10
bases), 5′TGGGAGTAGGTTGGTGTGGTTGGGGCTCCCCT-
TTTT[Btn]3′ (VL36, 36 bases), 5′ATACCAGTCTATTCAATTGG-
GCCCGTCCGTATGGTGGGTGTGCTGGCCAG[Btn]3′ (VL50,
50 bases), 5′ATGGTTAAACCTCACTACGCGTGGC[Btn]3′
(VL25/CP, 25 bases), 5′GCCACGCGTAGTGAGGTTTAACCAT3′
(cDNA, 25 bases), 5′GTAGTGAGGT3′ (MidT, 10 bases), 5′GTTT-
AACCAT3′ (EndT, 10 bases), and 5′GTGAGGTTTAACCATT-
TTTTTTTTTTTTTT3′ (OverT, 30 bases).
2.4. Phase Analysis Light Scattering (PALS). CPC200 zeta
potentials were measured on a Malvern Zetasizer Nano ZS. PALS
analysis was used to determine the average zeta potential of the
carboxylated polystyrene standards dispersed in PBS electrolyte.
2.5. Hybridizing DNA to Streptavidin Coated Particles. 120
nm diameter streptavidin coated particles (03121, Ademtech, France)
were diluted to a concentration of approximately 1 × 109 particles/mL.
The diluted particle solutions were then vortexed for 30 s, and
sonicated for 2 min, to ensure monodispersity.
The biotinylated DNA capture probe was added to the streptavidin
coated particles (4352 pmol/mg binding capacity−determined by the
supplier) at the required concentration. The samples were then placed
on a rotary wheel for 30 min. Any unbound DNA remaining in
solution was then removed via magnetic separation by placing the
samples onto a Magrack (GE Healthcare, U.K.) for 30 min. The
supernatant was then removed and replaced with new buffer (PBST).
2.6. Addition of Complementary Target DNA. Target DNA
was added in excess (500 nM) to ensure the maximum possible target
binding was reached. The samples were then placed on a rotary wheel
at room temperature to investigate the effect of DNA hybridization
time.
2.7. TRPS Setup. All measurements were conducted using the
qNano (Izon Science Ltd., NZ) combining tunable nanopores with
proprietary data capture and analysis software, Izon Control Suite
v.2.2.2.117. The lower fluid cell always contained the electrolyte buffer
(80 μL). The upper fluid cell always contained 40 μL of sample (that
was suspended in the buffer) when a measurement was being
completed with an inherent pressure on the system (47 Pa). Prior to
TRPS analysis, all samples were vortexed for 30 s and sonicated for 1
min. Between each sample run, the system was washed by placing
PBST (40 μL) into the upper fluid cell several times with various
pressures applied to ensure there were no residual particles remaining
and therefore no cross contamination between samples. A detailed
description of such a tunable resistive pulse sensing device can be
found in Willmott et al.50 and Vogel et al.49
2.8. Streaming Potential Measurement. Streaming potential
and current measurements of the thermoplastic polyurethane (TPU)
pore membrane were made using a Surpass instrument (Anton Paar
GMBH, USA). TPU membranes were cut to form a cylindrical cell
with an adjustable gap, and the streaming potential was measured for a
range of applied pressures within a cyclic pressure sweep. The zeta
potential was evaluated with the Surpass Visiolab software, applying
the Helmholtz-Smoluchowski equation.58
2.9. Calibration Zeta Potential Measurements. Based on the
size of the sample particles being used (∼120 nm) and calibration
CPC200s (220 nm), the most idealistic pore to use was an NP150
(size range 85−300 nm). The calibration particles are measured at 3
applied voltages that are dependent on the applied stretch and
consequent baseline current observed. Each sample measurement was
performed using a baseline current of 100 ± 10 nA, to allow us to
compare data sets across several runs and pores. To account for
variation in the pore size from the manufacturing process, the stretch
and voltage were adjusted to achieve a similar baseline current for each
experiment (see above). As well as matching the baseline current each
sample blockade signal was greater than 0.05 nA, compared to a
background noise of ca. 10 pA. Finally when performing an experiment
a calibration was performed on particles of known size and zeta
potential. For the purpose of measuring and comparing zeta potential,
it was imperative that the stretch of the nanopore and the applied
potential were not changed during a sample or calibration measure-
ment of a particular data set. The sample measurements were all
completed at the highest or second highest voltage that the calibration
measurements were carried out at. Calibration measurements were
completed on each new day analysis was completed and when a new
nanopore was introduced. The zeta potential distributions were
measured as D90/10 value, D90 is defined as the particle zeta potential
at 90% of the cumulative particle zeta potential, distribution and D10
is defined as the particle zeta potential at 10% of the cumulative
particle zeta potential.
3. RESULTS AND DISCUSSION
3.1. Zeta Calculation. In this study we are using a method
related to Arjmandi et al.,56 who described a calibration based
method of measuring particle zeta potentials using resistive
pulse sensing. This method is based on measuring the duration
of the translocation of particles through a nanopore as a
function of applied voltage, with particle velocity and electric
field being averaged over the entire sensing zone of a regular
conical pore. The electric field, E, can be determined using the
calculation of pore resistance, so that E is entirely parallel to the
z-axis, = − *E z I( )z
R
z0
d
d
, with Ez, I0, and R being the electric
field component along the pore axis, electric current, and
resistance, respectively.59 For a voltage V0 of 0.5 V, a small pore
opening diameter of 0.8 μm, a large pore opening diameter of
40 μm, and a membrane thickness of 250 μm, the maximum
electric field is approximately 105 V/m. Please note that the
above pore dimensions are estimates, which are in accordance
with SEM images of pores with similar dimensions to the ones
used for this study. The electrophoretic mobility is the
derivative of 1/T (with T being the signal duration) and
voltage multiplied by the square of the sensing zone length, l. l
is a fitting parameter that is included in a calibration constant,
which is calculated using a calibration particle with known zeta
potential. Convection and electroosmosis have been neglected
for being much smaller than the electrophoretic contribution to
particle motion. Finally, Henry’s equation is used to relate the
particle zeta potentials with the measured electrophoretic
mobility of single particles.60
We are using a related approach, in which we are considering
the effects of elecroosmosis and convection (through an applied
pressure) in addition to electrophoresis when calculating the
zeta potential of single particles. Samples of particles with a
wide spectrum of zeta potentials, potentially reaching from
positive to negative values and/or very dilute suspensions, may
require the application of an external pressure in order to
capture the whole spectrum of particle zeta potentials. Also,
without any net pressure, most neutral particles might not
translocate the pore and hence are not measured, skewing the
results.
Average velocities and electric fields at multiple points
through the sensing zone (as opposed to only at the end of the
sensing zone, see Figure 1b) will help to reduce errors that
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result from rogue events such as instantaneous background
noise. In other words, multi point analysis serves as a sort of
quality control of the acquired zeta potentials. The calibration
of the pore is based on measuring the linear dependence of 1/
Tx vs voltage, V, using standard carboxylated polystyrene
particles with a known average zeta potential (Figure 1c). The
calibration process is summarized in the Supporting Informa-
tion (eqs A.1−A.6). From this the electrokinetic particle
velocities of sample, (vx
i )el Sample, and calibration,(vx)el Cal, are
related with their zeta potentials, ξx net Sample
i and ξnet Cal (eq 1),
assuming a linear relationship between velocity (mobility) and
zeta potential as given in the Smoluchowski approximation.53,57
ξ
ξ
=
v
v
( )
( )
x
i
x
i
el Sample
el Cal
x net Sample
net Cal (1)
The net zeta potentials for both sample and calibration
particles are the differences in the respective particle zeta
potentials and the membrane zeta potential, ξm (eq 2)
ξ ξ ξ= +p Sample net Sample m (2)
The zeta potential of each sample particle i, ξsample
i , is given by
averaging respective zeta potential values, calculated at various
locations within the pore (eq 3), with lx being the position
within the pore reached after time, t = Tx. Please note that lx is
set to equal 0 right at the narrow pore entrance of the conical
pore, where the signal magnitude reaches its maximum, as
shown in Figure 1b. Zeta potentials are evaluated by taking the
average at several discrete points, lx.
ξ
ξ
ξ ξ
=
∑
Σ
=
∑ −
Σ
+
v v P V( )/(v )
i
i
x
i
x
Sample
x x Sample
x x Sample x Cal
P
x Cal
V
net Cal m
(3)
vix Sample is the sum of the time averaged electrokinetic
(electroosmotic and electrophoretic) and convection velocity
components of sample particulates at position lx within the pore
(eq 4).
∫
= =v l
T
v t t
T
( ) d
i
i
T i
ix Sample
x
x
0
x
i
X
(4)
vxCal
V , vxCal
P , P, and V are electrokinetic velocity per unit voltage,
convective velocity per unit pressure, applied pressure, and
voltage for the sample runs, respectively. The electrokinetic
velocity per unit voltage is equivalent to the electrokinetic
mobility, which is the sum of electroosmotic and electro-
phoretic mobility. vxCal
V and vxCal
P are calculated by averaging
typically over more than 500 calibration particles. ξnet Cal and ξm
are the zeta potentials of polystyrene standard particles and the
membrane, respectively. The zeta potentials of polystyrene
standards and the thermoplastic polyurethane membrane were
measured using PALS and streaming potential techniques, to be
−20 and −11 mV respectively (see the Supporting
Information).
3.2. Zeta Potential of DNA Modified Particles. To test
our method on DNA modified particles we first performed a
series of measurements increasing the concentration of ssDNA
(25 bases in length) on the streptavidin coated particle surfaces.
The concentration of DNA, termed here CP, was increased
from 10−210 nM, while the particle concentration remained
constant. At DNA concentrations over 188 nM the theoretical
binding capacity of the streptavidin particles (as given by the
supplier) has been reached (see the Supporting Information,
Figures A.2 and A.3a for the size and charge distributions of the
streptavidin coated particles without DNA). At the highest
concentration of DNA added to the particles there is ∼12648
pieces of DNA/particle, if all of these are attached to the
surface of the particles it would equate to 1 DNA molecule
every 2 nm across the particle surface. At lower concentrations
of the DNA this ratio changes to 602/particle at 10 nM, and
4517/particle for 75 nM. Figure 2 is an example of size and zeta
potential data that can be captured simultaneously in a single
TRPS measurement. The blue and red bars/data points show
the data at the lowest and middle concentration of CP (10 nM
and 47 nM respectively) and the green bars/data points show
results from the highest concentration of CP measured (210
nM). Please note that each data point in Figure 2 represents a
single particle.
From this, it can be found that although there are no
significant size changes observed between the samples, there are
significant changes observed in the zeta potential. The inferred
zeta potentials from the measured velocities of the samples at
varying CP concentration are shown in Figure 3a,b,
respectively. The particle velocities are determined from 1/
T0.50 (see the Supporting Information), which is an estimate of
the average particle speeds. The measured zeta potential in
Figure 3a shows that as the DNA concentration is increased,
the larger the absolute zeta potential, and follows the expected
trend based on the measured particle velocities; similar data for
repeat experiments are given in Figure A.4. This is attributed to
each phosphate group contributing to a negative point charge,
thereby increasing the charge density of the particle surface, as
described by Graham’s equation. Surface charge densities were
calculated using Graham’s equation.56,61 With mean zeta
potentials not exceeding an absolute value of 40 mV the
respective absolute surface charge densities lie below 0.035 C/
Figure 2. Size and zeta potential data captured simultaneously from a
single TRPS measurement. The blue bars/data points are results of a
sample containing 10 nM CP (570 particles measured), the red bars/
data points are of a sample containing 47 nM (524 particles measured)
and the green bars/data points are of a sample containing 210 nM CP
DNA (576 particles measured).
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m2, and acknowledge that while counterion condensation may
play a role under these situations it is beyond the scope of the
study to describe in detail. Figure 3c shows a series of
histograms of frequency versus measured zeta potential for each
concentration of DNA. The distribution at low concentrations
of DNA can be characterized as narrow with a long skewed tail,
which may in part be due to the particles themselves not having
a uniform coating of streptavidin. As the concentration of DNA
is increased the distribution changes, with the median skew
value going from −0.66, −0.51, and −0.36 for 10, 95, and 210
nM, respectively. It should be noted here that the skewed
histogram data in the figure may be an inherent property of the
particles themselves not having a uniform coating of the
streptavidin protein, as shown in Figure A3a. The charge
histograms for all of CP concentrations studied are shown in
Figures A.4 and A.5. Particle-by-particle measurements provide
more detailed analysis of a sample solution. Charge distribution
histograms are used to represent the spread of data among a
given sample population. The zeta potential of the sample can
then be analyzed in more depth.
A similar relationship between the length of the ssDNA and
measured zeta potential should also exist, that is as the length of
the DNA increases, the zeta potential is also predicted to
increase. Steinbock et al. have previously investigated the effect
of long double-stranded DNA strands (4 and 6 kilo base pairs)
hybridized to colloids using microparticles and a microcapillary
base Coulter counter system. They found that DNA coated
microparticles displayed a much smaller change in conductance
values due to the additional charge in the system.40 To
investigate the sensitivity of TRPS in its ability to measure
changes in zeta potential, we are focusing on much smaller
strands of single-stranded DNA. The ssDNA oligonucleotides
in this study were 10, 25, 36, and 50 bases in length equivalent
to 7.0, 17.5, 25.2, and 35 nm in length respectively if the ssDNA
is fully extended.62,63
Figure 4a shows how the zeta potential increases when the
length of the DNA is increased alongside the relative particle
velocity displayed in Figure 4b. In this example (red bars), the
concentration of DNA added to the particles is in excess of the
binding capacity. Figure 4a, blue bars, illustrate the same effect,
i.e. as the length of the DNA increases so does the measured
zeta potential. However, in this experiment, the DNA is at 75
nM, which is lower than the theoretical binding capacity of the
particles. At this lower concentration the DNA is much more
flexible and can exist in its condensed mushroom form.64 Figure
4c shows the charge distribution histograms for the densely
packed DNA particles (distributions for the 75 nM DNA are
Figure 3. (a) Mean zeta potential vs capture probe concentration. (b) 1/T0.50, see Figure 1b, estimating average particle speed vs capture probe
concentration. (c) Charge distributions among the sample population shown in panel a increasing in DNA concentration from left to right. 537, 605,
585, and 588 particles were measured for the samples containing 10, 47, 95, and 210 nM DNA, respectively.
Figure 4. (a) Mean zeta potential vs capture probe base length. Blue bars are representative of a 75 nM DNA concentration and red bars represent a
210 nM DNA concentration. (b) 1/T0.50, see Figure 1b, estimating average particle speed vs capture probe base length. (c) The charge distribution
of varied DNA base length using 210 nM DNA. 676, 1001, 996, and 693 particles were measured for the 10, 25, 36, and 50mer, respectively. Error
bars represent st.dev where n = 2.
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given in Figure A.6, and distributions from multiple runs are
presented in Figure A.7.).
The width of the distribution increases as the length of the
DNA increases (D90/10 goes from 2.87 to 5.3 for 10 and 50
base lengths respectively), we attribute this observation to the
steric hindrance of the longer strands, preventing a higher
packing density of the DNA around the particles due to their
radius of gyration, effectively blocking the binding of the DNA
onto the surface. It is also interesting to note that the median
skewness values go from −0.42 to −0.41, −0.12, and 0.45 for
10, 25, 35, and 50 bases, respectively. The particle charge
distributions for the lower DNA concentration (75 nM) and
comparative data sets for the higher concentration (210 nM)
illustrating the reproducibility of the data are given in the
Supporting Information, Figures A.6 and A.7.
3.3. Detecting Target DNA Hybridization. It was then
investigated if the technique could discriminate between
ssDNA and dsDNA. Initially the capture probe length was
kept constant at 25 bases in length, and was always added in
excess of the binding capacity of the particles. Any unbound
capture probe in solution was removed before the target probe
was incubated with the particles. As can be seen in Figure 5ai
and ii, the formation of dsDNA can be measured by an increase
in zeta potential for assay hybridization times of 16 h (green
triangles) and for hybridization times as short as 30 min (red
squares).
The change in structure from ssDNA to dsDNA is a 50-fold
increase in persistence length,30,31 and this will result in the
hydrodynamic radius of the particle upon forming dsDNA to
increase. Two competing factors then affect the surface charge
density. The first is the elongation of the DNA upon forming
the dsDNA structure which has the effect of spacing out the
charged phosphate groups away from the particle’s surface,
resulting in a decrease in charge density. However, this is
countered by the addition of a second strand of DNA doubling
the number of point charges resulting in a net increase in
electrophoretic mobility in solution, and thus resulting in
increased velocities and larger zeta potential values.
This is similar to the work done by Booth et al.
demonstrating the detection of target-probe DNA hybridization
and successfully discriminating between “probe” and “target-
probe” hybridized particles using TRPS.65 However, in these
previous examples the experiments utilized a 23mer capture
probe and 50mer target, as such the captured DNA extended
out into solution and was predominantly ssDNA. Here we were
curious as to the ability of the technique to discriminate
between ssDNA and dsDNA, as well as overhanging DNA. We
investigated a range of DNA targets binding to various
positions of the capture probe, to determine the sensitivity
and reliability of a zeta potential measurement for the detection
of varied DNA hybridization. We termed these target probes as
cDNA (fully complementary), MidT (binds to the middle of
the CP), EndT (binds to the end of the CP furthest from the
particle surface) and OverT (binds to the end 10 bases of the
CP and overhangs into solution by 15 bases). The results for
these measured zeta potential values are plotted in Figure 5aiii−
v. As we add target DNA in each of the hybridization
experiments to form dsDNA, be it at the middle or end of the
CP, there is a larger zeta potential recorded. The magnitude of
change in zeta potential is always greatest with the longer
hybridization times. Of interest is the fact that the overhanging
DNA sequence (OverT) gives the largest negative zeta
potential of all the samples despite being the longest length.
Increasing the length of the DNA could have slowed the speed
at which the particles traverse the pore due to additional drag
effects and lowered the recorded zeta potential. However, the
result indicates that the increase in charge due to the additional
30 based has a more dominant effect on particle translocation
Figure 5. (a) Relative change in mean zeta potential (mV) from DNA capture probe (CP, 250 nM) to when a variety of targets are hybridized for 30
min (red squares) and hybridized for 16 h (green triangles). The relative change in zeta potential was also investigated for a lower concentration (75
nM) and 30 min hybridization time (blue diamonds). (b) Charge distributions for each target at 250 nM CP concentrations and a hybridization time
of 16 h. 500, 990, 592, 707, and 964 particles were measured for samples (i−v), respectively, with median skewness values of −073, −0.59, −0.41,
−0.49, and −0.31. Error bars represent st.dev where n = 3.
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times. One suggestion for this observation could be down to
the ssDNA having a lower persistence length. The overhanging
ssDNA may coil/fold back toward the particle. This folding in
effect increased the surface charge density around the particle,
thus increasing the electrophoretic velocity through the
creation of a “hairy layer mechanism”.66 The ssDNA within
the overhanging DNA is also further from the particle’s surface
than the DNA in any other experiment. Given the curvature of
the particle the distance between each DNA molecule will
increase, and this room allowing for the DNA to fold back may
explain the enhanced effect over MidT and EndT experiments.
A surprising aspect of the data was the ability to distinguish
between dsDNA formed at the end or middle of the capture
probe. The target DNA that bound to the end of the CP
(EndT), recorded a smaller zeta potential than a same sized
target that was hybridized to the middle of the CP (MidT). We
attribute this to the effects of persistence lengths and the
location of the dsDNA in the capture probe. The MidT dsDNA
leaves a section of ssDNA exposed to the solution. This is more
flexible and we hypothesize that when the dsDNA is in the
middle of the DNA, the single stranded end section coils/folds
back to increase the charge density around the particle,66 thus
creating a larger zeta potential. In the case where the dsDNA is
at the end of the sequence, the ability of the DNA to fold back
on itself is restricted and forms a more rigid elongated oligomer
across the entire length of the DNA, moving the charge away
from the surface and lowering the surface charge density.
The observation that MidT produces a larger shift in zeta
potential could influence the design of future assays on TRPS
systems. The change in distribution shape indicates a difference
in the DNA hybridization or DNA target itself. Figure 5b shows
the change in charge histogram shape, dependent on the target
DNA hybridized to the CP. The ability to monitor any of these
discrete differences is an insightful prospect for future colloid
and nucleotide research.
As well as designing the location to capture target DNA,
there is also an interesting observation on the effect of DNA
density on hybridization kinetics. Previous studies have
illustrated that the kinetics of target DNA capture is influenced
by DNA probe density at a surface.67−70 At high DNA probe
densities, the ssDNA forms a dense packed polymer brush,56
the DNA forms a rigid polymer coating whose thickness is
equal to the length of the extended DNA sequence, H.72 The
effects on packing density then determine the electrostatic
potential, the position of the shear plane and the kinetics of
target DNA hybridization. The significance of the zeta potential
at polyelectrolyte layers becomes more complicated, and when
the debye length, κ−1, is sufficiently lower than the
polyelectrolyte layer thickness, H, i.e. κ−1/H≪ 1, the measured
zeta potential may no longer reflect the stern potential, as the
plane of shear is shifted to distances further away from the
particle’s surface.73 Therefore, at polyelectrolyte surfaces, the
term zeta potential in effect loses its original meaning. As the
density of the DNA packing decreases the plane of shear may
enter the DNA layer.73
Figure 6 shows the effect of hybridizing an excess of target
cDNA to different packing densities of CP. At a low capture
probe concentration and a target hybridization time of 30 min
(shown by Figure 6a), the charge distributions were much
narrower in shape with less of a tailing effect observed. In
agreement with previous studies,74 when the DNA capture
probe concentration is lower, there is a faster rate of reaction,
resulting in a much narrower charge distribution histogram. At
high capture probe concentrations, it is difficult to observe an
increase in zeta potential for small hybridization reaction times,
thus for quick assay times, low packing densities of CP produce
better results.
Panels b and c in Figure 6 both display results observed at
high CP concentrations and show the charge distribution
widening as the target hybridization time increases from 30 min
to 16 h. This is due to the increase in the amount of time the
target DNA has to reach the required orientation to achieve
successful complementary DNA binding. The more time there
is for this to happen, the higher the proportion of target DNA
that can successfully bind to the capture probe resulting in a
larger amount of dsDNA present on the particles. This
increases the particle velocity through the nanopore, thus
resulting in a larger absolute zeta potential.
A more Gaussian charge distribution was seen for particles
analyzed in panels a and c in Figure 6 than in panel b, with
skewness values of +0.1, −0.41, and −0.37, respectively. We
attribute this to an increase in ability to form dsDNA, and then
detect its presence on a particle. For example with a
hybridization time of 30 min and a lower capture probe
concentration (Figure 6a), the presence of dsDNA is easily
detected. This may be due to two factors, first there being less
steric hindrance for the target DNA to approach the particle
allowing the rate of dsDNA formation to be increased, and
second the resolution of the technique to measure the
incremental addition of dsDNA against a particle of lower
charge, compared to a high density ssDNA covered particle in
6b. Increasing the target hybridization time to 16 h (Figure 6c)
using the high concentrations of capture probe allows the target
to have more time to hybridize and thus more dsDNA is
present on the surface.
4. CONCLUSIONS
We have demonstrated that TRPS can successfully detect and
characterize both unmodified and DNA-modified particles in a
single, real-time measurement. Charge distributions, rather than
a single mean zeta potential value allow for more information to
be extracted from a sample data set using a particle-by-particle
perspective. DNA-based surface modifications to a nanoparticle
Figure 6. Charge distributions for a sample population at (a) low
concentration of capture probe (75 nM) + 30 min hybridization of
varied targets in excess (987, 998, and 996 particles were measured for
CP, cDNA, and OverT, respectively); (b) high concentration of
capture probe (250 nM) + 30 min hybridization of varied targets in
excess (502, 997, and 661 particles were measured for CP, cDNA, and
OverT, respectively); and (c) high concentration of capture probe
(250 nM) + 16 h hybridization of varied targets in excess (512, 916,
and 944 particles were measured for CP, cDNA, and OverT,
respectively) .
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affect the behavior of the nanoparticles in an electrolyte
solution and their mobility through a nanopore; and by
optimizing the hybridization time and DNA packing density on
a surface, we measure the successful capture of target DNA
after just 30 min incubation time. Successful analyte capture
after such short incubation times is advantageous and shows
great potential for medical applications, such as point of care
assays, for example.
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Abstract The zeta potential of the protein corona around car-
boxyl particles has been measured using tunable resistive
pulse sensing (TRPS). A simple and rapid assay for character-
ising zeta potentials within buffer, serum and plasma is pre-
sented monitoring the change, magnitude and distribution of
proteins on the particle surface. First, we measure the change
in zeta potential of carboxyl-functionalised nanoparticles in
solutions that contain biologically relevant concentrations of
individual proteins, typically constituted in plasma and serum,
and observe a significant difference in distributions and zeta
values between room temperature and 37 °C assays. The effect
is protein dependent, and the largest difference between the
two temperatures is recorded for the γ-globulin protein where
the mean zeta potential changes from −16.7 to −9.0 mV for 25
and 37 °C, respectively. This method is further applied to
monitor particles placed into serum and/or plasma. A
temperature-dependent change is again observed with serum
showing a 4.9 mV difference in zeta potential between sam-
ples incubated at 25 and 37 °C; this shift was larger than that
observed for samples in plasma (0.4 mV). Finally, we monitor
the kinetics of the corona reorientation for particles initially
placed into serum and then adding 5 % (V/V) plasma. The
technology presented offers an interesting insight into protein
corona structure and kinetics of formation measured in bio-
logically relevant solutions, i.e. high protein, high salt levels,
and its particle-by-particle analysis gives a measure of the
distribution of particle zeta potential that may offer a better
understanding of the behaviour of nanoparticles in solution.
Keywords Biosensor . TRPS . Zeta potential . Protein
corona . Tunable pores
Introduction
In recent years, synthesis methods for nanoparticles have
evolved to the extent that particle size, shape and composition
can be easily modified [1–4] and this had led in turn to great
advances in the field of diagnostics [5, 6], drug delivery [7–9]
and technology platforms [10, 11]. With the desire to under-
stand and improve nanomaterials comes a need for character-
isation platforms to offer rapid analysis of size, charge and
shape. Ensemble techniques that take measurements on sev-
eral particles simultaneously and provide an average measure-
ment can underestimate subpopulations within multimodal
samples [12, 13], and a raft of technologies have appeared to
help tackle this [14, 15]. Such technologies now offer an abil-
ity to quantify the population of particles with single particle
resolution building an understanding that not all particles are
created equal and there exists distributions such as particle
size or ligand density.
One such technology is based on the Coulter Counter
principle, referred to as resistive pulse sensing (RPS)
[16–18]. The technique allows the characterisation of proteins,
inorganic ions, colloids and nanoparticles within their natural
environment. Two categories of resistive pulse sensors exist
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that utilise either biological [19, 20] or inorganic nanopores
[21–23]. Here, we describe a recent adaptation to inorganic
pores that uses a tunable elastomeric pore termed tunable re-
sistive pulse sensing (TRPS) [14, 24–36]; the pore can be
stretched in real time to suit the sample. The brief setup and
theory for TRPS technologies is as follows: A stable ionic
current is established by two electrodes, separated by a pore;
as particles/analytes translocate the pore, they temporarily oc-
clude ions, leading to a transient decrease in current known as a
‘blockade event’, examples of which can be seen in Fig. 1. In
the TRPS arrangement used here, the pore is mounted laterally
so that particles typically move from the upper fluid cell into
the lower fluid cell, aided by an inherent pressure head due to
40 μl of liquid in the upper fluid cell of approximately 50 Pa
[35]. By monitoring changes in blockade width, blockade
magnitude (Δip) and blockade frequency (events/min), it is
possible to elucidate the zeta potential, size and concentration
of colloidal dispersions in situ [14, 37, 38]. By controlling the
aspect ratio of the pore, resistive pulse sensors have been used
to measure analytes that range from single molecules, DNA,
proteins, cellular vesicles to cell bacteria and viruses; detailed
reviews on the types of analytes and applications can be found
elsewhere [24, 36, 39, 40]. TRPS is becoming an increasingly
common variation of RPS for the characterisation of biological
and inorganic nanomaterials [24, 36] and since its conception
has been tested against alternative technologies such as DLS/
PALS [14, 15, 41–44], TEM [33], and ultracentrifugation [44]
for the characterisation of nanomaterials [15, 45].
The how and where of measuring the properties of particles
are important to consider as changing pH, ionic strength or
temperature, or purifying particles can give a misrepresenta-
tion of their behaviour in their natural environment. In the case
of nanomaterials that are intended to be used in vivo, it is not
properties within synthesis processes that determine their bio-
logical activity, but how they interact with proteins upon en-
tering the body. Upon the addition of nanoparticles to biolog-
ical fluids, there is an almost immediate fouling of their sur-
faces with proteins, peptides and other cellular apparatus
forming a layer known as the protein corona [46–48]. The
composition of the corona has been shown to determine the
eventual properties of the particles [49–51] and has been re-
ported as critically affecting pathophysiological effects of
nanoparticles [52]. The structure of the protein corona can
be dynamic and complex and is different for particles of the
same composition but with different surface chemistries and
size in the same solution [46, 53]. Detailed studies of the
corona have been performed using an array of technologies
including mass spectroscopy [54, 55]. Various techniques
have been used to look at a range of specificities of protein
coronas, for example, protein corona thickness has been in-
vestigated using ensemble techniques such as dynamic light
scattering (DLS) and differential centrifugal sedimentation
Fig. 1 Particles in the presence of
human plasma and serum
showing the formation of both a
‘hard’ and ‘soft’ protein corona.
I1.0, I0.8, I0.6, I0.4, I0.2 represent the
position of the particle as it
translocates the pore (where I1.0 is
the narrow pore entrance) and are
relative to T1.0, T0.8, T0.6, T0.4,
T0.2, which represent the time
taken (ms) for the particle to reach
that position. T1.0, is equivalent to
dRmax when the blockade event is
at 100 % magnitude; T0.8, T0.6,
T0.4, T0.2, correspond to when the
blockade is 80, 60, 40, and 20 %
of its dRmax and indicates the
particle traversing the pore
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(DCS) [49, 56]. Protein corona conformation has been studied
using circular dichroism (CD) and fluorescence quenching [57,
58]; the affinity has also been a popular characterisation pro-
perty of protein coronas and has previously been measured
using size exclusion chromatography (SEC), surface plasmon
resonance (SPR) and isothermal calorimetry (ITC) [49, 56,
59]. A frequent and easy value used to characterise the corona
is zeta potential [46, 48, 50, 54, 60]. The zeta potential repre-
sents the value of the electrostatic potential at the plane of
shear, and typically for nanoparticle systems, zeta potential
values of ±30 mVare representative of stabilised particles [61].
When nanoparticles are introduced to biological fluids, the
protein corona is formed in a series of layers, otherwise known
as the ‘hard’ and ‘soft’ corona. Proteins forming the hard
corona are those with a higher affinity that interact directly
with the nanoparticle surfaces, whereas proteins forming the
soft corona are those engaging in weaker protein–protein in-
teractions with the hard corona [56, 62]. It has previously been
found that a vast range of particles bind successfully to apoli-
poproteins in physiological fluids [55]. Formation of a protein
corona alters the size, aggregation properties and surface
properties of nanoparticles [63], thus creating a new biological
distinctiveness for further application. There are 5 main com-
ponents that define the composition of a protein corona: thick-
ness and density, identity and quantity, orientation, conforma-
tion and affinities [63].
Protein adsorption kinetics play a prominent role in this
study and are key to understanding the binding mechanisms
that will occur in a natural environment. Although this process
is time-dependent, the kinetics rely on kon and koff parameters,
indicating the rate constants for adsorption and desorption of
proteins. kon is largely dependent on how often the protein
contacts the nanoparticle surface, as well as the probability
of successful binding between the two materials [64]. The
strength of the protein–nanoparticle interaction defines koff
[64], and a strong, high-energy interaction will exert a low koff
value. Understanding the kinetics of formation and protein
corona composition is important to understand processes
nanoparticles may undertake when introduced into the body
and into physiological conditions.
Here, we present a protocol for the rapid analysis of the
corona zeta potential and demonstrate its versatility bymaking
the measurement in solutions that mimic the natural environ-
ment, i.e. high ionic strength and high protein composition.
By making comparable measurements of carboxyl polysty-
rene nanoparticles in a range of incubation temperatures and
with different proteins, a clear difference in magnitude and
variation of zeta potential within the particle population was
observed; the three proteins chosen to demonstrate this are the
most predominant (in terms of quantity) proteins in normal
human plasma and we perform the experiment concentrations
that would reflect normal plasma. The ability to have individ-
ual particle resolution provides an opportunity to see the full
variation of zeta potential in a single sample. The findings
highlight the need to monitor the protein corona and its for-
mation at biologically relevant temperatures and suggest that
the kinetics of protein adsorption and spread in zeta potential
values varies for each of the proteins and biological mediums
studied. Finally, we show the scope of the technology by
monitoring the change in the hard and soft corona elements
interacting with the particles through incubation in serum,
followed by the addition of a small amount (5 % (V/V)) of
plasma. It is known that protein components of a higher con-
centration or affinity to the particle can remove and restructure
the soft corona that is formed in biological fluid [55], and we
monitor the rate of this change and the kinetic effects that
eventually settle on a new zeta potential value.
Materials and methods
Chemicals and reagents
The initial buffer used for particle analysis was phosphate
buffered saline (1× PBS tablet (0.01 M phosphate buffer,
0.0027 M potassium chloride, 0.137 M sodium chloride) in
200 mL deionised water (18.2 MΩ cm)). PBS tablets (P4417)
were purchased from Sigma-Aldrich, UK.
Carboxyl polystyrene standards
Carboxylated polystyrene particles, denoted as CPC200, with a
mean nominal diameter of 210 nm and stock concentration of
1 × 1012 particles/mL, were purchased fromBangs Laboratories,
USA and used as a calibrant for zeta potential analysis, as well
as the sample particles. CPC200s were vortexed for 30 s follow-
ed by a 2 min sonication to ensure monodispersity prior to any
TRPS analysis or sample incubation.
Isolated proteins
All isolated proteins studied were purchased from Sigma-
Aldrich, UK, without modification or purification unless stat-
ed otherwise: fibrinogen from human plasma (F3879), albu-
min from human serum (A9511) and γ-globulin from human
blood (G4386).
Human plasma and serum samples
Blood samples were collected and prepared at Peterborough
City Hospital Pathology Laboratory, UK. Plasma collection
was completed using blood from a healthy volunteer donor
that was collected in citrate medium (Sarstedt, UK.) and cen-
trifuged at 3000 rpm for 8 min. Serum was gathered using
blood from a healthy volunteer donor that was collected into
a Sarstedt monovette/collection tube, and was centrifuged at
Characterisation of the protein corona using tunable resistive pulse sensing 5759
3000 rpm for 6 min. The supernatants from each sample were
transferred into separate sample vials and stored at room tem-
perature prior to use.
Isolated protein studies
Using PBS buffer, isolated albumin, fibrinogen and γ-
globulin samples were prepared to give the following concen-
trations: 43, 3.2 and 20 g/L, respectively, as to mimic protein
concentrations found in human blood. The concentrations of
proteins were measured from human plasma and serum sam-
ples. The samples used in this study were analysed by an
Instrument Laboratory ACL TOP CTS500 coagulation
analyser (Werfen, Spain) to obtain the fibrinogen concentra-
tion. Albumin and immunoglobulin levels were taken from
test serum samples that were analysed by a Roche Cobas
Biochemistry Analyser (Roche Diagnostics, Switzerland).
CPC200s were added resulting in a final concentration of
1 × 1010 particles/mL. Each sample was vortexed for 30 s
and sonicated for 1 min before incubation. Samples were then
incubated at 25 and 37 °C in a mini dry bath (Benchmark
Scientific, USA) for 10 min prior to TRPS analysis.
Serum and plasma studies
Human plasma and serum were prepared immediately before
the experiments to minimise ex vivo artefactual changes. The
prepared plasma and serum were separately diluted 10-fold
with PBS before CPC200s were added to both samples
resulting in a final particle concentration of 1 × 1010 parti-
cles/mL, herein these solutions are referred to as serum and
plasma. Samples were vortexed for 30 s and sonicated for
1 min, followed by incubation in a mini dry bath
(Benchmark Scientific, USA) at 25 and 37 °C for 10 min
before being removed for TRPS analysis. It should be noted
that it is possible for some proteins in human plasma and
serum to interact and adsorb onto the pore walls; therefore, a
control measurement of CPC200s in PBS (of known zeta po-
tential, -20 mV) was completed before and after each protein/
plasma/serum sample to establish if any changes had occurred
to the pore itself.
Plasma spiking assay
Human serum was 10× diluted in PBS before CPC200s were
added to a final concentration of 1 × 1010 particles/mL.
Samples were vortexed for 30 s and sonicated for 1 min before
being incubated for 10 min at 25 and 37 °C in a mini dry bath
(Benchmark Scientific, USA). At 10 min, 5 % (V/V) human
plasma was added to the serum samples and the samples were
vortexed for 30 s. TRPS measurements were completed once
the plasma had incubated with the serum sample for 5, 10, 15,
20, 30 and 60 min.
Tunable resistive pulse sensing
All measurements were completed using the qNano (Izon
Science Ltd, NZ). The system utilises tunable nanopores with
propriety data capturing software (Izon Control Suite
v3.1.2.53). In all experiments, the lower fluid cell contained
80μL of PBS buffer, ensuring no bubbles were present.When
a sample measurement was being taken, the upper fluid cell
contained 40 μL of the sample (suspended in PBS buffer).
After each measurement was taken, the nanopore was washed
several times by removing and replacing 40 μL of buffer, each
time applying varied pressures until no particles were ob-
served. This was performed several times to remove any re-
sidual particles in the system and thus ensure no cross-
contamination between samples. The nanopores used
throughout all experiments were capable of detecting particles
within the size range of 100–300 nm (as stated by the manu-
facturer, Izon Science Ltd) and denoted as an NP200. To ac-
count for the variation in the manufacturing of the nanopores,
appropriate stretch (44–46 mm), voltage and pressure were
applied in all experiments; the conditions were matched as
to the blockade magnitudes of CPC200s in PBS being of a
similar size throughout all experiments. All samples were
vortexed for 30 s and sonicated for 2 min prior to analysis.
Zeta potential measurements using TRPS
When carrying out zeta potential measurements, the nanopore
stretch was kept the same for a particular dataset and nanopore
between calibration and sample measurements. To calibrate a
nanopore for zeta potential analysis, the calibration particles,
of known size and zeta potential, were measured in PBS at 3
applied voltages; the particles measured at the highest voltage
were measured at 2 external pressures (in addition to the in-
herent 47 Pa pressure head on the system). When running the
samples, the blockade magnitudes were ensured to be at least
100× larger than the respective background noise of ca. 10 pA.
In accordance with the calibration runs, the samples were run
at the highest calibration voltage. Calibration measurements
were completed when a new nanopore (NP200) was intro-
duced to ensure conditions were matched so the blockade
magnitudes of CPC200s in PBS were of a similar size to other
NP200s used for this study. A CPC200 sample in PBSwas run
after each protein/plasma/serum sample to ensure the zeta po-
tential of the pore remained unchanged and as such did not
affect the measured zeta potential of further samples.
Results and discussion
Zeta potential values were determined from the particle veloc-
ities as they traversed the nanopore; a full description of the
protocol and theory can be found elsewhere [21, 38]. Briefly,
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the duration of particle translocation is measured as a function
of applied voltage, taking an average electric field and average
particle velocities over the entire sensing zone that is a regular
conical pore. Each particle’s electrophoretic mobility is de-
rived from 1/T, where T is the blockade duration and voltage,
multiplied by the square of the sensing zone length, L, as part
of a calibration constant. Figure 1 shows the conical sensing
zone and an example of the blockade duration times, T, as a
result of a blockade event at various positions, I, in the
nanopore. T1.0 for example is equivalent to when the blockade
is 100 % in magnitude and is indicative of I1.0, the position to
which the particle is approaching the pore entrance. T0.6 re-
lates to position I0.6 where the blockade is 60 % in magnitude
and the particle has traversed 40 % of the pore. It is important
to note each blockade depicted in the signal trace is indicative
of a single particle as it passes through the pore, highlighting
the advantages of using particle-by-particle technologies such
as TRPS.
Average velocities determined across multiple reference
points within the nanopore vastly reduce any errors in this zeta
potential calculation process [38]. The calibration of the pore
itself is based on a linear relationship between 1/Tand voltage,
V, at each blockade reference point. Equation 1 shows the
direct relationship between particle velocities and their zeta
potentials, vxð Þel Cal and vix
 
el Sample are the particle velocities
of calibration and sample particles, respectively, and ξnet Cal
and ξix net Sample represent their zeta potential values [38].
vix
 
el Sample
vxð Þel Cal
¼ ξ
i
x net Sample
ξnet Cal
ð1Þ
Equation 2 shows the zeta potentials measured at each of
the blockade reference points can then be used to determine
the zeta potential of each individual particle, i, as it passes
through the pore, ξiSample.
ξiSample ¼
∑xξ
i
x Sample
∑x
¼
∑x vix Sample−vPx Cal  P
 .
vVx Cal  V
 
∑x
 ξnet Cal þ ξm ð2Þ
Where vVx Cal,v
P
xCal, P and V are electrokinetic velocity per
unit voltage, convective velocity per unit pressure, applied
pressure and voltage, respectively. Ix is the position of the
particle in the nanopore after time t = Tx, vx Sample
i is the sum
of the particle velocities at relative positions, lx [38].
The proteins used in this study were chosen based on their
relative abundances in both blood plasma and serum samples.
Albumin and γ-globulin are present in both plasma and serum
samples at approximately 4 and 2 %, whereas fibrinogen (as
well as other clotting factors) is only found in plasma at ap-
proximately 0.4 %. Zeta potential values measured for parti-
cles incubated with each of the isolated proteins are shown in
Fig. 2 (for reference the starting zeta potential of a CPC200 in
PBS is −20 mV).
When the particles were incubatedwith each of the proteins
separately at 25 °C, both fibrinogen and γ-globulin showed a
relatively small change inmean zeta potential from particles in
PBS buffer, differences of 3.2 and 3.6 mV, respectively. The
size and zeta potential distributions of CPC200 carboxyl par-
ticles in PBS are shown in Fig. 3. Albumin was seen to have a
much larger effect on the particle zeta potentials at 25 °C as the
zeta values were reduced by 9.2 mV from the PBS control.
Albumin was at the highest concentration at 40 g/L in com-
parison to the fibrinogen and γ-globulin samples only having
protein concentrations of 4 and 20 g/L respectively. The pro-
tein concentrations were chosen to replicate the typical com-
position usually found in the human body, although it should
be noted that the concentration of proteins to that of the par-
ticles in each experiment was always in a large excess as to
coat each surface of every particle. The proteins were also
investigated at a constant concentration (5 g/L) at a 25 °C
incubation temperature for 10 min to determine whether pro-
tein concentration had an effect on the protein corona on the
particles, results of which are shown in the Electronic
Supplementary Material (ESM), Fig. S1. From this, it was
found that the relative change in zeta potential (from a control
of the particles just in PBS) was smallest for fibrinogen and γ-
globulin with values of 4.3 and 4.9 mV, respectively. The
largest change in zeta potential was again observed for the
albumin protein with a difference of 8.9 mV. These compara-
ble changes show the results are protein specific and not re-
lated to the concentration at these levels. It was therefore ex-
pected that the proteins would adsorb onto the particle surface,
forming the protein corona. Any such protein corona would
change the surface charge density on the particles and be mea-
sured by a change in particle velocity, which in turn is plotted
as the zeta potential. At 25 °C, the small zeta potential changes
for fibrinogen and γ-globulin samples are more than likely
because of the protein isoelectric points and their behaviour
at physiological pH. Albumin has an isoelectric point of 4.7
whereas fibrinogen and γ-globulin have isolectric points of
5.8 and 6.6, respectively [65]. Previous reports have found
that as the adsorption pH moves away from the protein
isolectric points, the adsorbed molecules will occupy a larger
area of the surface. This is due to internal electrostatic repul-
sions and thus a lower structural stability [66]. Our samples
were all suspended in PBS buffer at pH 7.4, and therefore, the
albumin is expected to occupy the largest area of the nanopar-
ticle surface as the adsorption is occurring at a pH furthest
from its isoelectric point. This may be the reason the albumin
shows the largest change in zeta potential after a 25 °C
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incubation in comparison to the smaller changes observed for
fibrinogen and γ-globulin (isoelectric points closer to 7.4).
Particles were also incubated with each of the proteins at a
higher temperature of 37 °C; it was hypothesised that as the
proteins are present in such a large excess that the incubation
time of 10 min would be enough to coat the particles with a
monolayer of protein, and that the temperature would have
little effect on the result. In contrast, at 37 °C, there were
significant differences from values at 25 °C and each protein
produced varying shifts in zeta potential values. At the elevat-
ed temperature, γ-globulin was seen to have the largest reduc-
tion in zeta potential from a value of −20.3 mV (particles in
PBS) to −9.0 mV. This is of particular interest as these results
indicate each protein interacts with the particle surface unique-
ly, having direct implications on the particle zeta potential. γ-
Globulin also showed the largest change in zeta potential as a
function of incubation temperature between 25 and 37 °C
(5.0 mV), whereas albumin showed the smallest change
(1.3 mV). The distribution of zeta potentials for each isolated
protein at 25 and at 37 °C are shown in the ESM, Fig. S2.
The particle-by-particle nature of TRPS allows for individ-
ual particles to be analysed, as well providing a measure of the
spread in values across the sample population. Figure 3 de-
picts the zeta potential versus particle size plots for the given
sample populations summarised in Fig. 2. Note here that each
data point in Fig. 3 is representative of a single particle.
Whilst the distribution of the values does not change as the
incubation temperature increases, the shift in mean zeta poten-
tial as the incubation temperature was significant. This shift
may be due to the affinities of the proteins for the particle
surface being affected by the incubation temperature.
Previous studies have found that negative particles have
Fig. 2 Mean zeta potential (mV) versus the protein the particles were
incubated with. The blue bars show results for a 10-min particle incuba-
tion at 25 °C and the red bars show the mean zeta potential values for
particles incubated with the proteins for 10 min at 37 °C. The green lines
represent the measured mean zeta potential for calibration particles of
known zeta potential (−20 mV) in PBS that were run after each protein
sample to show the protein samples were not having a direct effect on the
pore walls themselves that may influence the recorded zeta potentials of
future samples run on the same pore. Error bars are representative of the
st.dev where n = 3
Fig. 3 Zeta potential (mV) versus particle size (nm). The red, blue and
green datasets are zeta potential distributions for CPC200s incubated for
10min with fibrinogen, γ-globulin and albumin, respectively at (a) 25 °C
and (b) 37 °C. The black data points represent CPC200s in PBS for both
figure parts a and b
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maximum protein adsorption at 15, 35 and 37 °C [67] and
explain why the CPC200s incubated at 37 °C in each protein
medium shifted to a smaller zeta potential value more so than
those incubated at 25 °C. When proteins have a higher affinity
to the particle surface, there is either the formation of a robust
hard corona, or slower release of the proteins from the surface
once absorbed. The hard corona layer will alter the particle
surface chemistry and will result in a slower particle transloca-
tion velocity through the pore due to shielding of the negative
particle surface, which consequently results in a smaller zeta
potential value. Interestingly, at the 25 °C incubation (Fig. 3a),
the γ-globulin and particularly the fibrinogen sample showed a
wider spread of data than those samples incubated at 37 °C
(Fig. 3b). Figure 3b also shows that at elevated temperatures, a
thicker protein corona layer is formed resulting in an increase
in particle size. These results suggest the protein binding kinet-
ics may differ as a function of temperature. The population
spread may be wider at lower temperatures as the proteins
may not have reached maximum levels of adsorption to the
particle surface at 25 °C [67], also supporting the small chang-
es in mean zeta potential at 25 °C demonstrated in Fig. 2.
Monitoring individual protein–nanoparticle interactions is
interesting but becomes more complex in a medium containing
a protein mixture, such as plasma or serum. Both plasma and
serum are extracted from blood samples but contain a different
composition of proteins. Relevant to this study, serum contains
albumin, γ-globulin and apolipoproteins. Plasma has a similar
protein composition to serum, but also contains clotting factors
such as fibrinogen. Figure 4 shows the measured zeta poten-
tials of CPC200s in PBS and of CPC200s incubated in plasma
and serum for 10 min at both 25 and 37 °C.
As seen in the isolated fibrinogen and γ-globulin samples
above, only small changes in zeta values were observed for
both plasma and serum at 25 °C. Interestingly, at the elevated
incubation temperature of 37 °C, the plasma still did not ap-
pear to show a significant difference in zeta potential, whereas
the sample in serum showed a reduction in zeta potential of
5.9 mV. The most prominent difference between plasma and
serum is the presence of clotting factors in plasma; this will
have an inherent effect on the protein corona structure and
resulting interactions with the particle surface [63]. Protein
corona formation is complex in physiological environments
Fig. 4 (a) Mean zeta potential
(mV) versus incubation medium.
Comparison of CPC200 particles
incubated in PBS (green), plasma
and serum for 10 min at 25 °C
(blue) and 37 °C (red). Error bars
are representative of the st.dev
where n = 3. (b) Frequency (%)
versus zeta potential (mV). Zeta
potential distributions for
CPC200s incubated for 10 min at
37 °C in plasma (purple) and
serum (pink). Repeat datasets for
CPC200s incubated in both
plasma and serum at 37 °C for
10 min are illustrated in ESM
Fig. S3 and are compared to a zeta
potential distribution of CPC200s
in PBS only
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as it consists of the simultaneous binding of numerous pro-
teins to the particle surface creating both protein-nanoparticle
interactions as well as protein–protein interactions [63].
Proteins within plasma and serum are undergoing a com-
petitive binding assay to the particle’s surface, and proteins of
higher concentration and/or affinity will bind to the particle
surface more rapidly at the first instance. Protein–protein in-
teractions are also common in plasma and serum samples, and
some proteins will have a higher affinity to a subsequent pro-
tein over the particle surface. Zeta potential distribution as a
function of temperature for the particles incubated with plas-
ma and serum samples are shown in Fig. 5.
When the incubation temperature was increased, the zeta
potential for both particles in plasma and serum were smaller.
The advantage of distribution studies of a sample population is
the discrete differences that can be identified, that cannot be
determined immediately from mean values. For example, in
Fig. 5a, the distribution shape of the particles incubated with
plasma at 25 °C (red) is almost twice as wide as the distribution
for 37 °C (purple), yet themean values only changed by 0.4mV
between temperatures, a negligible difference. The difference in
distribution shape can be reflected using median skewness
values. The median skewness values for a given sample popu-
lation of particles incubated in plasma were 0.111 and −0.065
for incubation temperatures of 25 and 37 °C, respectively.
Particles in serum showed the same effect and as the incubation
temperature was increased, the median skewness values de-
creased from −0.105 (25 °C) to −0.343 (37 °C).
The protein–nanoparticle interactions in plasma and serum
were evidently varied, and to investigate this further, we com-
pleted a plasma spiking experiment. This aimed to ascertain if
the soft corona formed in the plasma would reorganise in the
presence of serum proteins. Figure 6 shows the effect on zeta
potential as plasma (5 % V/V) was used to spike samples con-
taining nanoparticles in serum at various time intervals.
Plasma protein adsorption onto a particle surface is due to
the Vroman effect and is defined as the constant change in
protein composition based on continuous adsorption and de-
sorption at an interface [68]. There can be both faster and
slower stages in this effect dependent on the protein. For ex-
ample, albumin, γ-globulin and fibrinogen are all proteins that
will adsorb rapidly onto a surface based on their high
Fig. 5 (a) Zeta potential
distributions for CPC200s
incubated in plasma for 10 min at
25 °C (red) and 37 °C (purple).
(b) Zeta potential distributions for
CPC200s incubated in serum for
10min at 25 °C (green) and 37 °C
(blue)
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abundances, but are generally replaced by apolipoproteins in a
matter of seconds [69] due to their fast dissociation properties.
Apolipoproteins, however, although of low abundance, have a
much slower dissociation constant and will therefore remain
on the potential surface for longer [70]. As with a lot of
nanoparticle-based assays, there may be an element of com-
petition between proteins in binding to the nanoparticle sur-
face that will affect the protein corona structure as displace-
ment and exchange reactions may then take place over time.
As the hard corona involves the higher affinitive proteins, this
should remain adsorbed onto the nanoparticle surface over
time and during any biophysical event that may occur [63].
The soft corona involves much weaker protein interactions in
the system and will therefore dissociate more rapidly and pro-
tein exchange will occur much more readily. This effect is
dependent on the relative protein concentrations of all proteins
present in the plasma and serum samples. It is well known that
protein concentration has a significant effect on the formation
of a protein corona when incubated with nanoparticles [55,
71]; when a protein is of high concentration in a given sample,
that protein will initially occupy the nanoparticle surface and
form a protein corona [55] at a potentially faster rate than
those of lower concentrations that may be later exchanged
for those at a lower concentration but higher affinity. This
effect also depends on the nanomaterial and there have been
cases where proteins that have adsorbed first have had the
longest residence time [72].
The first measurement was taken after the plasma had been
introduced to the serum sample for 5 min. Between 5 and
10 min of the plasma being present (Fig. 6(i-ii)), the zeta
potential of the particles was reduced. This is due to the addi-
tion of proteins into the sample, a higher concentration of
proteins interacting with the particles will result in a slower
pore translocation velocity, hence the reduced zeta potential.
Figure 6(iii) shows that after 15 min, the zeta potential was
reduced to its lowest measured value in this experiment. This
is due to some of the plasma proteins displacing those from
serum that may have reversibly bound to the particle surface
as part of a hard corona layer. The plasma proteins may have
been of a higher affinity to those present in the serum sample
and therefore form the new hard corona layer [56, 62]. After
20min and gradually onto 60min (Fig. 6(iv)), the particle zeta
potentials became more negative, indicating an increase in
particle translocation velocity through the pore. We attribute
Fig. 6 The effect of spiking a sample of CPC200s incubated in serum
with plasma. (a) Visual representation of the effect of protein
displacement and exchange within a protein corona system. (i) Protein
corona formed by particle incubation in serum, (ii) introduction of plasma
proteins to sample, (iii) displacement of hard corona proteins due to
proteins of higher affinities and exchange of soft corona proteins, (iv)
Depletion of soft corona layer as proteins dissociate from loose protein-
protein interaction. (b) Particles were incubated in serum for 10 min and
then spiked with 5% (v/v) plasma. Zeta potentials were measured at 5, 10,
15, 20, 30 and 60min. (i)–(iv) indicate the shift in zeta potential as a result
of the effects described in (a)
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this result to the weak interactions of the soft corona layers.
For example, once the plasma proteins have potentially
displaced those in the original hard corona, the displaced pro-
teins will form part of the soft corona and be part of weaker
protein–protein interactions. Over time, the soft corona pro-
teins will dissociate more readily away from the particle due to
their loose interactions [73], reducing the protein coverage
around the particle and thus resulting in a larger zeta potential.
The zeta potential becomes larger after this process as there are
less bound proteins surrounding the particle to reduce the par-
ticle’s translocation velocity. The faster the particle can traverse
the pore, the larger the zeta potential value. This is of particular
interest as it gathers valuable information on how the different
compositions of plasma and serum proteins in a blood sample
would affect a nanoparticle and how they behave differently
when isolated and in a mixture.
Conclusions
We have demonstrated the effects of more prominent pro-
teins found in protein coronas individually (isolated in
PBS) and within their natural environment (within plasma
and serum samples) on carboxylated polystyrene nanopar-
ticle surfaces. Protein–nanoparticle interactions involved
in the formation of a protein corona have been found to
be protein dependent at 25 °C, as well as temperature de-
pendent for each studied protein. Significant changes in
particle zeta potentials were observed when all of the pro-
teins interacted with the nanoparticles at 37 °C. TRPS tech-
nology has enabled the provision of single particle analy-
sis, as well as information on the zeta potential distribu-
tions amongst a given sample population in all experiments
carried out, a more detailed insight than some other previ-
ously used ensemble techniques. We have found that al-
though a stable hard and soft corona can be formed around
particles in serum, we can also track various protein dis-
placement and exchange processes occurring when plasma
proteins are introduced to these samples. This has provided
more detailed information on the affinities and reaction
kinetics of protein coronas dependent on their biological
medium and incubation conditions. A further understand-
ing of protein–nanoparticle interactions in complex matri-
ces and in physiological conditions is proving useful for
advances in biotechnological assays and therapeutics.
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We present the first comparison between assays that use resistive pulses or rectification
ratios on a tunable pore platform. We compare their ability to quantify the cancer
biomarker Vascular Endothelial Growth Factor (VEGF). The first assay measures the
electrophoretic mobility of aptamer modified nanoparticles as they traverse the pore. By
controlling the aptamer loading on the particle surface, and measuring the speed of
each translocation event we are able to observe a change in velocity as low as 18 pM. A
second non-particle assay exploits the current rectification properties of conical pores.
We report the first use of Layer-by-Layer (LbL) assembly of polyelectrolytes onto the
surface of the polyurethane pore. The current rectification ratios demonstrate the
presence of the polymers, producing pH and ionic strength-dependent currents. The
LbL assembly allows the facile immobilisation of DNA aptamers onto the pore allowing
a specific dose response to VEGF. Monitoring changes to the current rectification
allows for a rapid detection of 5 pM VEGF. Each assay format offers advantages in their
setup and ease of preparation but comparable sensitivities.Introduction
Interest in nanoscale channels within synthetic materials have grown over the last
two decades.1–3 These channels have applications in biosensing,4–6 material
characterisation,7,8 quantication of ligand–target interactions,9–11 drug delivery,12
and mimicking biological systems enabling the study of ionic transport within
conned geometries.13–16 These nanopores have been created in a range of
materials including graphene,17–20 polymers,21 silicon nitride22 and glass.13,14,23,24
The transport of the ions or analyte through the channel can by controlled by
tuning the applied potential, pore wall charge, pore size, supporting electrolyte
concentration and composition, with a further degree of selectivity by modifying
the pore walls with selective ligands.25–27Department of Chemistry, Loughborough University, Loughborough, LE11 3TU, United Kingdom. E-mail: m.
platt@lboro.ac.uk; Tel: +44 1509 222 573
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View Article OnlineIn addition to the pore properties, the translocation speed and frequency of
materials such as small molecules, proteins or nanosized particles are also gov-
erned by the analyte size and charge,5,28–31 Fig. 1a. Nanopore sensors can be cat-
egorised into two general areas: Resistive Pulse Sensors, RPS, where the
translocation of the analyte creates a characteristic change in resistivity within the
pore, Fig. 1a and b, or current ux/rectication studies that monitor current–
voltage, I–V, and can be dominated by the charge on the pore wall to measure,
Fig. 1c. The ux of material through the pore is determined by the small and large
pore geometries, ds and dl, pore length, L, and analyte charge. By controlling the
aspect ratio of the pore, RPS has been used to measure analytes that range from
single molecules, DNA, proteins and cellular vesicles to cells, bacteria and viruses;
detailed reviews on the types of analytes and applications can be found
elsewhere.4,5,28,30
We present a comparison between RPS and rectication ratios on a tunable
pore platform. The pore is made of polyurethane, PU, allowing manipulation
(stretching) in real time to suit the sample.32 The pores are conical in shape and
here typically ds > 700 nm. In the rst example we utilise an aptamer-modied
nanoparticle to detect Vascular Endothelial Growth Factor, VEGF. By measuring
the translocation velocities of the aptamer-modied particles the VEGF protein
was detected down to 18 pM, equating to circa 10 proteins per particle. In
comparison a second strategy was tested by modifying the pores directly with the
anti-VEGF aptamer and monitoring the current rectication ratio (measured at
1.6 V) in the presence of the VEGF protein. The surfaces of the pores were easily
modied using a layer-by-layer (LbL) assembly of polymers, such as polyethylene
amine, PEI, and polyacrylic acid–maleic acid and PAAMA. The use of PEI and
PAAMA allowed for easy modication, and reversible surface charge of the pores
giving a pH- and ionic strength-controlled current ow, with current rectication
ratios as high as 3. The LbL assembly was shown to be stable for days, allowing the
modication of the pore wall with DNA via standard carbodiimide chemistry. TheFig. 1 (a) Schematic of a conical PU pore with small, large pore diameter and pore length,
ds, dl and L respectively. The top surface of the pore is labelled Ts. (b) Example of a resistive
pulse. (c) Schematic of I–V curves for conical pores with different surface charges.
488 | Faraday Discuss., 2016, 193, 487–505 This journal is © The Royal Society of Chemistry 2016
Fig. 2 (a) Schematic of the protein bound to the aptamer-modified particle and typical
resistive pulse. (b) Plot of change in translocation time (relative to a blank¼ 0) versus VEGF
concentration for aptamer-modified beads, FC aptamer coverage– red, HC– blue circles.
Each assay was run in triplicate with over 500 particles counted in each run.
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View Article Onlinecurrent rectication assay allows for the detection of VEGF down to 5 pM. Despite
this comparable sensitivity, RPS offer a larger dynamic range. The scope and ease
of each assay format allows for a versatile technology that can be tailored to suite
the target analyte.Materials and methods
Poly(ethyleneimine), PEI, low molecular weight, LMW (LMW PEI Mw  2000 g
mol1, 50% wt, 408 700) and high molecular weight, HMW, (HMW PEI Mw
750 000 g mol1, analytical standard, 50% wt, P3143), poly(acrylic acid-co-maleic
acid) (PAAMA, Mw  3000 g mol1 50% wt, 416 053), phosphate buffered saline
solution (P4417 (0.01 M phosphate buffer, 0.0027 M potassium chloride, 0.137 MThis journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 489
Fig. 3 (a) Current–voltage curves for HMW PEI and PAAMA layers alongside a blank
unmodified pore in 5 mM KCl. (b) Current–voltage curves for layer 2 bilayers alongside
a blank unmodified pore. (c) Schematic of the layer-by-layer assembly of PEI and PAAMA.
Faraday Discussions Paper
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View Article Online
Table 1 Rectification ratios for pores measured in KCl solution at circa pH 7. Also listed is
the rectification value of the same surface in 1 PBS
[KCl] mM
Rectication ratio
Unmodied pore
PEI –
layer 1
PAAMA –
layer 1
PEI –
layer 2
PAAMA –
layer 2
5 1.38 0.46 2.41 0.37 2.86
10 1.09 0.67 1.69 0.29 2.44
50 1.09 0.90 1.10 0.73 2.09
PBS (pH 7.4) 1.15 0.81 1.10 0.93 1.29
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View Article Onlinesodium chloride, pH 7.4)), bovine serum albumin (BSA, lyophilized powder,
$96%, A2153) and 2-(N-morpholino)ethanesulfonic acid hydrate (MES hydrate,
$99.5%, M2933) brinogen from human plasma (F3879), albumin from human
serum (A9511) and g-globulin from human blood (G4386) were purchased from
Sigma Aldrich, UK. Tunable conical pores (NP200) were purchased from Izon
Science (Christchurch, NZ). Carboxylated polystyrene particles with a mean
nominal diameter of 220 nm were purchased from Bangs Laboratories, US and
are denoted as CPC200. Potassium chloride (KCl, >99%, P/4240/60) and potas-
sium hydroxide (KOH, 0.1 M, >85%, P/5600/60) were purchased from Fisher
Scientic, UK. Hydrochloric acid (HCl, 0.5 M, 37%) was purchased from VWR, UK.
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, 22 980) and
Recombinant Human Vascular Endothelial Cell Growth Factor (VEGF, lyophi-
lised, >95%, PHC9394) were purchased from Thermo Scientic, UK. Streptavidin-
coated superparamagnetic particles (120 nm, 4352 pmol mg1 binding capacity,
03 121) were purchased from Ademtech, France. The customDNA oligonucleotide
50TGTGGGGGTGGACGGGCCGGGTAGATTTTT (V7t1 amine),33 was purchased as
a lyophilised powder (100 pmol mL1) from Sigma Aldrich, UK. The sequence was
synthesised, with a biotin or amine functional group at the 30 end.
All reagents were used without further purication and all solutions were
prepared in puried water with a resistance of 18.2 MU cm (TKA, Smart2Pure). pH
of solutions were altered using HCl and KOH and the solutions were measured
using a Mettler Toledo easy ve pH meter with a Mettler Toledo InLab
microelectrode.Particle assay
120 nm diameter streptavidin-coated particles were diluted to a concentration of
approximately 5  109 particles per mL. The diluted particle solutions were then
vortexed for 30 s, and sonicated for 2 min, to ensure they were well dispersed. The
biotinylated aptamer was added to the streptavidin coated particles (4352 pmol
mg1 binding capacity – determined by the supplier) at 113 and 226 nM for 50 and
100% DNA coverage per particle, respectively. The samples were then placed on
a rotary wheel for 30 min. Any unbound DNA remaining in solution was then
removed via magnetic separation by placing the samples onto a Magrack (GE
Healthcare, UK) for 30 min. The supernatant was then removed and replaced with
new buffer (PBS). The VEGF was added at the required concentration and then
placed on a rotary wheel for 30 min before being analysed.This journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 491
Fig. 4 (a) I–V curves for three different NP200 pores coated with two bilayers. (b)
Consecutive scans across the voltage range; starting point is indicated with an arrow. A
forward scan refers to moving from +1.6 V to 1.6 V. Each current was recorded after a 5
second wait to the new voltage. (c) I–V curves for an individual pore coated with two
bilayers; each day the pore was set up and I–V curves recorded before being washed with
DI water and air dried. All data obtained at 45 mm stretch, pH 6.8 and 5 mM KCl.
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View Article Online
Fig. 5 (a) I–V curves for a NP200 pore coated with two bilayers. Measured at pH 6.8 and 5
mMKCl. (b) I–V curves for an unmodified pore, PAAMA (two complete bilayers) and PEI (1.5
bilayers). Obtained at 45 mm stretch, pH 3 and 5 mM KCl. (c) I–V curves for an unmodified
pore, PAAMA (two complete bilayers) and PEI (1.5 bilayers). Obtained at 45 mm stretch, pH
7 and 5 mM KCl.
Paper Faraday Discussions
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View Article Online
Table 2 Rectification ratios for pores with different surface chemistry as a function of pH.
The concentration of KCl was 5 mM for all experiments. HMW-PEI was used for the
bilayers
pH
Rectication ratio
Unmodied pore PEI – layer 2 PAAMA – layer 2
3 0.83 0.31 0.73
7 1.40 0.52 1.98
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View Article OnlineTRPS set-up
All measurements were conducted using a qNano (Izon Sciences Ltd, NZ)
instrument combining tunable nanopores with data capture and analysis so-
ware, Izon Control Suite v.3.2. The lower uid cell contains the electrolyte (75 mL).Fig. 6 (a – i) Schematic of the DNA-modified pore and (ii) aptamer-VEGF interaction. (b)
I–V curves for each layer in the DNA immobilisation. (c) Enlarged section of (b). All data are
recorded at 50 mM KCl, pH 6.8, 45 mm stretch.
494 | Faraday Discuss., 2016, 193, 487–505 This journal is © The Royal Society of Chemistry 2016
Fig. 7 (a) I–V curves for aptamer (DNA) and VEGF incubated pores. VEGF was at 50 nM. (b)
Equivalent data set for conditions given in a, for a second pore. The pore was first incu-
bated with BSA at 50 nM. KCl is 50 mM, stretch – 45 mm.
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View Article OnlineThe upper uid cell contains 40 mL of sample (which was suspended in the
electrolyte) and an inherent pressure on the system (47 Pa) was present when
making ameasurement. Aer each sample run, the system was washed by placing
40 mL of the run electrolyte into the upper uid cell several times with various
pressures applied to ensure there were no residual particles remaining and
therefore no cross contamination between samples. The membranes are placed
into jaws on the qNano instrument and are capable of being stretched.34 The
applied stretch is quantied by the distance between the jaws, with an
upstretched distance being 42 mm, any values quoted below are the additional
distances in mm applied to the membranes. Most experiments were run at 45
mm. The pore diameters measured in the SEM and in the text were calculated
from the current at 45 mm stretch.Translocation speed
The velocity of the particle was calculated by extracting the pulse width. Blockade
duration events are recorded from the peak of the blockade back to the baselineThis journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 495
Fig. 8 (a) Plot of rectification ratio versus VEGF concentration for a third pore. (b)
Magnified section of the current between 0 and 1.6 V. KCl 50 mM, pH 6.8. Stretch 45 mm.
Each measurement was taken in series on the same pore.
Table 3 Rectification ratios measured for the data shown in Fig. 8
Concentration of VEGF Rectication ratio
5 pM 1.36
50 pM 1.93
0.5 nM 3.64
5 nM 11.60
50 nM 10.12
DNA 1.33
BSA 1.53
Faraday Discussions Paper
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View Article Onlinecurrent; the total time gives the blockade duration. Nine time points are recorded
along the peak,29 relative to different positions within the pore and are denoted
T0.90, T0.80, T0.70 etc., here we use one measurement 1/T0.5 to represent the particle
velocity.
Pore modication
Conical pores were modied by incubating the pore in polymer solution (5% wt in
H2O) at a stretch of 45 mm for two hours, followed by rinsing the pores with
deionised water. The pores were then incubated with a second polymer layer for
2 hours, and again washed with deionised water. This process was repeated until
the required number of layers was achieved.
Modication of PAAMA modied pores with DNA
The aptamer was dissolved in 100 mMMES buffer (pH 5.9) containing 1 mg mL1
EDC. The nal concentration of the DNA was 220 nM. The pores were incubated
with the DNA and EDC solution for 2 hours.
VEGF I–V assay
VEGF was suspended in PBS buffer to give the desired concentration. DNA-
modied pores were incubated in VEGF solution, and in each experiment the
VEGF solution was only placed on the side of the pore with the small pore opening
Ds. When multiple solutions of different concentrations of VEGF were used, the
lowest concentration was measured rst. The VEGF solution was in contact with
the pore for 30 minutes with the pore being rinsed with water 3, and PBS 3
aer each protein concentration. The current rectication property of the pore
was then measured, in a range of KCl solutions starting with 5 nM rst and
working up to 50 mM. When a BSA control was used, 50 nM BSA was incubated
rst for 30 minutes, with the rectication properties being measured in KCl
solutions before adding VEGF to the pore.
I–V measurements
The pores were mounted between two uid cells which contain an electrolyte
solution. Current–voltage (I–V) curves were recorded using Izon control suite v3.2,
the potential was stepped in 100 mV increments from +1.6 to 1.6 V and the
resulting current measured.
Results and discussion
Assay 1 – measuring translocation times from resistive pulses
To facilitate sample handling and fast assays some RPS strategies have included
nanomaterials by either immobilising the target analytes onto their surface
facilitating an analyte-induced aggregation,35,36 or measuring the particle trans-
location speed/frequency upon the binding of the analyte.11,30,37–40 With the charge
of the particle being a contributing factor in pore translocation speed and
frequency, the use of DNA-modied materials and pores has become increasingly
popular.11,30,41–43 The polyanionic backbone of the DNA can enhance or determine
the translocation speed/direction and frequency of the current.28This journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 497
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View Article OnlineIn the rst assay format 120 nm particles were modied with a VEGF
aptamer.33 In two variations on this experiment different surface coverages of
VEGF aptamer were used. Under condition one, the streptavidin binding sites on
the particles are saturated with biotinylated aptamer (termed FC); in the second,
circa half of binding sites (dened by the suppliers specications) were lled with
the aptamer (termed HC). The change in translocation time relative to a particle
that was not incubated with the protein, i.e. a blank, is shown in Fig. 2. In previous
work we have shown how the translocation velocity can be measured from the
pulse width and then converted to zeta potentials using Henry's law.29 The
technique was able to distinguish between DNA coverage, in addition to length
and structure i.e. ssDNA or dsDNA, on the particle surface, with the detection of
dsDNA down to 10 nM LOD.29
In the strategy reported here rather than converting to zeta potentials, we
simply measure changes to the relative velocities and infer the presence of the
DNA and proteins. The hypothesis was that the binding of the aptamer to the
protein target, Fig. 2a, should result in a change in translocation time. Fig. 2b
shows the change in translocation times, relative to the blank, versus VEGF
concentration for the two coverages of DNA.
There is a decrease in velocity for both sets of aptamer-modied beads as the
VEGF concentration increases. The change in aptamer shape from ssDNA to one
of a folded tertiary structure upon binding the protein, bringing the DNA closer to
the particle surface, could lead to a higher surface change density on the particle.
This may result in an increase in particle speed. Conversely, as shown in Fig. 2b,
a decrease in particle velocity upon the addition of the protein is observed. The
velocity of the particles with HC remains constant at VEGF concentrations above 2
nM. This is attributed to the binding capacity of the beads being reached, and that
any additional protein to the solution does not change the numbers on the
particle surface, or if it does increase they cannot be measured via this technique.
The velocity of the FC beads continues to decrease until a concentration of 18 nM
is reached. By tuning the aptamer concentration on the particle surface, the
dynamic range of the assay can be extended.
The decrease in velocity is thought to be due several parameters that shield the
negative charge on the phosphate backbone, increasing the counter ion
condensation onto the DNA.43 Firstly the conformational change to the DNA
structure as it binds the protein requires an increased number of counter ions to
stabilise the tertiary structure, and secondly the protein pI is 8.5, and therefore is
positively charged at the pH used in the experiment. Both particle assays see
a decrease in speed, respective to their blanks, at a concentration of 18 pM.
Previous work using aptamer-modied nanomaterials on the TRPS platform
measured a change in particle translocation frequency as the transduction
signal.11,39 The benet of the method presented here is in the ability to use data
from each individual particle as they translocate the pore. Thus it does not rely
upon averaging data across hundreds of particles per min, reducing run times
and bias in samples with different particle concentrations. A potential limitation
for future assays within complex biological solutions is the tendency of proteins
to foul the pore wall or particle surface. The particle translocation speed is
a contribution of the electrophoretic speed of the particle and electroosmotic
contribution of the pore wall. If the pore wall charge changes throughout the
experiment it may impact on the assay’s reproducibility. A solution to this would498 | Faraday Discuss., 2016, 193, 487–505 This journal is © The Royal Society of Chemistry 2016
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View Article Onlinebe to develop a non-fouling coating on the particle and pore wall, preventing the
nonspecic adsorption of proteins. Alternatively, the modication of the pore
directly could facilitate the detection of the analyte of choice. Other nanopore
systems have either utilised the natural surface functionality of the material or
modied the pore walls with gold to allow the facile attachment of materials.44 To
date there has been no reported modication of tunable polyurethane (PU) pores
for RPS studies, although strategies for the modication of PU are available.45–47Assay 2 – modication of the pore walls and current rectication
An alternative to a particle-based assay is to use the change in ionic current
through the pore, which can be controlled through electrostatic interactions via
the pore wall. This effect is seen to a greater extent within conical pores, and
typically recorded for pore openings where the diameter, Ds, is equivalent to the
electrical double layer (DL) thickness,24,48 although the DL does not need to fully
extend across the pore opening,24 and larger pores exhibit current rectication
effects.23,49 Rectifying properties of conical pores are described in detail else-
where,48 with the degree of rectication being dened as the ratio of absolute
currents recorded at a given negative potential and the identical absolute positive
potential. Typically conical pores with charged surfaces do not exhibit ohmic
behaviour at lower electrolyte concentrations, and the magnitude of the current
through the nanopore at negative potentials is greater or less than the current at
positive potentials. The ratios can be tuned by changing the supporting electro-
lyte, pH, ionic strength and applied voltage, with the current–voltage, I–V, curves
recording a preferred direction of current ow24,48 (Fig. 1c).
Tunable pores fabricated from PU have a small negative surface charge29,49 at
pH > 5, and are conical in shape. The unmodied pores used here had an approx.
pore diameter, ds, of 800 nm, at a stretch of 45 mm, calculated from the measured
current in 50 mM KCl. This is likely to be an averaged dimension, as in some
instances the pore will not be spherical in shape, Fig. S1.†
In Fig. 3a, the black dashed line shows the I–V curves of an unmodied pore in
5 mM KCl. A weak current rectication ratio of 1.38 is recorded. The I–V curve for
an unmodied pore in 50 mM KCl is shown in Fig. 3b, and here the rectication
value is 1, illustrating the return of the ohmic response at higher ionic strengths.
In an attempt to introduce a facile method for modifying the surface chemistry
of the pore, a LbL assembly using PEI/PAAMA was investigated. This system is
well studied having been previously used to modify a range of materials.50–55 We
favoured this technique over other PU treatments such as plasma or the incor-
poration of graing polymers into the matrix via swelling,47,56,57 as it allows for
a simple and rapid dip-coating strategy. In addition, the LbL assembly would
allow the thickness and even the porosity of the PEI/PAAMA bilayer to be
controlled in the future.53 Here we have opted to use a similar system as Yang
et al.54 and Fu et al.53 that have shown how the thickness of the bilayers can be
controlled ensuring that they do not extend across the pore opening and that the
thickness of the bilayers remains in the order of a few nanometres.
Fig. 3c shows a schematic of the bilayer construction with consecutive PEI/
PAAMA layers. The resulting I–V curves in 5 mM KCl are shown in Fig. 3a
alongside the unmodied pore. The addition of PEI onto the pore surface resulted
in a change in the preferred direction of current ow, with a reduced andThis journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 499
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View Article Onlineenhanced current ow through the pore under a negative and positive applied
potential, respectively. This is indicative of a positive surface charge.58 Upon
coating with PAAMA, the surface charge switches to being negative, resulting in
the preferred direction of current ow being inverted (Fig. 3a). All rectication
ratios for the HMW PEI bilayers are listed in Table 1, and are measured at 1.6 V.
The addition of each layer of the LbL assembly caused the preferred current
direction, or “on state”, to be switched. The magnitude of the rectication can be
used to access the presence and quality of the pore coating and as the number of
bilayers increased the rectication ratios improved. It is interesting to note that
even with two bilayers added to the pore walls, the pore opening remains unob-
structed, as the addition of 210 nm particles to the upper uid cell results in
a standard resistive pulse response as they traverse the pore (data not shown).
Fig. 3b shows the effect of increasing the ionic strength of the solution on the
rectication ratio, again values are listed in Table 1. Increasing the ionic strength
reduced the rectication value, however it is interesting to note that even at >100
mM KCl with a pore diameter circa 800 nm some rectication was observed. The
current rectication may have been enhanced by the nature of the modication of
the pores here. The PU pores have a large area (diameter of circa 2.5 mm) on the
top surface, Ts, as shown in Fig. 1. This surface is also modied along with the
inner pore walls via the LbL route. A combination of top surface and pore wall
modication has been shown to have a larger effect on the rectication ratio.24
A similar set of I–V curves were obtained using LMW PEI, shown in Fig. S2.†
However the rectication ratios for each subsequent PEI and PAAMA layer were
smaller. This is likely due to the nature of the PEI layer placed onto the surface.
The mechanism for LbL assembly goes through island formation before forming
a full layer and it is hypothesised that when using the LMW PEI it takes longer to
form a fully coated surface layer.
The LbL approach was reproducible onmultiple pores (Fig. 4a) and shows little
hysteresis through multiple cycles, as shown in Fig. 4b. The LbL coating was also
stable over short periods of time even aer multiple uses, washes, and being dried
and stored overnight, as shown in Fig. 4c. Although multiple uses and storage for
over a week resulted in a deterioration of the surface chemistry (Fig. 4c), the same
pore could be reused and recoated with comparable results (data shown in
Fig. S3).†
Given the exible nature of the PU pore it should be possible to change the
rectication ratio by subjecting the pore to a smaller stretch producing a higher
rectication ratio. Fig. 5a shows the effect on the I–V curves as the stretch is
decreased from 5 to 2 mm. As the pore opening, ds, is reduced, the observed
current at positive potentials decreases. In addition to the pore size, both the PEI
and PAAMA have functional groups that should allow a pH controlled current
ow. Fig. 5b and c show the effect of pH on the I–V relationship for both the PEI
and PAAMA surfaces, for comparison the data for an unmodied pore is given
alongside. Lowering the pH of the solution to 3 increases the charge density on
the PEI surface as more amines become protonated; this results in an increased
current ow at positive potentials and a rectication ratio as low as 0.31.
Conversely, increasing the pH to 7 reduced the positive charge on the PEI and the
current rectication ratio increases to 0.52. Table 2 lists the rectication ratios for
PEI and PAAMA pores at pH 3 and 7. For the PAAMA surface at pH 3, the charge
density across the carboxyl groups is reduced and the response which is similar to500 | Faraday Discuss., 2016, 193, 487–505 This journal is © The Royal Society of Chemistry 2016
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View Article Onlinethe unmodied pore is recorded (Table 2). Increasing the pH to 7 for the PAAMA
pores increases the negative charge density of the PAAMA pore wall, with an
observed decrease in current ow at positive potentials and a current rectication
of 1.98. The unmodied pore shows a current rectication of 0.8 at a pH of 3,
indicating the surface groups have become protonated.
For all pores, a particle with 210 nm diameter suspended in PBS was passed
through the opening as we built up the layers. The particle’s ability to traverse the
opening was interpreted to mean that the pore remained unblocked with a thick
bilayer mesh, or that the bilayers have not restricted the pore orice to a large
extent.
The current ow through the pore has two contributing factors; the electro-
osmotic ow, EOF, across the pore surface and migration of ions through the
centre. Whilst others have shown the EOF to be a small contributing factor to
current rectication in smaller pores,24 and that a combined effect of the charge
on the pore wall and top surface has the largest contribution to the current
rectication.24 In the work reported here, a large area of Ts is also modied with
the bilayers and future work may be needed to ascertain if this has a larger
contribution in the PU pores. The observation of rectication behaviour does
illustrate that the enriched ion zone at the pore mouth used to describe the
rectication properties of smaller pores24,42 sufficiently exerts an inuence across
the larger opening, even when the electrical DL is much shorter than the opening
Ds. This effect has also been attributed to biphasic pulse behaviour in TRPS.49
The reported setup allows for the easy modication of the pore wall, and by
using different polymers of different thickness it may be possible to further tune
these larger pores to be ion selective.Modication of the pore walls with ssDNA
The main motivation for modifying the pore walls with LbL polymers was to
introduce a functionality to which biomolecules could be easily coupled to the
pore wall. Similar aspirations have led to the modication of pores with Au
allowing thiol-terminated ligands to be placed along the pore wall or the uti-
lisation of the carboxyl groups.43,59 Our method of immobilisation uses EDC
chemistry placing the DNA across the Ts and pore surface, shown schematically in
Fig. 6a. Fig. 6b shows the I–V plots for a pore having gone through the LbL and
DNA assembly, a magnied section through the origin is given in Fig. 6c. In the
case where DNA was immobilised onto the pore wall, only one bilayer was used.
The reason being that one bilayer was sufficient to introduce the carboxyl groups
on the surface, and stopping at one bilayer reduced the number of preparation
stages. The data in Fig. 6 was recorded at 50 mM KCl. At higher ionic strengths
(>50 mM KCl), the DNA-modied pores do not exhibit current rectication;
equivalent 5 mM KCl curves are given in Fig. S4.† The reduction in rectication
for the DNA surface over the PAAMA layer may be due to the high number of DNA
strands on the pore surface and the counter ion condensation shielding the high
charge densities; in addition the EDC chemistry may have crosslinked the PAAMA
to the underlying PEI causing a reduction in surface charge density.
Incubation of the pore with the target VEGF results in a strong rectication;
shown in Fig. 7a (equivalent data for 5mMKCl are given in Fig. S5†). The decrease
in current at positive potentials was shown to be specic to the aptamer–VEGFThis journal is © The Royal Society of Chemistry 2016 Faraday Discuss., 2016, 193, 487–505 | 501
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View Article Onlineinteraction in the presence of BSA (Fig. S6†), Fig. 7b, and a mixture of other
proteins whose pI values range from 5–7, Fig. S7.†
A similar trend in rectication properties was observed for the lysozyme system
in cylindrical pores,59 an explanation for the behaviour was attributed to the high
pI of the proteins, and the binding of the protein to the DNA inverting the surface
charge. This resulted in a positive surface on one side of the pore and the
asymmetric surface charge resulted in current rectication. Our experiment may
have produced a similar effect, i.e. the introduction of the protein on one side of
the pore produced a different surface charge density from top to bottom.
However, if in our study this resulted in a positively charged narrow pore opening,
studies into diode-like conical pores would suggest the rectication properties
would produce the opposite of the observed effects i.e. an increase in current at
positive potentials,60 which is not the observed result.
Our hypothesis for the observed rectication behaviour also relies upon the
high pI of VEGF (8.2), and that the protein is positively charged. The inclusion of
the protein to the DNA at the pore mouth and Ts increases the cation cloud
density at the pore mouth. In addition to this, the folding of the aptamer into
a tertiary structure to bind to the VEGFmust require an increase in counter ions to
stabilise the structure, and these two factors contribute to a decrease in
conductivity at the pore mouth for positive potentials, as described elsewhere.24
Fig. 8 shows the concentration dose response of the DNA-modied pore at 50
mM KCl, equivalent 5 mM curves are show in Fig. S8.† As the concentration of
VEGF is increased the current measured at 1.6 V decreases, and appears to
saturate or remain unchanged beyond 5 nM. The rectication ratios for the 50
mM KCl experiment are given in Table 3. The detection of the VEGF at such low
levels, when compared to RPS, may be aided by the inherent nature of the
membrane to pre-concentrate cations in the pore mouth.
Conclusions
Presented is a comparison between a resistive pulse and current rectication
aptamer assays using the same technology platform. To enable this we present the
rst LbL modication of PU pores that allows a pH- and ionic strength-controlled
current ow. We feel that the tunable pore is unique in this ability to be easily
adapted to both, and that the LbL assay reported here offers a simple and reusable
method for modifying the surface chemistry of the pores. The RPS assay offers
a format that can be easily prepared and multiplexed by pairing each target with
a unique particle size/shape. Whilst it offers a wider dynamic range, its sensitivity
is limited by the number of proteins required to change the particle surface
charge sufficiently to detect a measurable change in translocation velocity.
Further improvement to the sensitivity may require the specic design of the
particle size and surface to allow a limited and controlled number of aptamers,
although this offers a complication in assay time as the ux of material through
the pore decreases with smaller particles and pores, or the use of Janus particles
to localise the biorecognition.35
The LbL assembly of the pore offers a pH- and ionic strength-dependent
rectication behaviour and is the rst reported method on such a system. It
allows the rst observation of strong rectication on pores of this dimension. The
strong rectifying properties illustrate that the electric double layer does not need502 | Faraday Discuss., 2016, 193, 487–505 This journal is © The Royal Society of Chemistry 2016
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View Article Onlineto signicantly extend across the pore opening, although it is acknowledged that
further studies are required to assess what the effects of the modication of the
top surface of the pore have on the rectication mechanism, and the total
contrition of electroosmotic ow in these systems.Acknowledgements
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Abstract
Nanopore technologies, known collectively as Resistive Pulse Sensors (RPS), are being used to detect, quantify and characterize proteins,
molecules and nanoparticles. Tunable resistive pulse sensing (TRPS) is a relatively recent adaptation to RPS that incorporates a tunable pore
that can be altered in real time. Here, we use TRPS to monitor the translocation times of DNA-modified nanoparticles as they traverse the
tunable pore membrane as a function of DNA concentration and structure (i.e., single-stranded to double-stranded DNA).
TRPS is based on two Ag/AgCl electrodes, separated by an elastomeric pore membrane that establishes a stable ionic current upon an
applied electric field. Unlike various optical-based particle characterization technologies, TRPS can characterize individual particles amongst a
sample population, allowing for multimodal samples to be analyzed with ease. Here, we demonstrate zeta potential measurements via particle
translocation velocities of known standards and apply these to sample analyte translocation times, thus resulting in measuring the zeta potential
of those analytes.
As well as acquiring mean zeta potential values, the samples are all measured using a particle-by-particle perspective exhibiting more
information on a given sample through sample population distributions, for example. Of such, this method demonstrates potential within sensing
applications for both medical and environmental fields.
Video Link
The video component of this article can be found at http://www.jove.com/video/54577/
Introduction
Functionalized nanoparticles are becoming increasingly popular as biosensors in both medical and environmental fields. The ability to
alter a nanoparticle's surface chemistry, with DNA, for example, is proving useful for targeted drug delivery systems1 and monitoring DNA-
protein interactions2-4. An increasingly common nanoparticle property being utilized in bioassays and in the delivery of therapeutics is
superparamagnetism5. Superparamagnetic particles (SPPs) are extremely useful in identifying and removing specific analytes from complex
mixtures and can do so with the simple use of a single magnet. Once removed, the analyte-bound particles can be characterized and analyzed fit
for purpose.
Previous methods used for the detection and characterization of nanoparticles include optical techniques such as dynamic light scattering
(DLS), otherwise known as photon correlation spectroscopy. Although a high throughput technique, DLS is limited to being an averaging based
technique and when analyzing multimodal samples without the addition of specialist software, the larger particles will produce a much more
dominant signal, leaving some of the smaller particles completely unnoticed6,7. Particle-by-particle characterization techniques are therefore
much more favorable to analyze nanoparticle and functionalized nanoparticle systems.
RPS based technologies are based around applying an electric field to a sample and monitoring the transportation mechanism of the particles
through a synthetic or biological nanopore. A relatively recent nanoparticle detection and characterization technique based on RPS is tunable
resistive pulse sensing (TRPS)8-16. TRPS is a two-electrode system separated by an elastomeric, tunable pore membrane. A tunable pore
method allows for analytes of a range of shape17 and size to be measured via their transport mechanisms through the pore. Tunable pores
have previously been used for the detection of small particles (70-95 nm diameter) producing comparable results to other techniques such as
transmission electron spectroscopy (TEM)10. When an electric field is applied, an ionic current is observed and as particles/molecules pass
through the pore, they temporarily block the pore, causing a reduction in the current that can be defined as a 'blockade event'. Each blockade
event is representative of a single particle so that each particle within a sample can be characterized individually based on the blockade
magnitude, Δ , and full width half-maximum, FWHM, as well as other blockade properties. Analyzing individual particles as they pass through
a nanopore is advantageous for multimodal samples as TRPS can successfully and effectively distinguish a range of particle sizes amongst a
Journal of Visualized Experiments www.jove.com
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single sample. Tunable resistive pulse sensing completes size10, zeta potential12,18 and concentration15 measurements simultaneously in a single
run and can therefore still differentiate samples of similar, if not the same size by their surface charge19; an advantage over alternative sizing
techniques.
Zeta potential is defined as the electrostatic potential at the plane of shear20, and is calculated from particle velocities as they traverse a pore19.
Zeta potential measurements of individual particles thus gives insight into the translocation mechanisms and behavior of nanoparticle systems in
solution, valuable information for the future of nanoparticle assay designs for a range of applications. Particle-by-particle analysis of such nature
also allows for the spread and distribution of zeta potential values amongst a sample population to be explored, allowing for more information on
reaction kinetics (single-stranded to double-stranded DNA, for example) and particle stabilities in solution to be attained.
Here, we describe a technique that detects and characterizes both unmodified and DNA-modified SPP surfaces. The protocol described herein is
applicable to a range of inorganic and biological nanoparticles, but we demonstrate the procedure using DNA-modified surfaces due to their wide
range of applications. The technique allows the user to distinguish between single-stranded and double-stranded DNA targets on a nanoparticle
surface, based on particle translocation velocities through a pore system and thus their zeta potentials.
Protocol
1. Making the Phosphate Buffered Saline with Tween-20 (PBST) Buffer
1. Dissolve one PBS tablet (0.01 M phosphate buffer, 0.0027 M Potassium Chloride, 0.137 M Sodium Chloride, pH 7.4) in 200 ml deionized
water (18.2 MΩ cm).
2. Add 100 µl (0.05 (v/v)%) Tween-20 to the 200 ml buffer solution as a surfactant.
2. Preparing the Carboxyl Polystyrene Particle Standards
1. Vortex the calibration particles for 30 sec before sonication for 2 min at 80 watts to create monodispersity of the particles.
2. Dilute the calibration particles 1 in 100 to a concentration of 1x1010 particles/ml in PBST buffer and vortex for 30 sec.
3. Preparing Streptavidin Coated Particles
1. Vortex the particles for 30 sec before sonication for 2 min at 80 watts to ensure monodispersity.
2. Dilute the streptavidin coated particles 1 in 100 in PBST buffer to achieve a resulting concentration of 1x109 particles/ml and vortex for 30 sec.
 
Note: A typical sample volume is 200 µl. For example, if investigating five DNA concentrations prepare 1 ml of diluted streptavidin coated
particles.
4. Preparation of Oligonucleotides
1. Reconstitute oligonucleotides with deionized water to a resulting concentration of 100 µM.
5. Addition of Capture Probe (CP) DNA to the Streptavidin Coated Particles
1. Prior to DNA binding, vortex the streptavidin coated particles (200 µl sample volume) for 30 sec followed by a 2 min sonication at 80 watts.
2. Based on the binding capacity provided by the supplier (4,352 pmol/mg), add the appropriate concentration of DNA to the particles for
resulting concentrations of 10, 20, 30, 40, 47, 95, 140, and 210 nM DNA.
3. Vortex the samples for 10 sec and place on a rotary wheel at room temperature for 30 min to allow for the DNA to bind to the particle surfaces
via a streptavidin-biotin interaction.
4. Once the capture DNA has been added and incubated with the streptavidin coated particles, remove the excess DNA in solution via magnetic
separation by placing the samples onto a magnetic rack for 30 min.
5. Remove the supernatant, taking care not to disturb the newly formed cluster of particles closest to the magnet, and replace with the same
volume of new PBST buffer.
6. Hybridizing Complementary DNA to the CP-particles
1. Add the required amount of target DNA (in excess at 500 nM) to ensure the maximum possible target binding was reached.
2. Vortex the samples for 10 sec and place on a rotary wheel at room temperature for 30 min.
3. Once the hybridization is complete, remove the excess target DNA via magnetic separation by placing the samples onto a magnetic rack for
30 min.
4. Remove the supernatant, taking care not to disturb the newly formed cluster of particles closest to the magnet, and replace with the same
volume of new PBST buffer.
5. Repeat steps 6.1 to 6.4 for duplicate samples and place these samples on a rotary wheel at room temperature for 16 hours to investigate
DNA hybridization times.
7. TRPS Setup
1. Plug in the instrument into a computer system with software in place.
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2. Calibrate the initial stretch using a caliper.
1. Measure the distance between the outside of two parallel jaws.
2. Input into the software by typing the stretch in the 'stretch' field in the 'Instrument Settings' tab and clicking 'Calibrate stretch'
underneath the tab.
3. Laterally fit a polyurethane nanopore membrane of appropriate sizing for analysis onto the jaws with the nanopore ID number facing upward.
Then, stretch the jaws to the stretch required for analysis using the stretch adjustment handle on the side of the instrument. Stretch the jaws
between 43 and 48 mm.
 
Note: The exact value of the stretch is determined alongside applied voltage so that calibration particle blockades are at least 0.3 nA in size.
The stretch is already inputted into the software in step 7.2 and will automatically adjust as the jaws are stretched.
4. Place 80 µl of PBST buffer in the lower fluid cell, beneath the nanopore, ensuring there are no bubbles present that may affect the
measurement. If there are bubbles seen, remove and replace the buffer.
5. Click the upper fluid cell into place and place 40 µl of buffer into it, again ensuring there are no bubbles present. If bubbles are present in the
upper fluid cell, remove them by replacing the liquid.
6. When a reproducible baseline current has been reached from replacing the upper fluid cell with buffer, add 40 µl of the sample to the upper
fluid cell and measure by clicking 'start' in the 'Data Acquisition' tab on the software screen.
 
Note: The data acquisition is completed at a frequency of 50 kHz with a blockade magnitude lower limit of 0.05 nA, although this can be
altered using the software via the 'Analyse Data' tab (under 'Analysis Settings' and 'Resistive Blockades').
7. Place a Faraday cage over the top of the fluid cell system to reduce electrical background noise on the measurements.
8. Use a variable pressure module (VPM) to apply a pressure or vacuum to the samples.
1. To apply an external pressure connect the nozzle to the upper fluid cell, then rotate the pressure arm and click into place (depending on
whether a positive pressure (PRE) or a vacuum (VAC) will be applied).
2. Apply pressure in a 'cm' or 'mm' scale using the pressure stage knob situated on the top of the VPM. Press the knob down to apply
pressure on the 'cm' scale and pull it upward to apply pressure on the 'mm' scale.
8. Preparing Samples for TRPS Analysis
1. Vortex samples for 30 sec and sonicate for 2 min at 80 watts prior to TRPS analysis.
9. Calibrating the Nanopore for Zeta Analysis
1. After placing 40 µl calibration particles (1x1010 particles/ml) into the upper fluid cell, complete a TRPS measurement (setup as in section 7) at
3 applied voltages. Alter the voltage by clicking on the '+' and '-' buttons on the voltage scale in the 'Instrument Settings' tab on the software.
2. Check that the 3 voltages return background currents of approximately 140, 110, and 80 nA. Ensure that at the medium voltage the
calibration particles produce an average blockade magnitude of at least 0.3 nA.
3. Apply a pressure so the average full width half maximum (FWHM) durations of the calibration particles are at least 0.15 msec. Do this
manually using the pressure arm attached to the variable pressure module. Select pressure (PRE) or vacuum (VAC) by rotating the arm until
it clicks in the desired position and apply accordingly following set up instructions in step 7.8.2. Once these conditions have been achieved,
start the run by clicking 'start' on the software in the 'Data Acquisition' tab.
4. Complete the run by pressing 'stop' in the 'Data Acquisition' tab when at least 500 particles have been measured (see 'Particle Count' at the
bottom of the software screen during the measurement) and the run has exceeded 30 sec (see 'Run Time' also toward the bottom of the
screen).
5. Calibrate the system by completing a calibration run as described every time a new nanopore is introduced or for each new day of analysis by
completing step 9.1-9.4.
10. Running a Sample
1. Run the samples at the highest or second highest voltage as the calibration samples at ensuring a similar (±10 nA), if not the same, baseline
current.
1. Once the appropriate baseline current is achieved, replace the electrolyte in the upper fluid cell with 40 µl of sample. When a sample is
introduced, blockades will be seen on the signal trace. Start the sample run by clicking 'start' in the 'Data Acquisition' tab and record a
minimum of 500 particles (check 'Particle Count' situated under the signal trace) and ensure the run time is a minimum of 30 sec (see
'Run Time' also situated below the signal trace).
2. To complete the measurement, click 'stop' in the 'Data Acquisition tab' and save the data file.
2. To save the file, input the file information in the following format; 'Investigation' is the folder the file will be saved in, 'Nanopore ID' is the serial
number of the pore being used, 'Part #' is the type of pore (i.e., NP150/NP200), 'Sample ID' is the name of the sample, 'Calibration or sample'
details whether it is a calibration or sample measurement, 'Dilution' is used if the sample was diluted (type 100 if the sample was diluted 100-
fold), 'Pressure' is the applied pressure to the sample (in cm - see section 7.8), 'Electrolyte ID' is the name of the buffer the sample is made
up in, and 'Notes' are any personal notes about the sample or run.
3. Between each sample run, wash the system by placing 40 µl of PBST buffer into the upper fluid cell several times and applying various
pressures (usually at -10, -5 cm (vacuum), and 5 and 10 cm (positive pressure)) until no more blockade events are present, ensuring there
are no residual particles remaining in the system and therefore no cross contamination between samples. Run samples in triplicate with this
wash step completed between each repeat sample run as well as between different samples.
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Representative Results
 
Figure 1. Schematic representation of the processes of magnetic purification and a TRPS measurement. A) Example of magnetic
purification of sample starting with a sample containing excess, unbound capture probe DNA. B) TRPS measurement example i) Particle passing
through the nanopore and ii) Blockade event produced from particle temporarily occluding ions in the pore causing a temporary decrease in
current; Information from which is used to calculate particle translocation velocities. Please click here to view a larger version of this figure.
The removal of any excess DNA that has not bound to the particles surface from the samples is important prior to TRPS analysis, as to not
report any 'false-positive' results. The ability to use a magnet to extract and wash the SPPs is a huge benefit for TRPS (Figure 1A). Figure 1B
describes a basic example of a TRPS measurement and an example 'blockade event' achieved as a particle traverses the pore. Firstly, we have
demonstrated that TRPS is a high throughput technique that can distinguish between samples of a similar size but of a considerably different
charge. Its ability to complete both size and charge analysis simultaneously in a single measurement can be seen in Figure 2. Figure 2 is an
example of a) size and b) zeta potential analysis of streptavidin coated particles with no modifications (light pink data set) and streptavidin coated
particles saturated with single-stranded DNA on the surface (blue data set). Although both samples were of a similar size, the zeta potential was
significantly different and much larger when DNA was functionalized onto the particle's surface.
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Figure 2. Size and Zeta potential analysis of DNA-modified and unmodified streptavidin coated nanoparticles. The light pink bars
represent unmodified streptavidin coated particles and the blue bars represent DNA-modified particles. A) Frequency (%) vs particle diameter
(nm). B) Frequency (%) vs zeta potential (mV). Figure adapted from supplementary data in Blundell et al.19. Please click here to view a larger
version of this figure.
Not only can the technique differentiate between particles unmodified and modified with DNA, TRPS can also differentiate between samples with
different concentrations of DNA hybridized to the particle surface. Figure 3 shows the size and zeta potential data exhibited for samples with the
lowest (10 nM, light green data set) and highest (210 nM, blue data set) concentrations of DNA hybridized to the streptavidin coated particles. A
larger zeta potential value is recorded for particles hybridized with a higher concentration of DNA.
 
Figure 3. Simultaneous size and zeta potential data captured from a single TRPS measurement. The blue bars/data points are
representative of streptavidin coated particles hybridized with 210 nM CP DNA and the light green bars/data points represent streptavidin coated
particles hybridized with 10 nM CP DNA. Figure adapted from Blundell et al.19. Please click here to view a larger version of this figure.
It is useful to note that each data point in the scatter plot represents a single particle amongst a sample population, allowing for in depth
particle-by-particle analysis with every sample. Figure 4 supports the technique's effectiveness in determining minor changes in DNA structure
(single-stranded and double-stranded DNA), as well as identifying differences in samples with target DNA of the same size, but bound to a
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different area of the capture probe demonstrating high levels of sensitivity (i.e., Middle binding and End binding targets shown in Figure 4). The
particles shown in Figure 4 are those with the following surface modifications, from left to right; capture probe (CP) DNA only, CP and a fully
complementary DNA target, CP and a middle binding DNA target, CP and an end binding DNA target, CP and an overhanging DNA target.
 
Figure 4. Relative change in zeta potential measured for DNA-modified particles with a range of DNA targets. Change in zeta potential,
mV, from i) CP functionalized particle to a range of DNA targets; ii) Fully complementary, iii) Middle binding, iv) End binding, v) Overhanging
target. The error bars represent standard deviation where n=3. Figure adapted from Blundell et al.19. Please click here to view a larger version of
this figure.
Discussion
The calculation for the zeta potential used a calibration based method related to work by Arjmandi et al.21. The duration of the translocation of
particles as they traverse a nanopore is measured as a function of applied voltage, using an average electric field and particle velocities over the
entirety of a regular conical pore.  The electrophoretic mobility is the derivative of 1/T (where T is the blockade duration) with respect to voltage,
multiplied by the square of the sensing zone length, l. Average velocities at multiple reference points through the sensing zone are measured to
allow for minimal errors in calculating zeta potential using this method.
The calibration of the pore is based on the linearity of 1/T vs voltage, V, at each reference point in the sensing zone. The electrokinetic
particle velocities of calibration and sample particles,  and  respectively, are related to their zeta potentials,  and
 , as shown in equation 1, assuming a linear relationship between the two as given in the Smoluchowski approximation12,20. The net
zeta potential values for both calibration and sample are the differences in particle zeta potential and the membrane zeta potential, . The zeta
potential of the polyurethane pore was measured using streaming potential techniques12,18 as -11 mV in PBS for this study.
 (1)
The zeta potential of each individual particle, i, , is measured from the respective zeta potentials calculated at various reference points
within the pore (equation 2), where  is the position of the particle within the pore after time, t=Tx, and  is the particle velocity of single
sample particle i at relative positions lx; , , P, and V are electrokinetic velocity per unit voltage, convective velocity per unit pressure,
applied pressure and voltage for the sample runs respectively, a full derivation of this equation can be found in work by Blundell et al.19.
 (2)
When binding the capture probe DNA to the streptavidin coated nanoparticles, it is vital that the researcher removes excess, unbound capture
probe DNA left in solution. This is done easily using the SPPs and a simple magnet allowing the rapid and easy replacement of the supernatant
with new PBST buffer. If excess capture DNA is left in solution and target DNA added, the target DNA may bind to the free capture DNA in
solution, rather than that on the SPP surface. A change in particle velocity and zeta potential will only be observed if the target DNA binds to the
capture probe present on the particle's surface.
Analysis and comparison of a large number of samples across many days using TRPS may require the use of more than one pore membrane.
Some pores can have some minor differences in their size due to the manufacturing process and in these cases, the user must ensure the
baseline current remains identical across all runs. If the same baseline current is observed, the results obtained are comparable between pores.
Once the baseline is the same as previous runs, it is imperative that the user keeps the stretch unchanged between calibration and sample runs
to allow for accurate determination of particle translocation velocities as they traverse the pore.
The TRPS technology has a relatively simple set up, which can be disassembled easily and quickly during an experiment. If troubleshooting
problems, this can make the process a lot easier. For example, it is important not to allow any bubbles in the lower fluid cell or upper fluid cell
when undertaking analysis. This will lead to an unstable baseline current. If bubbles are present in the upper fluid cell, the sample may be
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removed and replaced. If bubbles appear in the lower fluid cell, the buffer should be removed and replaced with fresh buffer. If the bubbles are
a persistent problem, then there may be too much surfactant in the solution so this may have to be reduced16 (we only use 0.05% Tween-20).
Some samples may block the pore if their size exceeds the pore size or if the concentration of the sample is too high. To rectify this, the pore
size can be increased by increasing the stretch or the sample can be diluted to a lower particle concentration16. For single particle analysis, the
sample may also block the pore if there are a lot of large aggregates present, it is important to vortex and sonicate the sample before running it
through TRPS.
Amongst other methods, TRPS has various advantages including the ability to complete size and charge measurements of individual particles
simultaneously; allowing for multimodal samples to be analyzed effectively using this method. One advantage is the signal/blockades produced
can be optimized in minutes for a particular sample by simply changing the stretch and voltage to obtain a blockade magnitude, Δ , significantly
larger than the background noise (blockades are of nA scale in comparison to the background noise <10 pA). Being able to alter the stretch
of the pore makes the method more versatile over solid-state pore techniques as the pore size can be adjusted with respect to the size of the
analyte in question; particularly useful when investigating effects such as aggregation and DNA-protein binding that may result in analyte sizes
exceeding the original solid-state pore size range. Another advantageous aspect of TRPS is the level of sensitivity from the technique. The ability
to detect subtle differences in DNA binding (where the same amount of DNA has been added (same amount of added charge) and the samples
are of the same size) based on the position of target DNA binding is quite profound in this area of analysis and will be of great use for future
nanoparticle-assay design platforms. Each subtle difference can be detected and isolated using a particle-by-particle nature of TRPS technology.
This analysis exceeds that of ensemble techniques such as dynamic light scattering or photon correlation spectroscopy that will merely gage an
average of the sample population analyzed and can't differentiate in the cases of multimodal samples6,7.
Small solid-state nanopores (100-200 nm) have also been used to monitor particle dynamics and have found that particle mobility can be
affected as the diameter of the particle begins to approach that of the nanopore22,23. Nanopores much larger than the particles being analyzed
(as used in this study) have less of an effect on the particle mobility and thus the translocation dynamics within the pore. The pores used in this
study are however limited to their analyte size ranges, an NP150 for example has a size range of 60-480 nm so if a multimodal sample consisted
of particles within and exceeding this limit, they cannot be analyzed on the same pore as the pore may then become blocked. It is also important
to note that measuring a bimodal sample containing 60 and 480 nm particles (those at the absolute lower and higher limits of the pore), for
example, will require different stretch and voltage conditions, although both are within the size analysis range of the pore. This is because the
stretch required for the larger particles will result in the smaller particles having a particularly small blockade magnitude (based on the reduced
resistance) that could be regarded as background noise and thus not necessarily measured during a sample run.
Bubbles can be a problem with the sample measurements as bubbles in the lower or upper fluid cell will create an unstable baseline current, to
which sample runs cannot be completed. Electrolytes of an effervescent nature (some highly concentrated biological media, for example) may be
difficult to run and thus samples requiring suspension in these specific mediums may prove problematic. Most samples however, can be vastly
diluted or suspended into alternative buffers prior to TRPS analysis.
The method is adaptable and can be used to analyze a range of nanoparticle-based analytes, including the analysis of proteins, DNA, small
molecules, aggregation assays17,24 and biologically relevant particles. The versatility of TRPS in characterizing a vast range of analytes shows
the techniques potential in a range of areas such as drug delivery1,25, biosensing26-28, and environmental testing.
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